Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
Clin Infect Dis
    April 2024

  1. Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
    Clin Infect Dis. 2024 Apr 15:ciae165. doi: 10.1093.
    >> Share

  2. RUBIS AB, Cole M, Tondella ML, Pawloski LC, et al
    Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.
    Clin Infect Dis. 2024 Apr 12:ciae207. doi: 10.1093.
    >> Share

  3. PETROS BA, Milliren CE, Sabeti PC, Ozonoff A, et al
    Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of Severe Acute Respiratory Syndrome Coronavirus 2 Can Be Attributed to Changes in Testing.
    Clin Infect Dis. 2024 Apr 11:ciae140. doi: 10.1093.
    >> Share

  4. SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
    COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
    Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
    >> Share

  5. ZAWADZKA S
    Family Ties and COVID Lies.
    Clin Infect Dis. 2024;78:813-814.
    >> Share

  6. MCAULEY JB
    COVID at the Whiteriver Indian Hospital.
    Clin Infect Dis. 2024;78:815-817.
    >> Share

    March 2024
  7. TERZIC V, Miantezila Basilua J, Billard N, de Gastines L, et al
    Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
    Clin Infect Dis. 2024 Mar 29:ciae170. doi: 10.1093.
    >> Share

  8. GOTTLIEB RL, Kalil AC
    True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group.
    Clin Infect Dis. 2024 Mar 29:ciae172. doi: 10.1093.
    >> Share

  9. FUNK A, Florin TA, Kuppermann N, Finkelstein Y, et al
    Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study.
    Clin Infect Dis. 2024 Mar 26:ciae069. doi: 10.1093.
    >> Share

  10. KOLBERG L, Khanijau A, van der Velden FJS, Herberg J, et al
    Raising AWaRe-ness of Antimicrobial Stewardship Challenges in Pediatric Emergency Care: Results from the PERFORM Study Assessing Consistency and Appropriateness of Antibiotic Prescribing Across Europe.
    Clin Infect Dis. 2024;78:526-534.
    >> Share

  11. GOHEEN MM
    Growing Up COVID.
    Clin Infect Dis. 2024;78:496-498.
    >> Share

  12. HAYDEN MK, El Mikati IK, Hanson KE, Englund JA, et al
    Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing.
    Clin Infect Dis. 2024 Mar 15:ciae121. doi: 10.1093.
    >> Share

  13. ROMINE JK, Li H, Coughlin MM, Jones JM, et al
    Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study.
    Clin Infect Dis. 2024 Mar 11:ciae130. doi: 10.1093.
    >> Share

  14. ROWAN CM, LaBere B, Young CC, Zambrano LD, et al
    Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care.
    Clin Infect Dis. 2024 Mar 11:ciae133. doi: 10.1093.
    >> Share

  15. SHRESTHA NK, Burke PC, Nowacki AS, Gordon SM, et al
    Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA Vaccine.
    Clin Infect Dis. 2024 Mar 11:ciae132. doi: 10.1093.
    >> Share

  16. WENZEL RP
    Reflections on COVID-19: Solitude and Isolation.
    Clin Infect Dis. 2024 Mar 7:ciae099. doi: 10.1093.
    >> Share

  17. HUYGENS S, GeurtsvanKessel C, Gharbharan A, Bogers S, et al
    Clinical and Virological Outcome of Monoclonal Antibody Therapies Across Severe Acute Respiratory Syndrome Coronavirus 2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2024 Mar 6:ciae026. doi: 10.1093.
    >> Share

  18. NIMGAONKAR I, Yoke LH, Roychoudhury P, Flaherty PW, et al
    Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Mar 1:ciae116. doi: 10.1093.
    >> Share

    February 2024
  19. SHAH MM, Joyce B, Plumb ID, Sahakian S, et al
    Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19.
    Clin Infect Dis. 2024 Feb 27:ciae105. doi: 10.1093.
    >> Share

  20. KARMARKAR EN, Fitzpatrick T, Himmelfarb ST, Chow EJ, et al
    Cluster of non-toxigenic Corynebacterium diphtheriae infective endocarditis and rising background C. diphtheriae cases-Seattle, Washington 2020-2023.
    Clin Infect Dis. 2024 Feb 21:ciae094. doi: 10.1093.
    >> Share

  21. TOWNLEY B, Akin D, Dimaguila GL, Sawires R, et al
    Exploring the infectious contribution to intussusception causality using the effects of COVID-19 lockdowns in Australia: An ecological study.
    Clin Infect Dis. 2024 Feb 20:ciae084. doi: 10.1093.
    >> Share

  22. AGGARWAL NR, Nordwall J, Braun DL, Chung L, et al
    Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
    Clin Infect Dis. 2024 Feb 20:ciad780. doi: 10.1093.
    >> Share

  23. TROSEID M
    Viral, Host Factors or Both as Coronavirus Disease 2019 (COVID-19) Biomarkers.
    Clin Infect Dis. 2024 Feb 20:ciad779. doi: 10.1093.
    >> Share

  24. FOLLMANN D, Mateja A, Fay MP, Magaret CA, et al
    Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
    Clin Infect Dis. 2024 Feb 19:ciae081. doi: 10.1093.
    >> Share

  25. MONTEJANO R, Arribas JR
    COVID-19 Clinical Trials: Are Adaptive Methodologies the Solution?
    Clin Infect Dis. 2024 Feb 17:ciae079. doi: 10.1093.
    >> Share

  26. GIACOMELLI A, Antinori S, Gori A, Cozzi-Lepri A, et al
    COVID-19: find the right questions to be answered.
    Clin Infect Dis. 2024 Feb 17:ciae078. doi: 10.1093.
    >> Share

  27. KOMOROWSKI AS, Lo CKL, Kapoor AK, Smieja M, et al
    More Than a Decade Since the Latest CONSORT Non-inferiority Trials Extension: Do Infectious Diseases Trials Do Enough?
    Clin Infect Dis. 2024;78:324-329.
    >> Share

  28. TOEPFER AP, Amarin JZ, Spieker AJ, Stewart LS, et al
    Seasonality, clinical characteristics, and outcomes of respiratory syncytial virus disease by subtype among children less than five years old, New Vaccine Surveillance Network, United States, 2016-2020.
    Clin Infect Dis. 2024 Feb 15:ciae085. doi: 10.1093.
    >> Share

  29. HOFMEYER KA, Ventura CL, Armstrong KL, Houchens CR, et al
    Project NexGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future.
    Clin Infect Dis. 2024 Feb 13:ciae073. doi: 10.1093.
    >> Share

  30. MCCONEGHY KW, Hur K, Dahabreh IJ, Jiang R, et al
    Early Mortality After the First Dose of Coronavirus Disease 2019 Vaccination: A Target Trial Emulation.
    Clin Infect Dis. 2024 Feb 6:ciad604. doi: 10.1093.
    >> Share

    January 2024
  31. RYBOLT L, Oehler RL, Khalil FK, Khalil B, et al
    A 22-Year-Old With a Left Apical Chest Mass.
    Clin Infect Dis. 2024;78:199-201.
    >> Share

  32. HSUEH K, Teherani A, Guzman-Cottrill JA
    The Leaders in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship, a Novel Training Program in Public Health for Infectious Diseases Physicians.
    Clin Infect Dis. 2024 Jan 24:ciad787. doi: 10.1093.
    >> Share

  33. KEEHNER J, Abeles SR, Longhurst CA, Horton LE, et al
    Integrated Genomic and Social Network Analyses of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in the Healthcare Setting.
    Clin Infect Dis. 2024 Jan 16:ciad738. doi: 10.1093.
    >> Share

  34. NACHMAN S, Aldrovandi G
    Breastfeeding in the United States Among Women With HIV: Con Viewpoint.
    Clin Infect Dis. 2024 Jan 8:ciad778. doi: 10.1093.
    >> Share

  35. HEDBERG P, Valik JK, Halim LA, Alfven T, et al
    Reducing Diagnostic Bias Through Multiplex Polymerase Chain Reaction (PCR) Testing for SARS-CoV-2, Influenza A/B, and RSV.
    Clin Infect Dis. 2024 Jan 4:ciad747. doi: 10.1093.
    >> Share

  36. HARBOE ZB, Holler JG, Eiberg MF, Roed C, et al
    Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant, Influenza, and Respiratory Syncytial Virus on the Dissecting Table: Is Further Dissection Required?
    Clin Infect Dis. 2024 Jan 4:ciad739. doi: 10.1093.
    >> Share

  37. LEVY ME, Burrows E, Chilunda V, Pawloski PA, et al
    SARS-CoV-2 Antiviral Prescribing Gaps Among Non-Hospitalized High-Risk Adults.
    Clin Infect Dis. 2024 Jan 3:ciad796. doi: 10.1093.
    >> Share

    December 2023
  38. LAFONT E, Blez D, Bildan MA, Veyer D, et al
    Nirmatrelvir and Ritonavir combination in COVID-19 patients with advanced chronic kidney disease.
    Clin Infect Dis. 2023 Dec 30:ciad785. doi: 10.1093.
    >> Share

  39. VAN DER VAART TW, Prins JM, Goorhuis A, Lemkes BA, et al
    The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low MRSA prevalence.
    Clin Infect Dis. 2023 Dec 29:ciad784. doi: 10.1093.
    >> Share

  40. ABEGAZ FA, Dos Santos PT, Mogeni OD, Guarnacci T, et al
    Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 201
    Clin Infect Dis. 2023;77.
    >> Share

  41. KWON SY, Gautam S, Poudel K, Banneheke H, et al
    Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Clin Infect Dis. 2023;77.
    >> Share

  42. MUSTAFA T, Niazi MRK, Lakdawala Z, Mirza S, et al
    Regional and National Trends in Consumption of Antimicrobials in Pakistan; Pre and Post-COVID (2019-2021).
    Clin Infect Dis. 2023;77.
    >> Share

  43. LESLIE T, Parry C, Ondoa P, Walsh T, et al
    The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience.
    Clin Infect Dis. 2023;77.
    >> Share

  44. HAYDEN MK, Hanson KE, Englund JA, Lee MJ, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID-19): Molecular Diagnostic Testing.
    Clin Infect Dis. 2023 Dec 19:ciad646. doi: 10.1093.
    >> Share

  45. SMITH TC
    Long COVID: Alice Evans, Brucellosis, and Reflections on Infectious Causes of Chronic Disease.
    Clin Infect Dis. 2023;77:1644-1647.
    >> Share

  46. SCIENCE M, Orkin J, Maguire B, Bitnun A, et al
    Viral dynamics of the SARS-CoV-2 Omicron Variant in Paediatric Patients; A prospective cohort study.
    Clin Infect Dis. 2023 Dec 12:ciad740. doi: 10.1093.
    >> Share

  47. RYBAK A, Assad Z, Levy C, Bonarcorsi S, et al
    Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis.
    Clin Infect Dis. 2023 Dec 6:ciad746. doi: 10.1093.
    >> Share

  48. MAKAM AN
    Unlinking time zero from test-negative controls exaggerates risk from COVID-19.
    Clin Infect Dis. 2023 Dec 6:ciad731. doi: 10.1093.
    >> Share

  49. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    COVID-19 Vaccination: Safeguarding Against Post-COVID Cardiovascular Complications.
    Clin Infect Dis. 2023 Dec 6:ciad732. doi: 10.1093.
    >> Share

  50. LIM JT, En WL, Tay AT, Pang D, et al
    Unlinking time zero from test-negative date does not influence risk estimates of long-term cardiovascular complications due to COVID-19.
    Clin Infect Dis. 2023 Dec 6:ciad742. doi: 10.1093.
    >> Share

  51. LAVOIE T, Appaneal HJ, LaPlante KL
    Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention.
    Clin Infect Dis. 2023;77.
    >> Share

  52. LEWIS NM, Zhu Y, Peltan ID, Gaglani M, et al
    Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
    Clin Infect Dis. 2023 Dec 5:ciad677. doi: 10.1093.
    >> Share

  53. HOFFMANN CJ, Shearer K, Kekana B, Kerrigan D, et al
    Reducing HIV-associated post-hospital mortality through home-based care in South Africa: a randomized controlled trial.
    Clin Infect Dis. 2023 Dec 5:ciad727. doi: 10.1093.
    >> Share

    November 2023
  54. JAIN V
    Infection Control and Prevention During the COVID-19 Pandemic.
    Clin Infect Dis. 2023 Nov 30:ciad611. doi: 10.1093.
    >> Share

  55. GRANEROD J, Huang Y, Davies NWS, Sequeira PC, et al
    Global Landscape of Encephalitis: Key Priorities to Reduce Future Disease Burden.
    Clin Infect Dis. 2023;77:1552-1560.
    >> Share

  56. USDAN L, Patel S, Rodriguez H, Xu X, et al
    A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in >/=12-Year-Olds.
    Clin Infect Dis. 2023 Nov 28:ciad718. doi: 10.1093.
    >> Share

  57. LEE N, Nguyen L, Austin PC, Brown KA, et al
    Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults.
    Clin Infect Dis. 2023 Nov 24:ciad716. doi: 10.1093.
    >> Share

  58. BOULWARE DR
    When Someone Should Do Something About This: How a Cryptococcal Clinical Trialist Became Involved With the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2023 Nov 16:ciad648. doi: 10.1093.
    >> Share

  59. HERBERT C, Manabe YC, Filippaios A, Lin H, et al
    Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results from a Longitudinal Cohort Study.
    Clin Infect Dis. 2023 Nov 16:ciad701. doi: 10.1093.
    >> Share

  60. SMITH-JEFFCOAT SE, Biddle JE, Talbot HK, Morrisey KG, et al
    Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals.
    Clin Infect Dis. 2023 Nov 14:ciad696. doi: 10.1093.
    >> Share

  61. KANJILAL S
    Flying Into the Future With Large Language Models.
    Clin Infect Dis. 2023 Nov 14:ciad635. doi: 10.1093.
    >> Share

  62. SPINELLI MA, Christopoulos KA, Moreira CV, Jain JP, et al
    Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2023 Nov 14:ciad657. doi: 10.1093.
    >> Share

  63. MEYEROWITZ EA, Li Y
    Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses.
    Clin Infect Dis. 2023 Nov 9:ciad685. doi: 10.1093.
    >> Share

  64. SAAG MS
    Coronavirus Disease (COVID) and the Fog of War.
    Clin Infect Dis. 2023 Nov 8:ciad649. doi: 10.1093.
    >> Share

  65. TIPPETT A, Ess G, Hussaini L, Reese O, et al
    Influenza Vaccine Effectiveness Pre-pandemic among Adults Hospitalized with Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and Older Adults.
    Clin Infect Dis. 2023 Nov 8:ciad679. doi: 10.1093.
    >> Share

  66. KUPPALLI K
    Hostility Unmasked: Scientists on the Frontlines of the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Clin Infect Dis. 2023 Nov 6:ciad623. doi: 10.1093.
    >> Share

  67. HUMPHRIES R, Sefers S, Schmitz J, Seegmiller A, et al
    Clinical Laboratory Experiences During the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2023 Nov 2:ciad622. doi: 10.1093.
    >> Share

  68. ASLAM S
    Phage Therapy in Lung Transplantation: Current Status and Future Possibilities.
    Clin Infect Dis. 2023;77.
    >> Share

    October 2023
  69. KUUT TA, Muller F, Csorba I, Braamse AMJ, et al
    Letter to the editor: Positive effects of cognitive-behavioral therapy targeting severe fatigue following COVID-19 are sustained up to one year after treatment.
    Clin Infect Dis. 2023 Oct 27:ciad661. doi: 10.1093.
    >> Share

  70. HEDBERG P, Karlsson Valik J, Abdel Halim L, Alfven T, et al
    Outcomes of SARS-CoV-2 Omicron Variant Infections Compared with Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicentre Cohort Study.
    Clin Infect Dis. 2023 Oct 26:ciad660. doi: 10.1093.
    >> Share

  71. MONTEJANO R, Soler-Carracedo A, Borobia AM, Martin-Quiros A, et al
    The Current Mismatch between COVID-19 Clinical Trial Design and The Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis.
    Clin Infect Dis. 2023 Oct 26:ciad655. doi: 10.1093.
    >> Share

  72. HAMAD Y, Bell TD, Kadri SS
    Shifting Tides: Is It Time to Embrace Adjunctive Corticosteroids for Community-Acquired Pneumonia?
    Clin Infect Dis. 2023 Oct 25:ciad498. doi: 10.1093.
    >> Share

  73. APPEL KS, Geisler R, Maier D, Miljukov O, et al
    A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of COVID-19 Prognostic Scores.
    Clin Infect Dis. 2023 Oct 25:ciad618. doi: 10.1093.
    >> Share

  74. RHEE C, Strich JR, Chiotos K, Classen DC, et al
    Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.
    Clin Infect Dis. 2023 Oct 13:ciad447. doi: 10.1093.
    >> Share

  75. GREEN SI, Clark JR, Santos HH, Weesner KE, et al
    A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.
    Clin Infect Dis. 2023;77:1079-1091.
    >> Share

  76. CARAZO S, Guay CA, Skowronski DM, Amini R, et al
    Influenza hospitalization burden by subtype, age, comorbidity and vaccination status: 2012/13 to 2018/19 seasons, Quebec, Canada.
    Clin Infect Dis. 2023 Oct 11:ciad627. doi: 10.1093.
    >> Share

  77. ISLAM J, Hu W
    Heatwaves and Dengue Outbreak in Bangladesh after COVID-19 Pandemic- An Urgent Call for Climate-Driven Early Warning Systems.
    Clin Infect Dis. 2023 Oct 10:ciad625. doi: 10.1093.
    >> Share

  78. STIER EA, Jain M, Joshi H, Darragh TM, et al
    Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (anal precancer) among Women with HIV.
    Clin Infect Dis. 2023 Oct 8:ciad614. doi: 10.1093.
    >> Share

  79. SCHUSTER JE, Hamdan L, Dulek DE, Kitko CL, et al
    The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial.
    Clin Infect Dis. 2023 Oct 6:ciad534. doi: 10.1093.
    >> Share

  80. CONLY JM, Loeb M
    SARS-CoV-2 Exposures in a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccintion Era: A Randomized Trial is Possible During the Pandemic.
    Clin Infect Dis. 2023 Oct 5:ciad609. doi: 10.1093.
    >> Share

  81. LUONG NGUYEN LB, Goupil de Bouille J, Menant L, Noret M, et al
    A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study).
    Clin Infect Dis. 2023 Oct 5:ciad603. doi: 10.1093.
    >> Share

  82. BIERE-RAFI S, Janssen K, Jurgens E, Kooij S, et al
    Is Cognitive Behavioural Therapy Effective for Post-COVID Fatigue?
    Clin Infect Dis. 2023;77:1074-1075.
    >> Share

  83. MCCREARY EK
    Our "Side Hustle".
    Clin Infect Dis. 2023 Oct 4:ciad543. doi: 10.1093.
    >> Share

  84. GOFF DA
    Isolated and Lonely in a Nursing Home During the COVID 19 Pandemic: A Deadly Combination for My Mom.
    Clin Infect Dis. 2023 Oct 4:ciad591. doi: 10.1093.
    >> Share

  85. REGAN NN
    Just Breathe: My First 12 Hours as a Clinician Patient With COVID-19.
    Clin Infect Dis. 2023 Oct 4:ciad573. doi: 10.1093.
    >> Share

  86. MARCELIN GE, Marcelin NL, Marcelin JR, Marcelin A, et al
    Our parents were never home: seeing the pandemic through children's eyes.
    Clin Infect Dis. 2023 Oct 4:ciad564. doi: 10.1093.
    >> Share

    September 2023
  87. FREDIANI JK, Parsons R, McLendon KB, Westbrook AL, et al
    The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs.
    Clin Infect Dis. 2023 Sep 28:ciad582. doi: 10.1093.
    >> Share

  88. GUPTA A, Hughes MD, Cruz JL, Avihingsanon A, et al
    Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester.
    Clin Infect Dis. 2023 Sep 28:ciad583. doi: 10.1093.
    >> Share

  89. LOPEZ BERNAL J, Andrews N, Gower C, Stowe J, et al
    Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From Coronavirus Disease 2019 in Adults Aged >/=70 Years.
    Clin Infect Dis. 2023 Sep 27:ciab881. doi: 10.1093.
    >> Share

  90. LIM JT, En WL, Tay AT, Pang D, et al
    Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in Coronavirus Disease 2019 Survivors: A Retrospective Cohort Study.
    Clin Infect Dis. 2023 Sep 25:ciad469. doi: 10.1093.
    >> Share

  91. ANDERSSON NW, Thiesson EM, Lassauniere R, Hansen JV, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Postacute Risk of Non-Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged >/=50 Years.
    Clin Infect Dis. 2023 Sep 22:ciad531. doi: 10.1093.
    >> Share

  92. WALKER J, McCarty T, McGwin G, Ordaya EE, et al
    Description of Cryptococcosis following SARS-CoV-2 infection: A disease survey through the Mycosis Study Group Education and Research Consortium (MSG-19).
    Clin Infect Dis. 2023 Sep 15:ciad551. doi: 10.1093.
    >> Share

  93. FEYS S, Lagrou K, Lauwers HM, Haenen K, et al
    High burden of COVID-19-associated pulmonary aspergillosis (CAPA) in severely immunocompromised patients requiring mechanical ventilation.
    Clin Infect Dis. 2023 Sep 11:ciad546. doi: 10.1093.
    >> Share

  94. DZIECIOLOWSKA S, Charest H, Roy T, Fafard J, et al
    Timing and Predictors of Loss of Infectivity among Healthcare Workers with Mild Primary and Recurrent COVID-19: a Prospective Observational Cohort Study.
    Clin Infect Dis. 2023 Sep 7:ciad535. doi: 10.1093.
    >> Share

    August 2023
  95. WONG CKH, Lau KTK, Au ICH, Lau EHY, et al
    Comparison of bivalent and monovalent mRNA vaccine boosters.
    Clin Infect Dis. 2023 Aug 30:ciad519. doi: 10.1093.
    >> Share

  96. LAM T, Saso A, Ortiz AT, Hatcher J, et al
    The Socio-Economic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort Study.
    Clin Infect Dis. 2023 Aug 30:ciad522. doi: 10.1093.
    >> Share

  97. GRIGGS EP, Mitchell PK, Lazariu V, Gaglani M, et al
    Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 States, June 2021-March 2023.
    Clin Infect Dis. 2023 Aug 26:ciad505. doi: 10.1093.
    >> Share

  98. BRUMMER LE, Thompson RR, Malhotra A, Shrestha S, et al
    Cost effectiveness of low-complexity screening tests in community-based case-finding for tuberculosis.
    Clin Infect Dis. 2023 Aug 25:ciad501. doi: 10.1093.
    >> Share

  99. GENTRY CA, Nguyen PN, Thind SK, Kurdgelashvili G, et al
    Characteristics and outcomes of US Veterans with immunocompromised conditions at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents.
    Clin Infect Dis. 2023 Aug 24:ciad504. doi: 10.1093.
    >> Share

  100. KINAMON T, Gopinath R, Waack U, Needles M, et al
    Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs.
    Clin Infect Dis. 2023;77:649-656.
    >> Share

  101. ZUCKERMAN NS, Bucris E, Keidar-Friedman D, Amsalem M, et al
    Nirmatrelvir resistance - de novo E166V/L50V mutations in an immunocompromised patient treated with prolonged nirmatrelvir/ritonavir monotherapy leading to clinical and virological treatment failure - a case report.
    Clin Infect Dis. 2023 Aug 19:ciad494. doi: 10.1093.
    >> Share

  102. TATE JE, Mwenda JM, Keita AM, Tapsoba TW, et al
    Evaluation of Intussusception Following Pentavalent Rotavirus Vaccine (RotaTeq) Administration in Five Countries in Africa.
    Clin Infect Dis. 2023 Aug 19:ciad492. doi: 10.1093.
    >> Share

  103. SOTO CL, Hsu AJ, Lee JH, Dzintars K, et al
    Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
    Clin Infect Dis. 2023 Aug 16:ciad476. doi: 10.1093.
    >> Share

  104. LIANG TJ, Law JLM, Pietschmann T, Ray SC, et al
    Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model.
    Clin Infect Dis. 2023;77.
    >> Share

  105. CYBULSKI DJ, Matthews Z, Kieffer JW, Casey TM, et al
    Impact of SARS-CoV-2 Arrival Surveillance Screening by Nucleic Acid Amplification Versus Rapid Antigen Detection on Subsequent COVID-19 Infections in Military Trainees.
    Clin Infect Dis. 2023 Aug 10:ciad466. doi: 10.1093.
    >> Share

  106. MOZAFFARI E, Chandak A, Gottlieb RL, Chima-Melton C, et al
    Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice.
    Clin Infect Dis. 2023 Aug 9:ciad460. doi: 10.1093.
    >> Share

  107. UNO S, Goto R, Honda K, Uchida S, et al
    The cost-effectiveness of universal asymptomatic preoperative SARS-CoV-2 PCR screening: a cost-utility analysis.
    Clin Infect Dis. 2023 Aug 9:ciad463. doi: 10.1093.
    >> Share

  108. O'LEARY EN, Neuhauser MM, Srinivasan A, Dubendris H, et al
    Impact of the COVID-19 Pandemic on Inpatient Antibiotic Use in the United States, January 2019 through July 2022.
    Clin Infect Dis. 2023 Aug 3:ciad453. doi: 10.1093.
    >> Share

  109. EHRENZELLER S, Chen T, Vaidya V, Rhee C, et al
    Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis from 2015-2023.
    Clin Infect Dis. 2023 Aug 2:ciad451. doi: 10.1093.
    >> Share

  110. CHAN GCK, Lui GCY, Wong CNS, Yip SST, et al
    Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Aug 2:ciad371. doi: 10.1093.
    >> Share

    July 2023
  111. POZZI C, Sarti R, Levi R, Mollura M, et al
    Association between duration of SARS-CoV-2 positivity and long COVID.
    Clin Infect Dis. 2023 Jul 22:ciad434. doi: 10.1093.
    >> Share

  112. SAYAMA Y, Okamoto M, Saito M, Tamaki R, et al
    Lack of zoonotic coronavirus species detected among children hospitalized with pneumonia in the Philippines.
    Clin Infect Dis. 2023 Jul 20:ciad430. doi: 10.1093.
    >> Share

  113. BRUST K, Kobayashi T, Diekema DJ
    Asymptomatic testing of hospital admissions for SARS-CoV-2: Is it OK to stop?
    Clin Infect Dis. 2023 Jul 18:ciad423. doi: 10.1093.
    >> Share

  114. RHEE C, Klompas M, Pak TR, Kohler JR, et al
    In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission.
    Clin Infect Dis. 2023 Jul 18:ciad424. doi: 10.1093.
    >> Share

  115. NARAYANASAMY S, Curtis LH, Hernandez AF, Woods CW, et al
    Lessons from COVID-19 for Pandemic Preparedness: Proceedings from a Multi-Stakeholder Think Tank.
    Clin Infect Dis. 2023 Jul 12:ciad418. doi: 10.1093.
    >> Share

  116. ALLAN-BLITZ LT, Klausner JD
    SARS-CoV-2 Case-Definitions Must Include Clinical Criteria: Reply to Kojima et al.
    Clin Infect Dis. 2023 Jul 7:ciad413. doi: 10.1093.
    >> Share

  117. ALLEL K, Peters A, Conejeros J, Martinez JRW, et al
    Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis.
    Clin Infect Dis. 2023;77.
    >> Share

  118. SOLANKY D, McGovern OL, Edwards JR, Mahon G, et al
    Prescribing of Outpatient Antibiotics Commonly Used for Respiratory Infections Among Adults Before and During the Coronavirus Disease 2019 Pandemic in Brazil.
    Clin Infect Dis. 2023;77.
    >> Share

  119. RAMAY BM, Castillo C, Grajeda L, Santos LF, et al
    Colonization With Antibiotic-Resistant Bacteria in a Hospital and Associated Communities in Guatemala: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    >> Share

  120. BEZERRA CLPAM, Dos Santos EL, Oliveira MS, Dias MBS, et al
    Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort.
    Clin Infect Dis. 2023;77.
    >> Share

  121. ARAOS R, Smith RM, Styczynski A, Sanchez F, et al
    High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    >> Share

  122. PATEL TS, McGovern OL, Mahon G, Osuka H, et al
    Trends in Inpatient Antibiotic Use Among Adults Hospitalized During the Coronavirus Disease 2019 Pandemic in Argentina, Brazil, and Chile, 2018-2021.
    Clin Infect Dis. 2023;77.
    >> Share

  123. KIFFER CRV, Rezende TFT, Costa-Nobre DT, Marinonio ASS, et al
    A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence.
    Clin Infect Dis. 2023;77.
    >> Share

  124. FOCOSI D, Franchini M, Nicastri E, Sullivan DJ, et al
    Convalescent Plasma Versus Hyperimmune Immunoglobulins.
    Clin Infect Dis. 2023 Jul 3:ciad406. doi: 10.1093.
    >> Share

  125. BAERENDS EAM, Reekie J, Andreasen SR, Staerke NB, et al
    Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study.
    Clin Infect Dis. 2023 Jul 1:ciad402. doi: 10.1093.
    >> Share

    June 2023
  126. CRAWFORD JS
    Correspondence in relation to the recently published paper: Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial by Kuut and colleagues.
    Clin Infect Dis. 2023 Jun 30:ciad397. doi: 10.1093.
    >> Share

  127. EVANS ME, Simbartl LA, McCauley BP, Flarida LK, et al
    Active Surveillance and Contact Precautions for Preventing Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections during the COVID-19 Pandemic.
    Clin Infect Dis. 2023 Jun 30:ciad388. doi: 10.1093.
    >> Share

  128. FAUST JS, Kumar A, Shah J, Khadke S, et al
    Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years.
    Clin Infect Dis. 2023 Jun 30:ciad400. doi: 10.1093.
    >> Share

  129. MELGAR M, Abrams JY, Godfred-Cato S, Shah AB, et al
    A multicenter retrospective cohort study to characterize patients hospitalized with MIS-A and COVID-19 in the United States, 2020-2021.
    Clin Infect Dis. 2023 Jun 29:ciad374. doi: 10.1093.
    >> Share

  130. AMBROGGIO L, Cotter J, Hall M, Shapiro DJ, et al
    Management of Pediatric Pneumonia: A Decade After the PIDS/IDSA Guideline.
    Clin Infect Dis. 2023 Jun 23:ciad385. doi: 10.1093.
    >> Share

  131. TROTTIER C, La J, Li LL, Alsoubani M, et al
    Maintaining the Utility of COVID-19 Pandemic Severity Surveillance: Evaluation of Trends in Attributable Deaths and Development and Validation of a Measurement Tool.
    Clin Infect Dis. 2023 Jun 22:ciad381. doi: 10.1093.
    >> Share

  132. UPASANI V, Townsend K, Wu MY, Carr EJ, et al
    Commercial immunoglobulin products contain neutralising antibodies against SARS-CoV-2 spike protein.
    Clin Infect Dis. 2023 Jun 20:ciad368. doi: 10.1093.
    >> Share

  133. SENEFELD JW, Joyner MJ
    SARS-CoV-2 Antibody Replacement Therapy for Immunocompromised Patients.
    Clin Infect Dis. 2023 Jun 20:ciad367. doi: 10.1093.
    >> Share

  134. NAFICY A, Kuxhausen A, Pirrotta P, Leav B, et al
    No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial.
    Clin Infect Dis. 2023 Jun 19:ciad361. doi: 10.1093.
    >> Share

  135. GUAN Y, Puenpatom A, Johnson MG, Zhang Y, et al
    Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial.
    Clin Infect Dis. 2023 Jun 19:ciad409. doi: 10.1093.
    >> Share

  136. MONTASTRUC F, de Canecaude C
    Tixagevimab-Cilgavimab Treatment and Cardiovascular Events: Immortal Time Bias.
    Clin Infect Dis. 2023;76:2044-2045.
    >> Share

  137. ISRAEL A, Berkovitch M, Merzon E, Golan-Cohen A, et al
    Glucose-6-phosphate dehydrogenase (G6PD) Deficiency and COVID-19.
    Clin Infect Dis. 2023 Jun 7:ciad348. doi: 10.1093.
    >> Share

  138. WEE LE, Pang D, Chiew C, Tan J, et al
    Long-term real-world protection afforded by third mRNA doses against symptomatic SARS-COV-2 infections, COVID-19-related emergency attendances and hospitalizations amongst older Singaporeans during an Omicron XBB wave.
    Clin Infect Dis. 2023 Jun 6:ciad345. doi: 10.1093.
    >> Share

  139. JILG N, Chew KW, Giganti MJ, Daar ES, et al
    One Week of Oral Camostat Versus Placebo in Non-Hospitalized Adults with Mild-to-Moderate COVID-19: A Randomized Controlled Phase 2 Trial.
    Clin Infect Dis. 2023 Jun 5:ciad342. doi: 10.1093.
    >> Share

    May 2023
  140. LUNDGREN J
    Patients Hospitalized With Coronavirus Disease 2019: A Diverse Population.
    Clin Infect Dis. 2023 May 31:ciad280. doi: 10.1093.
    >> Share

  141. KOJIMA N, Adams K, Self WH, Gaglani M, et al
    Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
    Clin Infect Dis. 2023 May 31:ciad276. doi: 10.1093.
    >> Share


  142. Correction to: Relative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Period-Un
    Clin Infect Dis. 2023 May 30:ciad256. doi: 10.1093.
    >> Share

  143. ASTURIAS EJ, Excler JL, Ackland J, Cavaleri M, et al
    Safety of Streptococcus pyogenes vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post Marketing Monitoring.
    Clin Infect Dis. 2023 May 26:ciad311. doi: 10.1093.
    >> Share

  144. DEL AMO J
    Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019.
    Clin Infect Dis. 2023;76:1735-1737.
    >> Share

  145. TEJERINA F, Palomino R, Catalan P, Sanz A, et al
    Longitudinal Whole-Genome Sequence Characterization of a Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.5 Infection in an Immunocompromised Patient Successfully Treated With Sotrovimab 1000 mg.
    Clin Infect Dis. 2023;76:1872-1874.
    >> Share

  146. BLENNOW O, Vesterbacka J, Tovatt T, Nowak P, et al
    Successful Combination Treatment for Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Clin Infect Dis. 2023;76:1864-1865.
    >> Share

  147. MAOR Y, Shinar E, Izak M, Rahav G, et al
    A Randomized Controlled Study Assessing Convalescent Immunoglobulins versus Convalescent Plasma for Hospitalized COVID-19 Patients.
    Clin Infect Dis. 2023 May 23:ciad305. doi: 10.1093.
    >> Share

  148. GOWTHAMAN P, Vasoo S
    Zinc for the treatment of COVID-19: Yet to prove its mettle?
    Clin Infect Dis. 2023 May 22:ciad303. doi: 10.1093.
    >> Share

  149. YADAW AS, Sahner DK, Sidky H, Afzali B, et al
    Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C).
    Clin Infect Dis. 2023 May 19:ciad294. doi: 10.1093.
    >> Share


  150. Correction to: Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults.
    Clin Infect Dis. 2023 May 18:ciad191. doi: 10.1093.
    >> Share

  151. ZENG G, Zhou Y
    Association of virus variation and vaccination status with post-acute sequelae after SARS-cov-2 infection.
    Clin Infect Dis. 2023 May 10:ciad292. doi: 10.1093.
    >> Share

  152. GUDIPATI S, Shallal A, Peterson E, Cook B, et al
    Increase in False Positive Fourth Generation HIV Tests in Patients with COVID-19 Disease.
    Clin Infect Dis. 2023 May 9:ciad264. doi: 10.1093.
    >> Share

  153. WAALEWIJN H, Szubert AJ, Wasmann RE, Wiesner L, et al
    First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
    Clin Infect Dis. 2023 May 9:ciad267. doi: 10.1093.
    >> Share

  154. KUUT TA, Muller F, Csorba I, Braamse A, et al
    Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial.
    Clin Infect Dis. 2023 May 8:ciad257. doi: 10.1093.
    >> Share

  155. KABORE JL, Laffont B, Diop M, Tardif MR, et al
    Real-World Effectiveness of Nirmatrelvir/Ritonavir on Covid-19-Associated Hospitalization Prevention: A Population-Based Cohort Study in the Province of Quebec, Canada.
    Clin Infect Dis. 2023 May 7:ciad287. doi: 10.1093.
    >> Share

  156. KO JY, Pham H, Anglin O, Chai SJ, et al
    Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020-August 2022.
    Clin Infect Dis. 2023 May 3:ciad266. doi: 10.1093.
    >> Share

  157. TIMIRE C, Pedrazzoli D, Boccia D, Houben RM, et al
    Use of a sustainable livelihood framework-based measure to estimate socioeconomic impact of tuberculosis on house-holds.
    Clin Infect Dis. 2023 May 3:ciad273. doi: 10.1093.
    >> Share

  158. HASSANZADEH H, Baber J, Begier E, Noriega DC, et al
    Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STRIVE Randomized Clinical Trial.
    Clin Infect Dis. 2023 May 1:ciad218. doi: 10.1093.
    >> Share

    April 2023
  159. ADALJA A, McQuillen DP, Meyer D
    How Infectious Disease Experts Impacted the Coronavirus Disease 2019 (COVID-19) Response: Lessons From the Front Lines.
    Clin Infect Dis. 2023 Apr 27:ciad137. doi: 10.1093.
    >> Share

  160. GVINJILIA L, Baliashvili D, Shadaker S, Averhoff F, et al
    Impact of HCV infection and treatment on mortality in the country of Georgia, 2015-2020.
    Clin Infect Dis. 2023 Apr 26:ciad182. doi: 10.1093.
    >> Share

  161. GLEESON SE, Zapata H, Bathgate ME, Emu B, et al
    Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.
    Clin Infect Dis. 2023 Apr 20:ciad236. doi: 10.1093.
    >> Share

  162. HAIDAR G, Jacobs JL, Hughes Kramer K, Naqvi A, et al
    Therapy with Allogeneic SARS-CoV-2-specific T-cells for Persistent COVID-19 in Immunocompromised Patients.
    Clin Infect Dis. 2023 Apr 20:ciad233. doi: 10.1093.
    >> Share

  163. KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
    Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022.
    Clin Infect Dis. 2023 Apr 19:ciad210. doi: 10.1093.
    >> Share

  164. ERTEM Z, Nelson RE, Schechter-Perkins EM, Al-Amery A, et al
    Condition-Dependent and Dynamic Impacts of Indoor Masking Policies for COVID-19 Mitigation: A Nationwide, Interrupted Time-Series Analysis.
    Clin Infect Dis. 2023 Apr 19:ciad115. doi: 10.1093.
    >> Share

  165. JOFFE AR, Elliott A, Eapen R, Milburn C, et al
    Is vaccination acting as a placebo in preventing symptoms of Long-COVID?
    Clin Infect Dis. 2023 Apr 19:ciad234. doi: 10.1093.
    >> Share

  166. SWINDELLS S, Eschenauer GA, Nason M, Daar ES, et al
    Letter to the Editor.
    Clin Infect Dis. 2023 Apr 19:ciad229. doi: 10.1093.
    >> Share

  167. SABET N, Omar T, Milovanovic M, Magajane T, et al
    Undiagnosed pulmonary TB and COVID in adults dying at home in a high TB burden setting, before and during pandemic COVID-19: an autopsy study.
    Clin Infect Dis. 2023 Apr 12:ciad212. doi: 10.1093.
    >> Share

  168. OSTROSKY-ZEICHNER L
    COVID-19: Shehecheyanu.
    Clin Infect Dis. 2023 Apr 11:ciad213. doi: 10.1093.
    >> Share

  169. BRANCHE AR, Rouphael NG, Losada C, Baden LR, et al
    Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
    Clin Infect Dis. 2023 Apr 10:ciad209. doi: 10.1093.
    >> Share

  170. SCHWARTZ IS, Bahr NC
    Out of Bounds: A Critical Appraisal of the Changing Geography of the Endemic Mycoses.
    Clin Infect Dis. 2023;76:1302-1303.
    >> Share

    March 2023
  171. WERBEL WA, Weld ED, Advani SD, Patel PK, et al
    Your outpatient has COVID-19: what are their treatment options in the current SARS-CoV-2 variant climate?
    Clin Infect Dis. 2023 Mar 31:ciad178. doi: 10.1093.
    >> Share

  172. MACFADDEN DR, Maxwell C, Bowdish D, Bronskill S, et al
    COVID-19 Vaccination is Associated with Reduced Outpatient Antibiotic Prescribing In Older Adults with Confirmed SARS-CoV-2: A Population Wide Cohort Study.
    Clin Infect Dis. 2023 Mar 31:ciad190. doi: 10.1093.
    >> Share

  173. LEVITT JE, Hedlin H, Duong S, Lu D, et al
    Evaluation of acebilustat, a selective inhibitor of leukotriene B4 biosynthesis, for treatment of outpatients with mild-moderate COVID-19 disease: A randomized, double-blind, placebo- controlled Phase 2 trial.
    Clin Infect Dis. 2023 Mar 30:ciad187. doi: 10.1093.
    >> Share

  174. BLOCH EM, Goel R, Zhu X, Patel EU, et al
    COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample.
    Clin Infect Dis. 2023 Mar 29:ciad185. doi: 10.1093.
    >> Share

  175. MIKULSKA M, Sepulcri C, Dentone C, Magne F, et al
    Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients.
    Clin Infect Dis. 2023 Mar 28:ciad181. doi: 10.1093.
    >> Share

  176. FERREIRA VH, Ierullo M, Mavandadnejad F, Kurtesi A, et al
    Omicron BA.4/5 neutralization and T-cell responses in organ transplant recipients after Booster mRNA vaccine: a Multicenter Cohort Study.
    Clin Infect Dis. 2023 Mar 28:ciad175. doi: 10.1093.
    >> Share

  177. PEREZ MOLINA JA, Crespillo-Andujar C, Zamora J, Fernandez-Felix BM, et al
    Contribution of low CD4 cell counts and high HIV viral load to the efficacy of preferred first-line antiretroviral regimens for treating HIV infection: A systematic review and meta-analysis.
    Clin Infect Dis. 2023 Mar 28:ciad177. doi: 10.1093.
    >> Share

  178. VAN EFFELTERRE T, Hens N, White LJ, Gravenstein S, et al
    Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with a Dynamic Transmission Model.
    Clin Infect Dis. 2023 Mar 23:ciad161. doi: 10.1093.
    >> Share

  179. OELTMANN JE, Vohra D, Matulewicz HH, DeLuca N, et al
    Isolation and quarantine for COVID-19 in the United States, 2020-2022.
    Clin Infect Dis. 2023 Mar 22:ciad163. doi: 10.1093.
    >> Share

  180. OSBORN R, Alamri M, Tomic R, Ison MG, et al
    Infectious Complications of Lung Transplant for COVID-Associated Lung Injury (CALI): A Single Center Case-Control Cohort Study.
    Clin Infect Dis. 2023 Mar 21:ciad160. doi: 10.1093.
    >> Share

  181. WANG P, Xing H, Zhang X, Yang J, et al
    Complexity Interactions between Nirmatrelvir/Ritonavir and Voriconazole in Patients with Coronavirus Disease 2019.
    Clin Infect Dis. 2023 Mar 21:ciad159. doi: 10.1093.
    >> Share

  182. CHUNG H, Campitelli MA, Buchan SA, Campigotto A, et al
    Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults.
    Clin Infect Dis. 2023 Mar 21:ciad148. doi: 10.1093.
    >> Share

  183. MORI N, Hirai J, Asai N, Mikamo H, et al
    Appropriate outcome settings for the effectiveness of oral zinc treatment for Coronavirus Disease-2019.
    Clin Infect Dis. 2023 Mar 17:ciad153. doi: 10.1093.
    >> Share


  184. Correction to: Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
    Clin Infect Dis. 2023 Mar 15:ciac607. doi: 10.1093.
    >> Share

  185. LEWER D, Brothers TD, Croxford S, Desai M, et al
    Opioid injection-associated bacterial infections in England, 2002-2021: a time series analysis of seasonal variation and the impact of COVID-19.
    Clin Infect Dis. 2023 Mar 14:ciad144. doi: 10.1093.
    >> Share

  186. KAHLERT CR, Strahm C, Gusewell S, Cusini A, et al
    Post-acute sequelae after SARS-CoV-2 infection by viral variant and vaccination status: a multicenter cross-sectional study.
    Clin Infect Dis. 2023 Mar 11:ciad143. doi: 10.1093.
    >> Share

  187. NIRENBERG E, Perencevich EN
    Understanding and Improving Vaccine Effectiveness Estimates in the Age of Widespread Background Immunity: A Step Towards Improved Science Communication.
    Clin Infect Dis. 2023 Mar 8:ciad124. doi: 10.1093.
    >> Share

  188. RON R, Moreno E, Martinez-Sanz J, Branas F, et al
    CD4/CD8 ratio during HIV treatment: time for routine monitoring?
    Clin Infect Dis. 2023 Mar 8:ciad136. doi: 10.1093.
    >> Share

  189. PATEL R, Tsalik EL, Evans S, Fowler VG, et al
    Clinically Adjudicated Reference Standards for Evaluation of Infectious Diseases Diagnostics.
    Clin Infect Dis. 2023;76:938-943.
    >> Share

  190. MARCELIN JR, Khazanchi R, Lyden E, Cawcutt KA, et al
    Demographic Representation Among Speakers and Program Committee Members at the IDWeek Conference, 2013-2021.
    Clin Infect Dis. 2023;76:897-904.
    >> Share

  191. LEA AN, Leyden WA, Sofrygin O, Marafino BJ, et al
    Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
    Clin Infect Dis. 2023 Mar 2:ciad084. doi: 10.1093.
    >> Share

  192. DEL AMO J
    Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Mar 2:ciad086. doi: 10.1093.
    >> Share


  193. Correction to: Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients.
    Clin Infect Dis. 2023 Mar 1:ciac702. doi: 10.1093.
    >> Share


  194. Correction to: Effectiveness of Messenger RNA-based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.
    Clin Infect Dis. 2023 Mar 1:ciac810. doi: 10.1093.
    >> Share

    February 2023
  195. PANDIT JA, Radin JM, Chiang D, Spencer EG, et al
    The COVID-19 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated with Nirmatrelvir Plus Ritonavir Versus Untreated Controls.
    Clin Infect Dis. 2023 Feb 22:ciad102. doi: 10.1093.
    >> Share

  196. SHOHAM S
    COVID-19 Convalescent Plasma Reaches the Slope of Enlightenment in the Gartner Hype Cycle.
    Clin Infect Dis. 2023 Feb 21:ciad092. doi: 10.1093.
    >> Share

  197. LEVINE AC, Fukuta Y, Huaman MA, Ou J, et al
    COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials.
    Clin Infect Dis. 2023 Feb 21:ciad088. doi: 10.1093.
    >> Share

  198. TEJERINA F, Palomino R, Catalan P, Sanz A, et al
    Longitudinal whole-genome sequence characterization of a persistent SARS-CoV-2 Omicron BA.5 infection in an immunocompromised patient successfully treated with sotrovimab 1000 mg.
    Clin Infect Dis. 2023 Feb 17:ciad090. doi: 10.1093.
    >> Share

  199. NALINTYA E, Sekar P, Kavuma P, Kigozi J, et al
    Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda.
    Clin Infect Dis. 2023 Feb 17:ciad087. doi: 10.1093.
    >> Share

  200. HEMILA H, Chalker E
    Zinc and COVID-19.
    Clin Infect Dis. 2023 Feb 14:ciad078. doi: 10.1093.
    >> Share

  201. BLENNOW O, Vesterbacka J, Tovatt T, Nowak P, et al
    Successful combination treatment for persistent SARS-CoV-2 infection.
    Clin Infect Dis. 2023 Feb 14:ciad085. doi: 10.1093.
    >> Share

  202. CABRAL SM, Harris AD, Cosgrove SE, Magder LS, et al
    Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries across 825 United States Hospitals, 2019-2020.
    Clin Infect Dis. 2023 Feb 12:ciad077. doi: 10.1093.
    >> Share

  203. FRUTOS AM, Kuan G, Lopez R, Ojeda S, et al
    Infection-induced immunity is associated with protection against SARS-CoV-2 infection and decreased infectivity.
    Clin Infect Dis. 2023 Feb 12:ciad074. doi: 10.1093.
    >> Share

  204. MORAWSKA L, Bahnfleth W, Bluyssen PM, Boerstra A, et al
    COVID-19 and Airborne Transmission: Science Rejected, Lives Lost. Can Society Do Better?
    Clin Infect Dis. 2023 Feb 10:ciad068. doi: 10.1093.
    >> Share


  205. It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Feb 10:ciac612. doi: 10.1093.
    >> Share

  206. OKUMURA K, Jyothula S, Kaleekal T, Dhand A, et al
    One-year Outcomes of Lung Transplantation for COVID-19 Associated End Stage Lung Disease in the United States.
    Clin Infect Dis. 2023 Feb 9:ciad072. doi: 10.1093.
    >> Share


  207. Correction to: Coronavirus Disease 2019 [COVID-19] Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study.
    Clin Infect Dis. 2023 Feb 8:ciac632. doi: 10.1093.
    >> Share

  208. KOMPANIYETS L, Wiegand RE, Oyalowo AC, Bull-Otterson L, et al
    Relative effectiveness of COVID-19 vaccination and booster dose combinations among 18.9 million vaccinated adults during the early SARS-CoV-2 Omicron period - United States, January 1, 2022-March 31, 2022.
    Clin Infect Dis. 2023 Feb 8:ciad063. doi: 10.1093.
    >> Share

  209. KORPE P, Ni Z, Kabir M, Alam M, et al
    Prospective cohort study of Cryptosporidium infection and shedding in infants and their households.
    Clin Infect Dis. 2023 Feb 8:ciad059. doi: 10.1093.
    >> Share

  210. WILDENTHAL JA, Atkinson A, Lewis S, Sayood S, et al
    Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs.
    Clin Infect Dis. 2023;76:487-496.
    >> Share

  211. TORRICO F, Gascon J, Ortiz L, Pinto J, et al
    A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease.
    Clin Infect Dis. 2023;76:e1186-e1194.
    >> Share

  212. MORGAN DJ, Dubberke ER, Hink T, Paszkiewicz G, et al
    The Impact of Universal Glove and Gown Use on Clostridioides Difficile Acquisition: A Cluster-Randomized Trial.
    Clin Infect Dis. 2023;76:e1202-e1207.
    >> Share

  213. SCHIAFFINO F, Colston JM, Paredes Olortegui M, Rengifo Pinedo S, et al
    Antibiotic Use and Stewardship Practices in a Pediatric Community-based Cohort Study in Peru: Shorter Would be Sweeter.
    Clin Infect Dis. 2023;76:e1054-e1061.
    >> Share

  214. JUNKER D, Becker M, Wagner TR, Kaiser PD, et al
    Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants.
    Clin Infect Dis. 2023;76:e240-e249.
    >> Share

  215. BLOCH EM, Focosi D, Shoham S, Senefeld J, et al
    Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19.
    Clin Infect Dis. 2023 Feb 6:ciad066. doi: 10.1093.
    >> Share


  216. Correction to: Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.
    Clin Infect Dis. 2023 Feb 3:ciad014. doi: 10.1093.
    >> Share

  217. SCHULTZ JS, Mace KE, Tan KR
    Return to travel in the COVID-19 pandemic recovery period and implications for imported malaria: Reinforcing prevention, early diagnosis, and appropriate treatment of malaria.
    Clin Infect Dis. 2023 Feb 1:ciad061. doi: 10.1093.
    >> Share

    January 2023
  218. HERNANDEZ-TAMAYO C, Qato DM, Jewell MP, Gounder P, et al
    COVID-19 Pandemic Associated Declines and Subsequent Increases in Hepatitis C Virus Treatment Prescriptions in Los Angeles County.
    Clin Infect Dis. 2023 Jan 31:ciad050. doi: 10.1093.
    >> Share

  219. MOLLDREM S
    Research on the Development of SARS-CoV-2 Variants of Concern in People with Advanced HIV Disease Should Highlight Structural Conditions and Avoid Harmful Stereotypes.
    Clin Infect Dis. 2023 Jan 31:ciad048. doi: 10.1093.
    >> Share

  220. GOTTLIEB M, Wang R, Yu H, Spatz ES, et al
    Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2023 Jan 27:ciad045. doi: 10.1093.
    >> Share

  221. MELICA G, Bartolucci P, Audureau E, Le Corvoisier P, et al
    Immunological efficacy of pneumococcal vaccination including the 13-valent pneumococcal vaccine in adult patients with sickle-cell disease: results of the randomized DREVAC controlled trial.
    Clin Infect Dis. 2023 Jan 27:ciad037. doi: 10.1093.
    >> Share

  222. HAYDEN MK, Hanson KE, Englund JA, Lee F, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing.
    Clin Infect Dis. 2023 Jan 26:ciad032. doi: 10.1093.
    >> Share


  223. Correction to: Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
    Clin Infect Dis. 2023 Jan 18:ciac584. doi: 10.1093.
    >> Share

  224. BONAZZETTI C, Tazza B, Gibertoni D, Pasquini Z, et al
    Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort.
    Clin Infect Dis. 2023 Jan 13:ciad016. doi: 10.1093.
    >> Share

  225. STEELE EJ, Gorczynski RM, Lindley RA, Wickramasinghe NC, et al
    Natural Antibodies and SARS CoV-2 Specific Antibodies in Healthy Asymptomatic Individuals.
    Clin Infect Dis. 2023 Jan 10:ciad004. doi: 10.1093.
    >> Share


  226. Correction to: Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2023 Jan 6:ciac964. doi: 10.1093.
    >> Share

  227. DALTON AF, Weber ZA, Allen KS, Stenehjem E, et al
    Relationships between social vulnerability and COVID-19 vaccination coverage and vaccine effectiveness.
    Clin Infect Dis. 2023 Jan 6:ciad003. doi: 10.1093.
    >> Share

  228. TITANJI BK
    The Last Mile Problem - COVID-19 Vaccine Coverage Among the Most Socially Vulnerable.
    Clin Infect Dis. 2023 Jan 6:ciad006. doi: 10.1093.
    >> Share

  229. DEDRICK RM, Smith BE, Cristinziano M, Freeman KG, et al
    Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.
    Clin Infect Dis. 2023;76:103-112.
    >> Share

  230. MALCHAIR P, Giol J, Garcia V, Rodriguez O, et al
    Three-day icatibant on top of standard care in patients with COVID-19 pneumonia (ICAT.COVID): a randomized, open-label, phase 2, proof-of-concept trial.
    Clin Infect Dis. 2023 Jan 4:ciac984. doi: 10.1093.
    >> Share

    December 2022

  231. Correction to: Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China.
    Clin Infect Dis. 2022 Dec 31:ciac576. doi: 10.1093.
    >> Share

  232. HERRING MK, Romine JK, Wesley MG, Ellingson KD, et al
    SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses.
    Clin Infect Dis. 2022 Dec 29:ciac976. doi: 10.1093.
    >> Share

  233. SPATZ ES, Gottlieb M, Wisk LE, Anderson J, et al
    Three-month symptom profiles among symptomatic adults with positive and negative SARS-CoV-2 tests: a prospective cohort study from the INSPIRE group.
    Clin Infect Dis. 2022 Dec 27:ciac966. doi: 10.1093.
    >> Share

  234. ROBERTSON MM, Qasmieh SA, Kulkarni SG, Teasdale CA, et al
    The epidemiology of long COVID in US adults.
    Clin Infect Dis. 2022 Dec 21:ciac961. doi: 10.1093.
    >> Share

  235. VUORIO A, Kovanen PT, Raal F
    Statin Needs to be Continued During Paxlovid Therapy in COVID-19.
    Clin Infect Dis. 2022;75:2281-2282.
    >> Share

  236. ROBINSON ML, Morris CP, Betz JF, Zhang Y, et al
    Impact of SARS-CoV-2 variants on inpatient clinical outcome.
    Clin Infect Dis. 2022 Dec 19:ciac957. doi: 10.1093.
    >> Share

  237. CHOWERS M, Gerassy-Vainberg S, Cohen-Poradosu R, Wiener-Well Y, et al
    The Effect of Macrolides on Mortality in Bacteremic Pneumococcal Pneumonia: A Retrospective, Nationwide Cohort Study, Israel, 2009-2017.
    Clin Infect Dis. 2022;75:2219-2224.
    >> Share

  238. NEHME M, Vetter P, Chappuis F, Kaiser L, et al
    Prevalence of post-COVID Condition 12 Weeks after Omicron Infection Compared to Negative Controls and Association with Vaccination Status.
    Clin Infect Dis. 2022 Dec 15:ciac947. doi: 10.1093.
    >> Share

  239. PRICE AM, Flannery B, Talbot HK, Grijalva CG, et al
    Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
    Clin Infect Dis. 2022 Dec 12:ciac941. doi: 10.1093.
    >> Share

  240. HETRICH MK, Oliva J, Wanionek K, Knoll MD, et al
    Epidemiology of human parainfluenza virus type 3 (HPIV-3) and respiratory syncytial virus (RSV) infections in the time of COVID-19: findings from a household cohort in Maryland.
    Clin Infect Dis. 2022 Dec 12:ciac942. doi: 10.1093.
    >> Share

  241. PRUNAS O, Weinberger DM, Pitzer VE, Gazit S, et al
    Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel.
    Clin Infect Dis. 2022 Dec 9:ciac315. doi: 10.1093.
    >> Share

  242. EDWARDS KM, Neuzil KM
    Developing mucosal vaccines for SARS-CoV-2: What will it take?
    Clin Infect Dis. 2022 Dec 9:ciac935. doi: 10.1093.
    >> Share

  243. COHEN JI, Dropulic L, Wang K, Gangler K, et al
    Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination.
    Clin Infect Dis. 2022 Dec 9:ciac934. doi: 10.1093.
    >> Share

  244. MUKAE H, Yotsuyanagi H, Ohmagari N, Doi Y, et al
    Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study.
    Clin Infect Dis. 2022 Dec 7:ciac933. doi: 10.1093.
    >> Share

  245. JASSAT W, Abdool Karim SS, Ozougwu L, Welch R, et al
    Trends in Cases, Hospitalization and Mortality Related to the Omicron BA.4/BA.5 Sub-Variants in South Africa.
    Clin Infect Dis. 2022 Dec 1:ciac921. doi: 10.1093.
    >> Share


  246. Correction to: Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa.
    Clin Infect Dis. 2022 Dec 1:ciac897. doi: 10.1093.
    >> Share

    November 2022
  247. KAMIDANI S, Garg S, Rolfes MA, Campbell AP, et al
    Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic.
    Clin Infect Dis. 2022;75:1930-1939.
    >> Share

  248. YAN J, Steiger SN, Kodama R, Fender J, et al
    Predictors of COVID-19 hospitalization after sotrovimab in hematologic malignancy patients during the BA.1 Omicron surge.
    Clin Infect Dis. 2022 Nov 29:ciac916. doi: 10.1093.
    >> Share

  249. MOKHTAR S, Parpia AS, Lo NC, Ndeffo-Mbah ML, et al
    Evaluation of the United States definitions for COVID-19 community risk levels.
    Clin Infect Dis. 2022 Nov 26:ciac922. doi: 10.1093.
    >> Share

  250. TADESSE BT, Bravo L, Marks F, Aziz AB, et al
    Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines.
    Clin Infect Dis. 2022 Nov 26:ciac914. doi: 10.1093.
    >> Share

  251. DAVIS JM, Li JZ
    The Promise and Peril of Anti-SARS-CoV-2 Monoclonal Antibodies.
    Clin Infect Dis. 2022 Nov 22:ciac902. doi: 10.1093.
    >> Share

  252. LEVIN MJ, Ustianowski A, Thomas S, Templeton A, et al
    AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of Symptomatic COVID-19.
    Clin Infect Dis. 2022 Nov 22:ciac899. doi: 10.1093.
    >> Share

  253. CASKEY M, Kuritzkes DR
    Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?
    Clin Infect Dis. 2022;75.
    >> Share

  254. PARKER AM, Jackson N, Awasthi S, Kim H, et al
    Association of upper respiratory Streptococcus pneumoniae colonization with SARS-CoV-2 infection among adults.
    Clin Infect Dis. 2022 Nov 19:ciac907. doi: 10.1093.
    >> Share

  255. ALAEDINI A, Wormser GP
    Persistence of SARS-CoV-2 to Explain Long COVID Is Not Consistent with the Available Data.
    Clin Infect Dis. 2022 Nov 17. pii: 6831665. doi: 10.1093.
    >> Share

  256. BIRABAHARAN M, Hill E, Begur M, Kaelber DC, et al
    Cardiovascular outcomes after tixagevimab and cilgavimab use for pre-exposure prophylaxis against COVID-19: a population-based propensity-matched cohort study.
    Clin Infect Dis. 2022 Nov 16. pii: 6830248. doi: 10.1093.
    >> Share

  257. SHAH MM, Spencer BR, Feldstein LR, Haynes JM, et al
    Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021.
    Clin Infect Dis. 2022 Nov 14. pii: 6825618. doi: 10.1093.
    >> Share

  258. PAI MANGALORE R, Ashok A, Lee SJ, Romero L, et al
    Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2022;75:1848-1860.
    >> Share

  259. BAKER MA, Rhee C, Tucker R, Vaidya V, et al
    Ralstonia pickettii and Pseudomonas aeruginosa Bloodstream Infections Associated With Contaminated Extracorporeal Membrane Oxygenation Water Heater Devices.
    Clin Infect Dis. 2022;75:1838-1840.
    >> Share

  260. MORRIS CP, Eldesouki RE, Sachithanandham J, Fall A, et al
    Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization.
    Clin Infect Dis. 2022 Nov 11. pii: 6822482. doi: 10.1093.
    >> Share

  261. BARDA N, Canetti M, Gilboa M, Asraf K, et al
    The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 Nov 11. pii: 6821340. doi: 10.1093.
    >> Share

  262. BLOSSEY AM, Bruckner S, May M, Parzmair GP, et al
    VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including COVID-19 in the Elderly: a phase III randomised, double-blind, placebo-controlled, multicenter clinical study.
    Clin Infect Dis. 2022 Nov 11. pii: 6821343. doi: 10.1093.
    >> Share

  263. OTERO S, Miller ES, Sunderraj A, Shanes ED, et al
    Maternal Antibody Response and Transplacental Transfer Following SARS-CoV-2 Infection or Vaccination in Pregnancy.
    Clin Infect Dis. 2022 Nov 9. pii: 6812657. doi: 10.1093.
    >> Share

  264. YAN VC
    Test 5- versus 10-day remdesivir treatment in immunocompromised patients with COVID-19.
    Clin Infect Dis. 2022 Nov 8. pii: 6809131. doi: 10.1093.
    >> Share

  265. SIEGHART D, Hana CA, Haslacher H, Perkmann T, et al
    MULTI-PARAMETRIC PREDICTION MODELS FOR COVID-19 VACCINE SELECTION: RESULTS OF A COMPARATIVE POPULATION-BASED COHORT STUDY.
    Clin Infect Dis. 2022 Nov 4. pii: 6795267. doi: 10.1093.
    >> Share

  266. BEN ABDALLAH S, Mhalla Y, Trabelsi I, Sekma A, et al
    Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.
    Clin Infect Dis. 2022 Nov 4. pii: 6795268. doi: 10.1093.
    >> Share

  267. HOLMGAARD FB, Guglielmetti L, Lillebaek T, Andersen AB, et al
    Efficacy and tolerability of concomitant use of bedaquiline and delamanid for multidrug- and extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Clin Infect Dis. 2022 Nov 4. pii: 6801118. doi: 10.1093.
    >> Share

  268. SNELL LB, Medina-Alcolea A, Charalampous T, Alder C, et al
    Real-time whole genome sequencing to guide patient-tailored therapy of SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Nov 3. pii: 6785897. doi: 10.1093.
    >> Share

  269. TENFORDE MW, Patel MM, Lewis NM, Adams K, et al
    Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness, United States, 2022.
    Clin Infect Dis. 2022 Nov 3. pii: 6795261. doi: 10.1093.
    >> Share

  270. FORD ES, Simmons W, Karmarkar EN, Yoke LH, et al
    Successful treatment of prolonged, severe COVID-19 lower respiratory tract disease in a B-cell ALL patient with an extended course of remdesivir and nirmatrelvir/ritonavir.
    Clin Infect Dis. 2022 Nov 3. pii: 6795102. doi: 10.1093.
    >> Share

    October 2022
  271. NAJJAR-DEBBINY R, Gronich N, Weber G, Stein N, et al
    Effectiveness of Evusheld in Immunocompromised Patients: Propensity Score-Matched Analysis.
    Clin Infect Dis. 2022 Oct 31. pii: 6780937. doi: 10.1093.
    >> Share

  272. BETTINGER JA, Irvine MA, Shulha HP, Valiquette L, et al
    Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network.
    Clin Infect Dis. 2022 Oct 31. pii: 6780916. doi: 10.1093.
    >> Share

  273. WANG L, Calzavara A, Baral S, Smylie J, et al
    Differential patterns by area-level social determinants of health in COVID-19 related mortality and non-COVID-19 mortality: a population-based study of 11.8 million people in Ontario, Canada.
    Clin Infect Dis. 2022 Oct 28. pii: 6776118. doi: 10.1093.
    >> Share

  274. BAHR NC, Skipper CP, Huppler-Hullsiek K, Ssebambulidde K, et al
    Recurrence of symptoms following cryptococcal meningitis - characterizing a diagnostic conundrum with multiple etiologies.
    Clin Infect Dis. 2022 Oct 28. pii: 6776123. doi: 10.1093.
    >> Share

  275. LAI J, Coleman KK, Tai SS, German J, et al
    Exhaled Breath Aerosol Shedding by Highly Transmissible Versus Prior SARS-CoV-2 Variants.
    Clin Infect Dis. 2022 Oct 26. pii: 6773834. doi: 10.1093.
    >> Share

  276. TROTTIER CA, Wong B, Kohli R, Boomsma C, et al
    Dual antiviral therapy for persistent COVID-19 and associated organizing pneumonia in an immunocompromised host.
    Clin Infect Dis. 2022 Oct 25. pii: 6771205. doi: 10.1093.
    >> Share

  277. VINCETI M, Filippini T, Fairweather-Tait S
    A potential role for zinc to enhance treatment for COVID-19?
    Clin Infect Dis. 2022 Oct 25. pii: 6771230. doi: 10.1093.
    >> Share

  278. PENALVA G, Crespo-Rivas JC, Guisado-Gil AB, Rodriguez-Villodres A, et al
    Clinical and ecological impact of an educational program to optimize antibiotic treatments in nursing homes (PROA-SENIOR): a cluster randomized controlled trial and interrupted time-series analysis.
    Clin Infect Dis. 2022 Oct 21. pii: 6765270. doi: 10.1093.
    >> Share

  279. TURBETT SE, Tomkins-Tinch CH, Anahtar MN, Dugdale CM, et al
    Distinguishing SARS-CoV-2 persistence and reinfection: A retrospective cohort study.
    Clin Infect Dis. 2022 Oct 21. pii: 6765222. doi: 10.1093.
    >> Share

  280. CLARKE KEN, Hong K, Schoonveld M, Greenspan AI, et al
    Severity of COVID-19 Hospitalization Outcomes and Patient Disposition Differ by Disability Status and Disability Type.
    Clin Infect Dis. 2022 Oct 19. pii: 6763266. doi: 10.1093.
    >> Share

  281. ASARE K, Andine T, Naicker N, Dorward J, et al
    Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial.
    Clin Infect Dis. 2022 Oct 15. pii: 6761890. doi: 10.1093.
    >> Share

  282. MALOSH RE, McGovern I, Monto AS
    Influenza During the 2010-2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions.
    Clin Infect Dis. 2022 Oct 11. pii: 6758391. doi: 10.1093.
    >> Share

  283. LI Y, Harrison LJ, Chew KW, Currier JS, et al
    Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19.
    Clin Infect Dis. 2022 Oct 10. pii: 6754602. doi: 10.1093.
    >> Share

  284. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
    Clin Infect Dis. 2022 Oct 10. pii: 6754597. doi: 10.1093.
    >> Share

  285. HAN AX, Girdwood S, Khan S, Sacks JA, et al
    Strategies for using antigen rapid diagnostic tests to reduce transmission of SARS-CoV-2 in low- and middle-income countries: a mathematical modelling study applied to Zambia.
    Clin Infect Dis. 2022 Oct 8. pii: 6754174. doi: 10.1093.
    >> Share

  286. COPPEE R, Sarrasin V, Zaffaroulah R, Bouzayene A, et al
    Nosocomial malaria transmissions resolved by genomic analyses - a retrospective case report study in France (2007-2021).
    Clin Infect Dis. 2022 Oct 8. pii: 6754169. doi: 10.1093.
    >> Share

  287. EPLING BP, Rocco JM, Boswell KL, Laidlaw E, et al
    Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment.
    Clin Infect Dis. 2022 Oct 6. pii: 6749408. doi: 10.1093.
    >> Share

  288. FIDLER S, Fox J, Tipoe T, Longet S, et al
    Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
    Clin Infect Dis. 2022 Oct 5. pii: 6748267. doi: 10.1093.
    >> Share

  289. KOGAN NE, Gantt S, Swerdlow D, Viboud C, et al
    Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of COVID-19 in Africa.
    Clin Infect Dis. 2022 Oct 5. pii: 6748257. doi: 10.1093.
    >> Share

  290. GLIGA S, Luebke N, Killer A, Gruell H, et al
    Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients.
    Clin Infect Dis. 2022 Oct 3. pii: 6746719. doi: 10.1093.
    >> Share

    September 2022
  291. VAUGHN VM, Ratz D, Greene MT, Flanders SA, et al
    Antibiotic Stewardship Strategies and Their Association With Antibiotic Overuse After Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework.
    Clin Infect Dis. 2022;75:1063-1072.
    >> Share

  292. STOCKWELL MS, Reed C, Vargas CY, Wang L, et al
    Five-Year Community Surveillance Study for Acute Respiratory Infections Using Text Messaging: Findings From the MoSAIC Study.
    Clin Infect Dis. 2022;75:987-995.
    >> Share

  293. HOGAN JI, Duerr R, Dimartino D, Marier C, et al
    Remdesivir resistance in transplant recipients with persistent COVID-19.
    Clin Infect Dis. 2022 Sep 26. pii: 6717535. doi: 10.1093.
    >> Share

  294. FLOREA A, Sy LS, Qian L, Ackerson BK, et al
    Effectiveness of mRNA-1273 vaccine booster against COVID-19 in immunocompetent adults.
    Clin Infect Dis. 2022 Sep 22. pii: 6711079. doi: 10.1093.
    >> Share

  295. SCHERER EM, Backer M, Carvajal K, Danziger-Isakov L, et al
    The COVID-19 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action.
    Clin Infect Dis. 2022 Sep 22. pii: 6710388. doi: 10.1093.
    >> Share

  296. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Molnupiravir in High Risk Patients: a Propensity Score Matched Analysis.
    Clin Infect Dis. 2022 Sep 20. pii: 6708264. doi: 10.1093.
    >> Share

  297. SIANGPHOE U, Baden LR, El Sahly HM, Essink B, et al
    Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials.
    Clin Infect Dis. 2022 Sep 20. pii: 6708263. doi: 10.1093.
    >> Share

  298. ONO S, Michihata N, Yamana H, Uemura K, et al
    Comparative effectiveness of BNT162b2 and mRNA-1273 booster dose after BNT162b2 primary vaccination against the Omicron variants: A retrospective cohort study using large-scale population-based registries in Japan.
    Clin Infect Dis. 2022 Sep 18. pii: 6696997. doi: 10.1093.
    >> Share

  299. BOULWARE DR, Murray TA, Proper JL, Tignanelli CJ, et al
    Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial.
    Clin Infect Dis. 2022 Sep 17. pii: 6702474. doi: 10.1093.
    >> Share

  300. DONLAN AN, Mallawaarachi I, Sasson JM, Preissner R, et al
    Dupilumab use is associated with protection from COVID-19 mortality: A retrospective analysis.
    Clin Infect Dis. 2022 Sep 15. pii: 6698736. doi: 10.1093.
    >> Share

  301. ALONSO-NAVARRO R, Cuesta G, Santos M, Cardozo C, et al
    Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients with COVID-19: impact on the length of hospital stay and mortality.
    Clin Infect Dis. 2022 Sep 13. pii: 6696600. doi: 10.1093.
    >> Share

  302. CUOMO RE, Li Z, Purushothaman V, Basavapatna-Shankar C, et al
    Predictors of Time to COVID-19 Infection in the National Basketball Association: A Retrospective Case-Control Study.
    Clin Infect Dis. 2022 Sep 13. pii: 6696551. doi: 10.1093.
    >> Share

  303. KAKIUCHI S, Livorsi DJ, Perencevich EN, Diekema DJ, et al
    Days of Antibiotic Spectrum Coverage: A Novel Metric for Inpatient Antibiotic Consumption.
    Clin Infect Dis. 2022;75:567-576.
    >> Share

  304. MAGNUS MC, Haberg SE, Carlsen EO, Kwong JC, et al
    Pregnancy status at the time of COVID-19 vaccination and incidence of SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Sep 8. pii: 6693880. doi: 10.1093.
    >> Share

  305. KOJIMA N, Klausner JD
    Usage and awareness of antiviral medications for COVID-19 among individuals at risk for severe COVID-19, March 2021 to 1 August 2022.
    Clin Infect Dis. 2022 Sep 7. pii: 6693563. doi: 10.1093.
    >> Share

  306. GOLAN Y, Campos JAS, Woolson R, Cilla D, et al
    Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial.
    Clin Infect Dis. 2022 Sep 6. pii: 6692456. doi: 10.1093.
    >> Share

  307. BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
    Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
    Clin Infect Dis. 2022 Sep 5. pii: 6692369. doi: 10.1093.
    >> Share

  308. SWANK Z, Senussi Y, Manickas-Hill Z, Yu XG, et al
    Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae.
    Clin Infect Dis. 2022 Sep 2. pii: 6686531. doi: 10.1093.
    >> Share

    August 2022
  309. WIRTH KE, Edwards JK, Feinstein L, Breskin A, et al
    When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose.
    Clin Infect Dis. 2022 Aug 30. pii: 6679241. doi: 10.1093.
    >> Share

  310. HARRIGAN SP, Wilton J, Chong M, Abdia Y, et al
    Clinical severity of Omicron SARS-CoV-2 variant relative to Delta in British Columbia, Canada: A retrospective analysis of whole genome sequenced cases.
    Clin Infect Dis. 2022 Aug 30. pii: 6679248. doi: 10.1093.
    >> Share

  311. YIP TCF, Lui GCY, Lai MSM, Wong VWS, et al
    Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients.
    Clin Infect Dis. 2022 Aug 29. pii: 6678124. doi: 10.1093.
    >> Share

  312. GAGLANI M, Kim SS, Naleway AL, Levine MZ, et al
    Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
    Clin Infect Dis. 2022 Aug 29. pii: 6678123. doi: 10.1093.
    >> Share

  313. LOHSE ZM, Shapiro JJ, Lednicky JA, Cash MN, et al
    Persistence of SARS-CoV-2 omicron variant in children and utility of rapid antigen testing as an indicator of culturable virus.
    Clin Infect Dis. 2022 Aug 27. pii: 6677545. doi: 10.1093.
    >> Share

  314. FISHER BT, Boge CLK, Xiao R, Shuster S, et al
    Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
    Clin Infect Dis. 2022;75:248-259.
    >> Share

  315. KLOMPAS M, Baker MA, Rhee C
    Coronavirus Disease 2019's Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission.
    Clin Infect Dis. 2022;75:e102-e104.
    >> Share

  316. KLEIN B, Harris DA
    Examining the Robustness of 3 Versus 6 Feet of Physical Distancing in Schools: A Reanalysis of van den Berg et al.
    Clin Infect Dis. 2022;75:e310-e311.
    >> Share

  317. FERNANDEZ-DE-LAS-PENAS C
    Are Patients Exhibiting Post-Coronavirus Disease (COVID) Symptoms at 12 months the Same at 5 or 9 Months? The Fluctuating Nature of Post-COVID.
    Clin Infect Dis. 2022;75:e1208.
    >> Share

  318. ADVANI SD, Sickbert-Bennett E, Moehring R, Cromer A, et al
    The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce.
    Clin Infect Dis. 2022 Aug 23. pii: 6673939. doi: 10.1093.
    >> Share

  319. GANATRA S, Dani SS, Ahmad J, Kumar A, et al
    Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19.
    Clin Infect Dis. 2022 Aug 20. pii: 6672670. doi: 10.1093.
    >> Share

  320. WIEMKEN TL, McGrath LJ, Andersen KM, Khan F, et al
    COVID-19 severity and risk of subsequent cardiovascular events.
    Clin Infect Dis. 2022 Aug 19. pii: 6671924. doi: 10.1093.
    >> Share

  321. NASREEN S, Febriani Y, Velasquez Garcia HA, Zhang G, et al
    Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study.
    Clin Infect Dis. 2022 Aug 17. pii: 6668859. doi: 10.1093.
    >> Share

  322. PERSON AK, Armstrong WS, Evans T, Fangman JJ, et al
    Principles for Ending HIV as an Epidemic in the United States: A Policy Paper of IDSA and HIVMA.
    Clin Infect Dis. 2022 Aug 15. pii: 6662275. doi: 10.1093.
    >> Share

  323. DELAHOY MJ, Munoz F, Li K, Arriola CS, et al
    SARS-CoV-2 testing and detection during peripartum hospitalizations among a multi-center cohort of pregnant persons, March 2020-February 2021.
    Clin Infect Dis. 2022 Aug 12. pii: 6663759. doi: 10.1093.
    >> Share

  324. PECK H, Anbumurali N, McMahon K, Freeman K, et al
    Detection of influenza in managed quarantine in Australia and the estimated risk of importation.
    Clin Infect Dis. 2022 Aug 12. pii: 6663754. doi: 10.1093.
    >> Share

  325. FJELLTVEIT EB, Blomberg B, Kuwelker K, Zhou F, et al
    Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study.
    Clin Infect Dis. 2022 Aug 12. pii: 6663664. doi: 10.1093.
    >> Share

  326. KARABA AH, Zhou W, Li S, Aytenfisu TY, et al
    Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2022 Aug 12. pii: 6663288. doi: 10.1093.
    >> Share

  327. QASMIEH SA, Robertson MM, Teasdale CA, Kulkarni SG, et al
    Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022.
    Clin Infect Dis. 2022 Aug 12. pii: 6662085. doi: 10.1093.
    >> Share

  328. MOESTRUP KS, Reekie J, Zucco AG, Jensen TO, et al
    Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19.
    Clin Infect Dis. 2022 Aug 8. pii: 6658187. doi: 10.1093.
    >> Share

  329. FOPPIANO PALACIOS C, Tucker EW, Travassos MA
    COVID-19 burden among unaccompanied minors in United States custody.
    Clin Infect Dis. 2022 Aug 5. pii: 6656047. doi: 10.1093.
    >> Share

  330. AWASTHI M, Golding H, Khurana S
    SARS-CoV-2 hyperimmune intravenous human immunoglobulins neutralizes Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.3 and BA.4/BA.5 for treatment of COVID-19.
    Clin Infect Dis. 2022 Aug 4. pii: 6655744. doi: 10.1093.
    >> Share

  331. KLEYNHANS J, Walaza S, Martinson NA, Neti M, et al
    Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study.
    Clin Infect Dis. 2022 Aug 4. pii: 6655792. doi: 10.1093.
    >> Share

  332. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
    Clin Infect Dis. 2022 Aug 4. pii: 6655523. doi: 10.1093.
    >> Share

  333. PRAY IW, Grajewski B, Morris C, Modji K, et al
    Measuring work-related risk of COVID-19: comparison of COVID-19 incidence by occupation and industry - Wisconsin, September 2020-May 2021.
    Clin Infect Dis. 2022 Aug 4. pii: 6655522. doi: 10.1093.
    >> Share

  334. ARASHIRO T, Arima Y, Muraoka H, Sato A, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study).
    Clin Infect Dis. 2022 Aug 3. pii: 6653543. doi: 10.1093.
    >> Share

  335. VIHTA KD, Pouwels KB, Peto TE, Pritchard E, et al
    Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.
    Clin Infect Dis. 2022 Aug 3. pii: 6653436. doi: 10.1093.
    >> Share

  336. KRISHNA BA, Metaxaki M, Wills MR, Sithole N, et al
    Reduced incidence of Long COVID referrals to the Cambridge University Teaching Hospital Long COVID clinic.
    Clin Infect Dis. 2022 Aug 1. pii: 6652885. doi: 10.1093.
    >> Share

  337. ATCHISON CJ, Moshe M, Brown JC, Whitaker M, et al
    Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay.
    Clin Infect Dis. 2022 Aug 1. pii: 6652878. doi: 10.1093.
    >> Share

    July 2022
  338. MONTEJANO R, de la Calle-Prieto F, Velasco M, Guijarro C, et al
    Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jul 30. pii: 6652179. doi: 10.1093.
    >> Share

  339. SINE K, Appaneal H, Dosa D, LaPlante KL, et al
    Antimicrobial Prescribing in the Telehealth Setting: Framework for stewardship during a period of rapid acceleration within primary care.
    Clin Infect Dis. 2022 Jul 30. pii: 6652160. doi: 10.1093.
    >> Share

  340. KERTES J, David SSB, Engel-Zohar N, Rosen K, et al
    Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality.
    Clin Infect Dis. 2022 Jul 29. pii: 6651663. doi: 10.1093.
    >> Share

  341. MARTINEZ-SANZ J, Serrano-Villar S, Muriel A, Fraile LJG, et al
    Metabolic-related outcomes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in adults with HIV: a multicenter prospective cohort study.
    Clin Infect Dis. 2022 Jul 29. pii: 6651472. doi: 10.1093.
    >> Share

  342. LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
    Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
    >> Share

  343. LI H, Gao M, You H, Zhang P, et al
    Association of nirmatrelvir/ritonavir treatment on upper respiratory SARS-CoV-2 RT-PCR negative conversion rates among high-risk patients with COVID-19.
    Clin Infect Dis. 2022 Jul 23. pii: 6649232. doi: 10.1093.
    >> Share

  344. ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
    Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
    Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
    >> Share

  345. MALAHE SRK, Hoek RAS, Dalm VASH, Broers AEC, et al
    Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study.
    Clin Infect Dis. 2022 Jul 23. pii: 6649068. doi: 10.1093.
    >> Share

  346. HUYGENS S, Munnink BO, Gharbharan A, Koopmans M, et al
    Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Jul 22. pii: 6648554. doi: 10.1093.
    >> Share

  347. ROTHBERG MB, Kim P, Shrestha NK, Kojima L, et al
    Protection Against the Omicron Variant Offered by Previous SARS-CoV-2 Infection: A Retrospective Cohort Study.
    Clin Infect Dis. 2022 Jul 22. pii: 6648553. doi: 10.1093.
    >> Share

  348. SAHNI LC, Naioti EA, Olson SM, Campbell AP, et al
    Sustained within-season vaccine effectiveness against influenza-associated hospitalization in children: Evidence from the New Vaccine Surveillance Network, 2015-2016 through 2019-2020.
    Clin Infect Dis. 2022 Jul 22. pii: 6648556. doi: 10.1093.
    >> Share

  349. HATFIELD KM, Baggs J, Wolford H, Fang M, et al
    Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
    Clin Infect Dis. 2022 Jul 20. pii: 6646955. doi: 10.1093.
    >> Share

  350. VIEL KR
    Response to 'Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome'.
    Clin Infect Dis. 2022 Jul 12. pii: 6640218. doi: 10.1093.
    >> Share

  351. HUNYADY P, Streller L, Ruther DF, Groba SR, et al
    Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study.
    Clin Infect Dis. 2022 Jul 9. pii: 6637421. doi: 10.1093.
    >> Share

  352. MIGUERES M, Dimeglio C, Mansuy JM, Abravanel F, et al
    The influence of the nasopharyngeal viral load on the spread of the Omicron BA.2 variant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633281. doi: 10.1093.
    >> Share

  353. SANDERS JSF, Lianne Messchendorp A, de Vries RD, Baan CC, et al
    Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633280. doi: 10.1093.
    >> Share

  354. MAPONGA TG, Jeffries M, Tegally H, Sutherland A, et al
    Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection.
    Clin Infect Dis. 2022 Jul 6. pii: 6632801. doi: 10.1093.
    >> Share

  355. MURISON KR, Grima AA, Simmons AE, Tuite AR, et al
    Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis.
    Clin Infect Dis. 2022 Jul 6. pii: 6632524. doi: 10.1093.
    >> Share

  356. DANIEL KELLY J, Lu S, Anglin K, Garcia-Knight M, et al
    Magnitude and determinants of SARS-CoV-2 household transmission: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jul 5. pii: 6631204. doi: 10.1093.
    >> Share

  357. COHEN JM, Carter MJ, Ronny Cheung C, Ladhani S, et al
    Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2.
    Clin Infect Dis. 2022 Jul 5. pii: 6631205. doi: 10.1093.
    >> Share

  358. RIDOLFI F, Peetluk L, Amorim G, Turner M, et al
    TB TREATMENT OUTCOMES IN BRAZIL: DIFFERENT PREDICTORS FOR EACH TYPE OF UNSUCCESSFUL OUTCOME.
    Clin Infect Dis. 2022 Jul 5. pii: 6631480. doi: 10.1093.
    >> Share

  359. BAGGS J, Rose AN, McCarthy NL, Wolford H, et al
    Antibiotic Resistant Infections among COVID-19 Inpatients in U.S. Hospitals.
    Clin Infect Dis. 2022 Jul 2. pii: 6627591. doi: 10.1093.
    >> Share

  360. SAMSON ME, Still WL, Mark-Carew M, Jarris DK, et al
    Utility of a Test to Return Strategy to Identify Individuals with COVID-19 in the Pre-Kindergarten through Grade 12 School Setting - District of Columbia, January 2022.
    Clin Infect Dis. 2022 Jul 1. pii: 6625819. doi: 10.1093.
    >> Share

    June 2022
  361. GOOD MK, Czarnik M, Harmon KG, Aukerman D, et al
    SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021.
    Clin Infect Dis. 2022 Jun 30. pii: 6623463. doi: 10.1093.
    >> Share

  362. MOORING EQ, Newell K, Castrodale L, Tompkins M, et al
    Increased Mortality among Persons with Symptomatic COVID-19 During the Period of SARS-CoV-2 B.1.617.2 (Delta Variant) Predominance-Alaska, November 2020-October 2021.
    Clin Infect Dis. 2022 Jun 29. pii: 6619623. doi: 10.1093.
    >> Share

  363. GLATMAN-FREEDMAN A, Feldman SF, Hershkovitz Y, Kaufman Z, et al
    Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis.
    Clin Infect Dis. 2022 Jun 28. pii: 6619125. doi: 10.1093.
    >> Share

  364. TAM AR, Zhang RR, Lung KC, Liu R, et al
    Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trial.
    Clin Infect Dis. 2022 Jun 28. pii: 6619124. doi: 10.1093.
    >> Share

  365. MOLINE HL, Keaton A, Rice W, Varghese J, et al
    Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
    Clin Infect Dis. 2022 Jun 27. pii: 6618595. doi: 10.1093.
    >> Share

  366. IDOKO OT, Usuf E, Okomo U, Wonodi C, et al
    SARS-CoV-2 in Africa: current considerations and future projections.
    Clin Infect Dis. 2022 Jun 25. pii: 6617636. doi: 10.1093.
    >> Share

  367. OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
    Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
    Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
    >> Share

  368. BORAH BF, Pringle J, Flaherty M, Oeltmann JE, et al
    High Community Transmission of SARS-CoV-2 Associated with Decreased Contact Tracing Effectiveness for Identifying Persons at Elevated Risk of Infection - Vermont.
    Clin Infect Dis. 2022 Jun 24. pii: 6617336. doi: 10.1093.
    >> Share

  369. ARNALDO P, Mabunda N, Young PW, Tran T, et al
    Prevalence of SARS-CoV-2 antibodies in the Mozambican population: a cross-sectional Serologic study in three cities, July-August 2020.
    Clin Infect Dis. 2022 Jun 24. pii: 6617331. doi: 10.1093.
    >> Share

  370. KUTTY PK, Stuckey MJ, Koumans EH
    Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations.
    Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
    >> Share

  371. CHOI D, Nielsen J, Waller LA, Patel SA, et al
    The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination.
    Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
    >> Share

  372. MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
    Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
    Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
    >> Share

  373. OHLSEN EC, Yankey D, Pezzi C, Kriss JL, et al
    COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022.
    Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
    >> Share

  374. BOUTON TC, Atarere J, Turcinovic J, Seitz S, et al
    Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jun 23. pii: 6614634. doi: 10.1093.
    >> Share

  375. BOUCAU J, Uddin R, Marino C, Regan J, et al
    Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19.
    Clin Infect Dis. 2022 Jun 23. pii: 6614635. doi: 10.1093.
    >> Share

  376. TEMTE JL, Barlow S, Temte E, Goss M, et al
    SARS-CoV-2 co-detection with influenza A and other respiratory viruses among school-aged children and their household members- March 12, 2020, to February 22, 2022, Dane County, Wisconsin.
    Clin Infect Dis. 2022 Jun 23. pii: 6614626. doi: 10.1093.
    >> Share

  377. LEVY R, Cohen R, Lev-Shalem L, Eisenkraft A, et al
    A Retrospective Database Analysis of Before and After Social Distancing in Relation to Pediatric Infection Rate and Healthcare Services Usage During the COVID-19 Pandemic.
    Clin Infect Dis. 2022 Jun 20. pii: 6611849. doi: 10.1093.
    >> Share

  378. BROSH-NISSIMOV T, Hussein K, Wiener-Well Y, Orenbuch-Harroch E, et al
    Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose.
    Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
    >> Share

  379. ZIPFEL CM, Paul P, Gowler CD, Reddy SC, et al
    Modeling the effectiveness of healthcare personnel reactive testing and screening for the SARS-CoV-2 Omicron variant within nursing homes.
    Clin Infect Dis. 2022 Jun 20. pii: 6611848. doi: 10.1093.
    >> Share

  380. STARGEL A, Taylor MM, Zansky S, Spencer K, et al
    Case Investigation and Contact Tracing Efforts from Health Departments in the United States, November 2020-December 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611688. doi: 10.1093.
    >> Share

  381. CARLIN AF, Clark AE, Chaillon A, Garretson AF, et al
    Virologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment.
    Clin Infect Dis. 2022 Jun 20. pii: 6611663. doi: 10.1093.
    >> Share

  382. ROSKOSKY M, Moni G, Kawakami V, Lambert J, et al
    SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
    >> Share

  383. SABLEROLLES RSG, Rietdijk WJR, Goorhuis A, Postma DF, et al
    Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
    Clin Infect Dis. 2022 Jun 20. pii: 6611568. doi: 10.1093.
    >> Share

  384. VU DM, Vu DTB, Do TTT, Olmsted AE, et al
    Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
    Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
    >> Share

  385. KEATING P, Sell J, Chen J, Ackelsberg J, et al
    Delayed Recognition of COVID-19 in New York City: A descriptive analysis of COVID-19 illness prior to February 29, 2020.
    Clin Infect Dis. 2022 Jun 20. pii: 6611571. doi: 10.1093.
    >> Share

  386. KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
    Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611479. doi: 10.1093.
    >> Share

  387. GOLD JAW, Ahmad FB, Cisewski JA, Rossen LM, et al
    Increased deaths from fungal infections during the COVID-19 pandemic-National Vital Statistics System, United States, January 2020-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611491. doi: 10.1093.
    >> Share

  388. CZECH-SIOLI M, Gunther T, Robitaille A, Roggenkamp H, et al
    Integration of sequencing and epidemiological data for surveillance of SARS-CoV-2 infections in a tertiary-care hospital.
    Clin Infect Dis. 2022 Jun 19. pii: 6611489. doi: 10.1093.
    >> Share

  389. STRID P, Zapata LB, Tong VT, Zambrano LD, et al
    COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status - United States, Jan 1, 2020 - Dec 25, 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611488. doi: 10.1093.
    >> Share

  390. RICHARDSON VL, Franco MAC, Marquez AB, Valdez LM, et al
    Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
    >> Share

  391. HALASA NB, Spieker AJ, Young CC, Olson SM, et al
    Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children.
    Clin Infect Dis. 2022 Jun 19. pii: 6611483. doi: 10.1093.
    >> Share

  392. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination.
    Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
    >> Share

  393. FREE H, Luckhaupt SE, Billock RM, Groenewold MR, et al
    Reported exposures among in-person workers with SARS-CoV-2 infection in 6 states, September 2020-June 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611490. doi: 10.1093.
    >> Share

  394. TONG SYC, Mora J, Bowen AC, Cheng MP, et al
    The Staphylococcus aureus Network Adaptive Platform Trial protocol: New tools for an old foe.
    Clin Infect Dis. 2022 Jun 19. pii: 6611482. doi: 10.1093.
    >> Share

  395. RANGANATH N, O'Horo JC, Challener DW, Tulledge-Scheitel SM, et al
    Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons.
    Clin Infect Dis. 2022 Jun 14. pii: 6607746. doi: 10.1093.
    >> Share

  396. MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
    Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.
    Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
    >> Share

  397. WEGRZYN RD, Appiah GD, Morfino R, Milford SR, et al
    Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605116. doi: 10.1093.
    >> Share

  398. LIND ML, Schultes OL, Robertson AJ, Houde AJ, et al
    Testing Frequency Matters | An Evaluation of the Diagnostic Performance of a SARS-CoV-2 Rapid Antigen Test in United States Correctional Facilities.
    Clin Infect Dis. 2022 Jun 10. pii: 6605088. doi: 10.1093.
    >> Share

  399. LIM SY, Park S, Kim JY, Kim S, et al
    Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.
    Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
    >> Share

  400. RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
    Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
    >> Share

  401. MILLER MJ, Himschoot A, Fitch N, Jawalkar S, et al
    Association of Trends in SARS-CoV-2 Seroprevalence and State-Issued Nonpharmaceutical Interventions- United States, August 1, 2020 - March 30, 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605073. doi: 10.1093.
    >> Share

  402. BUSCH MP, Stramer SL, Stone M, Yu EA, et al
    Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
    >> Share

  403. LI ZN, Liu F, Jefferson S, Horner L, et al
    Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
    Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
    >> Share

  404. MILLER AD, Yousaf AR, Bornstein E, Wu MJ, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) During SARS-CoV-2 Delta and Omicron Variant Circulation- United States, July 2021 - January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605071. doi: 10.1093.
    >> Share

  405. TOP KA, Chen RT, Levy O, Ozonoff A, et al
    Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services.
    Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
    >> Share

  406. WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
    mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
    >> Share

  407. BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
    SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021.
    Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
    >> Share

  408. LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
    Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
    >> Share

  409. LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
    Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine.
    Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
    >> Share

  410. DOYLE TJ, Kiros GE, Schmitt-Matzen EN, Propper R, et al
    Maternal and perinatal outcomes associated with SARS-CoV-2 infection during pregnancy, Florida, 2020-2021: A retrospective cohort study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604396. doi: 10.1093.
    >> Share

  411. ALHABBAB RY, Algaissi A, Mahmoud AB, Alkayyal AA, et al
    MERS-CoV infection elicits long-lasting specific antibody, T and B cell immune responses in recovered individuals.
    Clin Infect Dis. 2022 Jun 8. pii: 6604398. doi: 10.1093.
    >> Share

  412. NACHEGA JB, Sam-Agudu NA, Machekano RN, Rosenthal PJ, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis.
    Clin Infect Dis. 2022 Jun 8. pii: 6603567. doi: 10.1093.
    >> Share

  413. NACHEGA JB, Sam-Agudu NA, Siedner MJ, Rosenthal PJ, et al
    Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries.
    Clin Infect Dis. 2022 Jun 8. pii: 6603568. doi: 10.1093.
    >> Share

  414. STRAUS W, Urdaneta V, Esposito DB, Mansi JA, et al
    Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide.
    Clin Infect Dis. 2022 Jun 6. pii: 6603291. doi: 10.1093.
    >> Share

  415. RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
    Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among Health Care Workers with a Vaccine Mandate.
    Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
    >> Share

  416. LIN Y, Yue S, Yang Y, Yang S, et al
    Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern (VOCs): A Small-scale Clinical Trial.
    Clin Infect Dis. 2022 Jun 6. pii: 6603292. doi: 10.1093.
    >> Share

  417. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients.
    Clin Infect Dis. 2022 Jun 2. pii: 6599020. doi: 10.1093.
    >> Share

    May 2022
  418. MARRA AR, Miraglia JL, Malheiros DT, Guozhang Y, et al
    Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021.
    Clin Infect Dis. 2022 May 27. pii: 6594056. doi: 10.1093.
    >> Share

  419. NASH D, Rane MS, Robertson MM, Chang M, et al
    SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults.
    Clin Infect Dis. 2022 May 27. pii: 6594058. doi: 10.1093.
    >> Share

  420. ZHAO M, Slotkin R, Sheth AH, Pischel L, et al
    Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
    Clin Infect Dis. 2022 May 26. pii: 6593314. doi: 10.1093.
    >> Share

  421. PETROS BA, Turcinovic J, Welch NL, White LF, et al
    Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations.
    Clin Infect Dis. 2022 May 25. pii: 6591846. doi: 10.1093.
    >> Share

  422. GRIMA AA, Murison KR, Simmons AE, Tuite AR, et al
    Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2.
    Clin Infect Dis. 2022 May 25. pii: 6591845. doi: 10.1093.
    >> Share

  423. RIDDELL AC, Kele B, Harris K, Bible J, et al
    Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease.
    Clin Infect Dis. 2022 May 25. pii: 6591841. doi: 10.1093.
    >> Share


  424. Correction to: Investigation of a Suspect Severe Acute Respiratory Syndrome Coronavirus-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide.
    Clin Infect Dis. 2022 May 24. pii: 6591404. doi: 10.1093.
    >> Share


  425. Correction to: Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2-Related Illness in Children: Hospital Experience in Cape Town, South Africa.
    Clin Infect Dis. 2022 May 24. pii: 6591403. doi: 10.1093.
    >> Share

  426. EPSI NJ, Richard SA, Lindholm DA, Mende K, et al
    Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
    Clin Infect Dis. 2022 May 24. pii: 6591282. doi: 10.1093.
    >> Share

  427. KIM DY, Lin MY, Jennings C, Li H, et al
    Duration of replication-competent SARS-CoV-2 shedding among patients with severe or critical coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2022 May 24. pii: 6590994. doi: 10.1093.
    >> Share

  428. CORRADINI P, Agrati C, Apolone G, Mantovani A, et al
    Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.
    Clin Infect Dis. 2022 May 24. pii: 6590993. doi: 10.1093.
    >> Share

  429. LOFGREN E, Naumova EN, Gorski J, Naumov Y, et al
    How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges.
    Clin Infect Dis. 2022 May 24. pii: 6590989. doi: 10.1093.
    >> Share

  430. EYAL N, Gheaus A, Gosseries A, Magalhaes M, et al
    COVID vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries' age priorities.
    Clin Infect Dis. 2022 May 24. pii: 6590988. doi: 10.1093.
    >> Share

  431. LAGOUSI T, Papadatou I, Strempas P, Chatzikalil E, et al
    PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION.
    Clin Infect Dis. 2022 May 24. pii: 6590985. doi: 10.1093.
    >> Share

  432. SHAPIRO JR, Sitaras I, Park HS, Aytenfisu TY, et al
    Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults.
    Clin Infect Dis. 2022 May 24. pii: 6590987. doi: 10.1093.
    >> Share

  433. ROTTENSTREICH A, Vorontsov O, Alfi O, Zarbiv G, et al
    Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination.
    Clin Infect Dis. 2022 May 24. pii: 6590984. doi: 10.1093.
    >> Share

  434. DELAHOY MJ, Ujamaa D, Taylor CA, Cummings C, et al
    Comparison of influenza and COVID-19-associated hospitalizations among children < 18 years old in the United States-FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).
    Clin Infect Dis. 2022 May 20. pii: 6589788. doi: 10.1093.
    >> Share

  435. LEVIN-RECTOR A, Firestein L, McGibbon E, Sell J, et al
    Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021.
    Clin Infect Dis. 2022 May 20. pii: 6589783. doi: 10.1093.
    >> Share

  436. TENFORDE MW, Self WH, Zhu Y, Naioti EA, et al
    Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
    Clin Infect Dis. 2022 May 17. pii: 6587132. doi: 10.1093.
    >> Share

  437. MARTINUZZI E, Benzaquen J, Guerin O, Leroy S, et al
    A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects.
    Clin Infect Dis. 2022 May 17. pii: 6586846. doi: 10.1093.
    >> Share

  438. SHOHAM S, Bloch EM, Casadevall A, Hanley D, et al
    Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial.
    Clin Infect Dis. 2022 May 17. pii: 6586841. doi: 10.1093.
    >> Share

  439. WEITZMAN ER, Kossowsky J, Blakemore LM, Cox R, et al
    Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
    Clin Infect Dis. 2022 May 17. pii: 6586840. doi: 10.1093.
    >> Share

  440. ODUMADE OA, van Haren SD, Angelidou A
    Implications of the SARS-CoV-2 pandemic on the epidemiology of pediatric Respiratory Syncytial Virus (RSV) infection.
    Clin Infect Dis. 2022 May 17. pii: 6586842. doi: 10.1093.
    >> Share

  441. WEITZMAN ER, Sherman AC, Levy O
    Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
    Clin Infect Dis. 2022 May 17. pii: 6586838. doi: 10.1093.
    >> Share

  442. COLE KA, Zhou AY, Jones T, Moore WJ, et al
    How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists.
    Clin Infect Dis. 2022;74.
    >> Share

  443. NEMATOLLAHI S, Minter DJ, Barlow B, Nolan NS, et al
    The Digital Classroom: How to Leverage Social Media for Infectious Diseases Education.
    Clin Infect Dis. 2022;74.
    >> Share

  444. SCHWARTZ IS, McCarty T, Woc-Colburn LE, Titanji BK, et al
    Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club.
    Clin Infect Dis. 2022;74.
    >> Share

  445. BARI A, Heymann M, Cohen RJ, Zhao R, et al
    Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms.
    Clin Infect Dis. 2022;74.
    >> Share

  446. ZENG C, Zhang J, Li Z, Sun X, et al
    Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis.
    Clin Infect Dis. 2022;74.
    >> Share

  447. DESAI AN, Ruidera D, Steinbrink JM, Granwehr B, et al
    Misinformation and Disinformation: The Potential Disadvantages of Social Media in Infectious Disease and How to Combat Them.
    Clin Infect Dis. 2022;74.
    >> Share

  448. POH XY, Tan CW, Lee IR, Chavatte JM, et al
    Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial.
    Clin Infect Dis. 2022 May 11. pii: 6583615. doi: 10.1093.
    >> Share

  449. DE CASTILHOS J, Zamir E, Hippchen T, Rohrbach R, et al
    Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
    Clin Infect Dis. 2022 May 10. pii: 6583345. doi: 10.1093.
    >> Share

  450. CONTI MG, Terreri S, Terrin G, Natale F, et al
    SARS-CoV-2 infection versus vaccination in pregnancy: Implications for maternal and infant immunity.
    Clin Infect Dis. 2022 May 10. pii: 6583148. doi: 10.1093.
    >> Share

  451. MOISAN A, Mastrovito B, De Oliveira F, Martel M, et al
    Evidence of transmission and circulation of Deltacron XD recombinant SARS-CoV-2 in Northwest France.
    Clin Infect Dis. 2022 May 10. pii: 6583149. doi: 10.1093.
    >> Share

  452. SPARKE M, Levy O
    Competing responses to global inequalities in access to COVID vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
    Clin Infect Dis. 2022 May 10. pii: 6583150. doi: 10.1093.
    >> Share

  453. ZURCHER K, Abela IA, Stange M, Dupont C, et al
    Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies.
    Clin Infect Dis. 2022 May 6. pii: 6582009. doi: 10.1093/cid/ciab1005.
    >> Share

  454. DALAI SC, Dines JN, Snyder TM, Gittelman RM, et al
    Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 May 6. pii: 6581622. doi: 10.1093.
    >> Share

  455. DOWLING DJ, Levy O
    A Precision Adjuvant Approach to Enhance SARS-CoV-2 Vaccines Optimized for Immunologically Distinct Vulnerable Populations.
    Clin Infect Dis. 2022 May 4. pii: 6580093. doi: 10.1093.
    >> Share

  456. LASSER J, Hell T, Garcia D
    Assessment of the effectiveness of Omicron transmission mitigation strategies for European universities using an agent-based network model.
    Clin Infect Dis. 2022 May 3. pii: 6577094. doi: 10.1093.
    >> Share

  457. BUTT AA, Talisa VB, Shaikh OS, Omer SB, et al
    Relative Vaccine Effectiveness of a SARS-CoV-2 mRNA Vaccine Booster Dose Against the Omicron Variant.
    Clin Infect Dis. 2022 May 3. pii: 6577096. doi: 10.1093.
    >> Share

  458. VERDERESE JP, Henry L, Younossi ZM
    Reply to Bailly et al.
    Clin Infect Dis. 2022;74:1707-1708.
    >> Share

    April 2022
  459. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Correction to: Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574996. doi: 10.1093.
    >> Share

  460. ROSS JA, Malone PK, Levy S
    The Impact of the SARS-CoV-2 Pandemic on Substance Use in the US.
    Clin Infect Dis. 2022 Apr 27. pii: 6574792. doi: 10.1093.
    >> Share

  461. CADNUM JL, Jencson AL, Alhmidi H, Zabarsky TF, et al
    Airflow patterns in double occupancy patient rooms may contribute to roommate-to-roommate transmission of severe acute respiratory syndrome coronavirus 2.
    Clin Infect Dis. 2022 Apr 27. pii: 6574835. doi: 10.1093.
    >> Share

  462. SHRESTHA NK, Shrestha P, Burke PC, Nowacki AS, et al
    Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals.
    Clin Infect Dis. 2022 Apr 27. pii: 6574819. doi: 10.1093.
    >> Share

  463. CORVOL H, de Miranda S, Dehillotte C, Lemonnier L, et al
    Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis.
    Clin Infect Dis. 2022 Apr 27. pii: 6574734. doi: 10.1093.
    >> Share

  464. SHARMA A, Oda G, Holodniy M
    Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Apr 27. pii: 6574744. doi: 10.1093.
    >> Share

  465. BUSKERMOLEN M, Molthof I, Voeten HA, van Twillert J, et al
    Vaccination did not prevent severe COVID in an outbreak among older residents of a nursing home, B.1.617.2 variant, July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574733. doi: 10.1093.
    >> Share

  466. BENFIELD T, Bodilsen J, Brieghel C, Harboe ZB, et al
    Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.
    Clin Infect Dis. 2022 Apr 23. pii: 6572821. doi: 10.1093.
    >> Share

  467. GAYLIS NB, Ritter A, Kelly SA, Pourhassan NZ, et al
    Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome.
    Clin Infect Dis. 2022 Apr 22. pii: 6572226. doi: 10.1093.
    >> Share

  468. HOLUBAR M, Subramanian A, Purington N, Hedlin H, et al
    Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial.
    Clin Infect Dis. 2022 Apr 21. pii: 6572081. doi: 10.1093.
    >> Share

  469. SOLERA JT, Arbol BG, Alshahrani A, Bahinskaya I, et al
    Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Clin Infect Dis. 2022 Apr 21. pii: 6571785. doi: 10.1093.
    >> Share

  470. LIANG EN W, Ko KK, Conceicao EP, Aung MK, et al
    Enhanced infection-prevention measures including universal N95 usage and daily testing: the impact on SARS-CoV-2 transmission in cohorted hospital cubicles through successive Delta and Omicron waves.
    Clin Infect Dis. 2022 Apr 21. pii: 6571575. doi: 10.1093.
    >> Share

  471. ZAHRA FT, Grubbs G, Dummer K, Tremoulet AH, et al
    Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.
    Clin Infect Dis. 2022 Apr 21. pii: 6571576. doi: 10.1093.
    >> Share

  472. LONG SM, Chern A, Cooley V, Chung S, et al
    Temporal Dynamics of Nasopharyngeal and Tracheal SARS-CoV-2 Cycle Thresholds in COVID-19 Patients with Tracheostomy.
    Clin Infect Dis. 2022 Apr 20. pii: 6571468. doi: 10.1093.
    >> Share

  473. LOPEZ MONTESINOS I, Arrieta-Aldea I, Dicastillo A, Zuccarino F, et al
    Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption.
    Clin Infect Dis. 2022 Apr 20. pii: 6571459. doi: 10.1093.
    >> Share

  474. BONENFANT G, Deyoe J, Wong T, Grijalva CG, et al
    Surveillance and correlation of SARS-CoV-2 viral RNA, antigen, virus isolation, and self-reported symptoms in a longitudinal study with daily sampling.
    Clin Infect Dis. 2022 Apr 20. pii: 6571330. doi: 10.1093.
    >> Share

  475. MELGAR M, Haston J, DeCuir J, Cheng Q, et al
    Multisystem inflammatory syndrome in adults (MIS-A): case finding through systematic review of electronic medical records.
    Clin Infect Dis. 2022 Apr 20. pii: 6571412. doi: 10.1093.
    >> Share

  476. DAN J, da Silva Antunes R, Grifoni A, Weiskopf D, et al
    Observations and perspectives on adaptive immunity to SARS-CoV-2.
    Clin Infect Dis. 2022 Apr 20. pii: 6571103. doi: 10.1093.
    >> Share

  477. KIM J, Choe YJ, Jang EJ, Lim DS, et al
    Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022.
    Clin Infect Dis. 2022 Apr 19. pii: 6570782. doi: 10.1093.
    >> Share

  478. NANISHI E, Angelidou A, Rotman C, Dowling DJ, et al
    Precision Vaccine Adjuvants for Older Adults: A Scoping Review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570880. doi: 10.1093.
    >> Share

  479. LEVY O, Angelidou A, Idoko O, Lewis NP, et al
    Precision Vaccines: Lessons Learned from the Coronavirus Pandemic.
    Clin Infect Dis. 2022 Apr 19. pii: 6570826. doi: 10.1093.
    >> Share

  480. PLUMMER JT, Contreras D, Zhang W, Binek A, et al
    USA SARS-CoV-2 Epsilon Variant: Though Highly Transmissible has an Adjusted Muted Host T-Cell Response.
    Clin Infect Dis. 2022 Apr 19. pii: 6570676. doi: 10.1093.
    >> Share

  481. WOLDEMESKEL BA, Garliss CC, Aytenfisu TY, Johnston TS, et al
    Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient.
    Clin Infect Dis. 2022 Apr 19. pii: 6570698. doi: 10.1093.
    >> Share

  482. SKOWRONSKI DM, Febriani Y, Ouakki M, Setayeshgar S, et al
    Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada.
    Clin Infect Dis. 2022 Apr 19. pii: 6570607. doi: 10.1093.
    >> Share

  483. MAEDA H, Saito N, Igarashi A, Ishida M, et al
    Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
    Clin Infect Dis. 2022 Apr 19. pii: 6570603. doi: 10.1093.
    >> Share

  484. ALYSSA FITZPATRICK A, Cooper C, Vasilunas N, Ritchie B, et al
    Describing the impact of maternal hyperimmune globulin and valaciclovir on the outcomes of CMV infection in pregnancy: a systematic review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570695. doi: 10.1093.
    >> Share

  485. SHERMAN AC, Rouphael N, Baden LR
    COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic.
    Clin Infect Dis. 2022 Apr 18. pii: 6569988. doi: 10.1093.
    >> Share

  486. MASSO-SILVA JA, Moshensky A, Lam MTY, Odish M, et al
    Correction to: Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 Patients: A Case Series and Review of the Literature.
    Clin Infect Dis. 2022 Apr 13. pii: 6568031. doi: 10.1093.
    >> Share

  487. DALE AP, Almendares O, Howard B, Burnett E, et al
    Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021.
    Clin Infect Dis. 2022 Apr 12. pii: 6567536. doi: 10.1093.
    >> Share

  488. PREMIKHA M, Chiew CJ, Wei WE, Leo YS, et al
    Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore.
    Clin Infect Dis. 2022 Apr 12. pii: 6567428. doi: 10.1093.
    >> Share

  489. PAREDES MI, Lunn SM, Famulare M, Frisbie LA, et al
    Associations between SARS-CoV-2 variants and risk of COVID-19 hospitalization among confirmed cases in Washington State: a retrospective cohort study.
    Clin Infect Dis. 2022 Apr 12. pii: 6567408. doi: 10.1093.
    >> Share

  490. MOLODTSOV IA, Kegeles E, Mitin AN, Mityaeva O, et al
    SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study.
    Clin Infect Dis. 2022 Apr 12. pii: 6567222. doi: 10.1093.
    >> Share

  491. TADESSE BT, Khanam F, Ahmed F, Im J, et al
    Prevention of typhoid by Vi conjugate vaccine and achievable improvements in household WASH: Evidence from a cluster-randomized trial in Dhaka, Bangladesh.
    Clin Infect Dis. 2022 Apr 12. pii: 6567455. doi: 10.1093.
    >> Share

  492. BUTT AA, Dargham SR, Loka S, Shaik RM, et al
    COVID-19 Disease Severity in Children Infected with the Omicron Variant.
    Clin Infect Dis. 2022 Apr 11. pii: 6566327. doi: 10.1093.
    >> Share

  493. SKEGGS J, MacPhail A, Korman T, Woolley I, et al
    Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data.
    Clin Infect Dis. 2022 Apr 11. pii: 6566296. doi: 10.1093.
    >> Share

  494. MARGALIT I, Yelin D, Sagi M, Rahat MM, et al
    Risk factors and multidimensional assessment of long COVID fatigue: a nested case-control study.
    Clin Infect Dis. 2022 Apr 11. pii: 6566295. doi: 10.1093.
    >> Share

  495. RZYMSKI P, Falfushynska H, Fal A
    Vaccination of Ukrainian Refugees: Need for Urgent Action.
    Clin Infect Dis. 2022 Apr 11. pii: 6569707. doi: 10.1093.
    >> Share

  496. KUSEJKO K, Salazar-Vizcaya L, Shah C, Stockle M, et al
    Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV Cohort Study: A systematic re-screening for hepatitis C RNA two years following a nation-wide elimination program.
    Clin Infect Dis. 2022 Apr 11. pii: 6566325. doi: 10.1093.
    >> Share

  497. CAI J, Lin Y, Wu MJ
    Letter to editor regarding "Clinical Presentation and Outcomes of Pregnant Women With Coronavirus Disease 2019: A Systematic Review and Meta-analysis".
    Clin Infect Dis. 2022;74:1319.
    >> Share

  498. RASMUSSEN TA, Ahuja SK, Kuwanda L, Vjecha MJ, et al
    Antiretroviral initiation at >/=800 CD4+ cells/ mm 3 associated with lower HIV reservoir size.
    Clin Infect Dis. 2022 Apr 9. pii: 6565728. doi: 10.1093.
    >> Share

  499. KOLODZIEJ LM, van Lelyveld SFL, Haverkort ME, Mariman R, et al
    High SARS-CoV-2 household transmission rates detected by dense saliva sampling.
    Clin Infect Dis. 2022 Apr 6. pii: 6564312. doi: 10.1093.
    >> Share

  500. GAZIT S, Shlezinger R, Perez G, Lotan R, et al
    SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.
    Clin Infect Dis. 2022 Apr 5. pii: 6563799. doi: 10.1093.
    >> Share

  501. ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
    Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
    Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
    >> Share

  502. PARK S, Lim SY, Kim JY, Park H, et al
    Clinical and virological characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant: a prospective cohort study.
    Clin Infect Dis. 2022 Apr 1. pii: 6562005. doi: 10.1093.
    >> Share

    March 2022
  503. GARRETT N, Tapley A, Andriesen J, Seocharan I, et al
    High Asymptomatic Carriage with the Omicron Variant in South Africa.
    Clin Infect Dis. 2022 Mar 30. pii: 6556153. doi: 10.1093.
    >> Share

  504. TANDE AJ, Swift MD, Challener DW, Berbari EF, et al
    Utility of Follow-up COVID-19 Antigen Tests After Acute SARS-CoV-2 Infection Among Healthcare Personnel.
    Clin Infect Dis. 2022 Mar 30. pii: 6555774. doi: 10.1093.
    >> Share

  505. NATHAVITHARANA RR, Mishra H, Sullivan A, Hurwitz S, et al
    Predicting airborne infection risk: Association between personal ambient carbon dioxide level monitoring and incidence of tuberculosis infection in South African health workers.
    Clin Infect Dis. 2022 Mar 26. pii: 6554598. doi: 10.1093.
    >> Share

  506. DOLL MK, Pettigrew SM, Ma J, Verma A, et al
    Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Clin Infect Dis. 2022 Mar 24. pii: 6553950. doi: 10.1093.
    >> Share

  507. HERNANDEZ AV, Roman YM, Burela PA, Pasupuleti V, et al
    Reply to Banno et al and Padhi et al.
    Clin Infect Dis. 2022;74:1122-1123.
    >> Share

  508. NG OT, Koh V, Chiew CJ, Marimuthu K, et al
    Impact of SARS-CoV-2 Vaccination and Paediatric Age on Delta Variant Household Transmission.
    Clin Infect Dis. 2022 Mar 22. pii: 6551710. doi: 10.1093.
    >> Share

  509. CHANDNA A, Mahajan R, Gautam P, Mwandigha L, et al
    Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings.
    Clin Infect Dis. 2022 Mar 21. pii: 6551704. doi: 10.1093.
    >> Share

  510. GIMENEZ E, Albert E, Zulaica J, Torres I, et al
    SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty(R) COVID-19 vaccine.
    Clin Infect Dis. 2022 Mar 21. pii: 6551700. doi: 10.1093.
    >> Share


  511. Erratum to: Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.
    Clin Infect Dis. 2022 Mar 17. pii: 6549865. doi: 10.1093.
    >> Share

  512. EDELSTEIN M, Beiruti KW, Ben-Amram H, Bar-Zeev N, et al
    Antibody-mediated Immunogenicity against SARS-CoV-2 following priming, boosting and hybrid immunity: insights from 11 months of follow-up of a healthcare worker cohort in Israel, December 2020-October 2021.
    Clin Infect Dis. 2022 Mar 12. pii: 6547893. doi: 10.1093.
    >> Share

  513. DOERNBERG SB, Holubar M, Jain V, Weng Y, et al
    Incidence and prevalence of COVID-19 within a healthcare worker cohort during the first year of the SARS-CoV-2 pandemic.
    Clin Infect Dis. 2022 Mar 12. pii: 6547892. doi: 10.1093.
    >> Share

  514. GALLAGHER KME, Leick MB, Larson RC, Berger TR, et al
    Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals.
    Clin Infect Dis. 2022 Mar 12. pii: 6547848. doi: 10.1093.
    >> Share

  515. ALSVED M, Nygren D, Thuresson S, Medstrand P, et al
    SARS-CoV-2 in exhaled aerosol particles from covid-19 cases and its association to household transmission.
    Clin Infect Dis. 2022 Mar 10. pii: 6546685. doi: 10.1093.
    >> Share

  516. FITZGERALD R, Dickinson L, Else L, Fletcher T, et al
    Pharmacokinetics of ss-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in non-plasma compartments of patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Mar 10. pii: 6546684. doi: 10.1093.
    >> Share

  517. CHENG VC, Ip JD, Chu AW, Tam AR, et al
    Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak.
    Clin Infect Dis. 2022 Mar 10. pii: 6546687. doi: 10.1093.
    >> Share

  518. RIFE MAGALIS B, Rich S, Tagliamonte MS, Mavian C, et al
    SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida.
    Clin Infect Dis. 2022 Mar 10. pii: 6546683. doi: 10.1093.
    >> Share

  519. WESTBROOK AL, Benedit LC, Frediani JK, Griffiths MA, et al
    Predictive value of isolated symptoms for diagnosis of SARS-CoV-2 infection in children tested during peak circulation of the delta variant.
    Clin Infect Dis. 2022 Mar 10. pii: 6546602. doi: 10.1093.
    >> Share

  520. WOLTER N, Tempia S, von Gottberg A, Bhiman JN, et al
    Seroprevalence of SARS-CoV-2 after the second wave in South Africa in HIV-infected and uninfected persons: a cross-sectional household survey.
    Clin Infect Dis. 2022 Mar 10. pii: 6546682. doi: 10.1093.
    >> Share

  521. LUSTIG Y, Mendelson E, Mandelboim M, Biber A, et al
    Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis.
    Clin Infect Dis. 2022 Mar 10. pii: 6546613. doi: 10.1093.
    >> Share

  522. YAU CH, Masuda Y, Ng QX, Teoh SE, et al
    Addressing the Elephant in the Room: Intravenous Injection of COVID-19 mRNA.
    Clin Infect Dis. 2022 Mar 9. pii: 6545850. doi: 10.1093.
    >> Share

  523. BALCELLS ME, Le Corre N, Duran J, Ceballos ME, et al
    Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile.
    Clin Infect Dis. 2022 Mar 7. pii: 6543937. doi: 10.1093.
    >> Share

  524. SANDMANN FG, Tessier E, Lacy J, Kall M, et al
    Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls.
    Clin Infect Dis. 2022 Mar 5. pii: 6542727. doi: 10.1093.
    >> Share

  525. MOORLAG SJCFM, Taks E, Ten Doesschate T, van der Vaart TW, et al
    Efficacy of Bacillus Calmette-Guerin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic.
    Clin Infect Dis. 2022 Mar 5. pii: 6543010. doi: 10.1093.
    >> Share

  526. POLLOCK BD, Storlie CB, Tande AJ, Sampathkumar P, et al
    Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis.
    Clin Infect Dis. 2022 Mar 5. pii: 6542971. doi: 10.1093.
    >> Share

  527. HURST JH, McCumber AW, Aquino JN, Rodriguez J, et al
    Age-related changes in the nasopharyngeal microbiome are associated with SARS-CoV-2 infection and symptoms among children, adolescents, and young adults.
    Clin Infect Dis. 2022 Mar 5. pii: 6542968. doi: 10.1093.
    >> Share

  528. SARAVOLATZ LD, Depcinski S, Sharma M
    Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs.
    Clin Infect Dis. 2022 Mar 4. pii: 6542722. doi: 10.1093.
    >> Share

  529. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population.
    Clin Infect Dis. 2022 Mar 4. pii: 6542712. doi: 10.1093.
    >> Share

  530. SPINELLI MA, Le Tourneau N, Glidden DV, Hsu L, et al
    Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates during COVID-19: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2022 Mar 4. pii: 6542721. doi: 10.1093.
    >> Share

  531. BAI AD, Lo CKL, Komorowski AS, Suresh M, et al
    How generalizable are randomized controlled trials (RCTs) in Staphylococcus aureus bacteremia? A description of the mortality gap between RCTs and observational studies.
    Clin Infect Dis. 2022 Mar 4. pii: 6542216. doi: 10.1093.
    >> Share

  532. CHAN JF, Siu GK, Yuan S, Ip JD, et al
    Probable Animal-to-Human Transmission of SARS-CoV-2 Delta Variant AY.127 Causing a Pet Shop-Related COVID-19 Outbreak in Hong Kong.
    Clin Infect Dis. 2022 Mar 2. pii: 6541148. doi: 10.1093.
    >> Share

  533. SPEICH B, Chammartin F, Abela IA, Amico P, et al
    Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial.
    Clin Infect Dis. 2022 Mar 2. pii: 6540899. doi: 10.1093.
    >> Share

  534. HOENIGL M, Abramovitz D, Flores Ortega RE, Martin NK, et al
    Sustained impact of the COVID-2019 pandemic on HCV treatment initiations in the United States.
    Clin Infect Dis. 2022 Mar 2. pii: 6540915. doi: 10.1093.
    >> Share

  535. FISMAN DN, Tuite AR
    Age-Specific Changes in Virulence Associated with SARS-CoV-2 Variants of Concern.
    Clin Infect Dis. 2022 Mar 2. pii: 6541156. doi: 10.1093.
    >> Share

  536. KOTILOGLU-KARAA E, Kele B, Kulasegaran-Shylini R, Broad CE, et al
    SARS-CoV-2 placental infection is associated with massive perivillous fibrin deposition at the maternal-fetal interface: a preliminary study".
    Clin Infect Dis. 2022 Mar 2. pii: 6540910. doi: 10.1093.
    >> Share

  537. GANDHI M
    Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
    Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
    >> Share

  538. SAUD Z, Ponsford M, Bentley K, Cole JM, et al
    Mechanically ventilated patients shed high titre live SARS-CoV2 for extended periods from both the upper and lower respiratory tract.
    Clin Infect Dis. 2022 Mar 1. pii: 6540532. doi: 10.1093.
    >> Share

    February 2022
  539. THURESSON S, Fraenkel CJ, Sasinovich S, Soldemyr J, et al
    Airborne SARS-CoV-2 in hospitals - effects of aerosol-generating procedures, HEPA-filtration units, patient viral load and physical distance.
    Clin Infect Dis. 2022 Feb 28. pii: 6539846. doi: 10.1093.
    >> Share

  540. SIVAPALASINGAM S, Lederer DJ, Bhore R, Hajizadeh N, et al
    Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Feb 26. pii: 6537638. doi: 10.1093.
    >> Share

  541. KATONA P, Kullar R, Zhang K
    Bringing Transmission of SARS-CoV-2 to the Surface: Is there a Role for Fomites?
    Clin Infect Dis. 2022 Feb 26. pii: 6537376. doi: 10.1093.
    >> Share

  542. MA KC, Hale JE, Grad YH, Alter G, et al
    Trends in SARS-CoV-2 seroprevalence in Massachusetts estimated from newborn screening specimens.
    Clin Infect Dis. 2022 Feb 25. pii: 6537111. doi: 10.1093.
    >> Share

  543. SIGAL GB, Novak T, Mathew A, Chou J, et al
    Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay.
    Clin Infect Dis. 2022 Feb 25. pii: 6537114. doi: 10.1093.
    >> Share

  544. HELDMAN MR, Kates OS, Safa K, Kotton CN, et al
    Delayed mortality among solid organ transplant recipients hospitalized for COVID-19.
    Clin Infect Dis. 2022 Feb 25. pii: 6536752. doi: 10.1093.
    >> Share

  545. WANG Y, He Y, Tong J, Qin Y, et al
    Erratum to: Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China.
    Clin Infect Dis. 2022 Feb 24. pii: 6535534. doi: 10.1093.
    >> Share

  546. HAIDAR G, Agha M, Bilderback A, Lukanski A, et al
    Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.
    Clin Infect Dis. 2022 Feb 18. pii: 6530582. doi: 10.1093.
    >> Share

  547. LI C, Ye Z, Zhang AJ, Chan JF, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters.
    Clin Infect Dis. 2022 Feb 18. pii: 6530400. doi: 10.1093.
    >> Share

  548. COOPER DJ, Grigg MJ, Plewes K, Rajahram GS, et al
    The effect of regularly dosed acetaminophen versus no acetaminophen on renal function in Plasmodium knowlesi malaria (PACKNOW): a randomised controlled trial.
    Clin Infect Dis. 2022 Feb 18. pii: 6532035. doi: 10.1093.
    >> Share

  549. BRIZZI A, O'Driscoll M, Dorigatti I
    Refining reproduction number estimates to account for unobserved generations of infection in emerging epidemics.
    Clin Infect Dis. 2022 Feb 17. pii: 6530349. doi: 10.1093.
    >> Share

  550. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels.
    Clin Infect Dis. 2022 Feb 16. pii: 6529520. doi: 10.1093.
    >> Share

  551. DU Z, Liu C, Wang C, Xu L, et al
    Reproduction Numbers of SARS-CoV-2 Variants: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2022 Feb 16. pii: 6529536. doi: 10.1093.
    >> Share

  552. VAN DEN BERG P, Schechter-Perkins EM, Jack RS, Epshtein I, et al
    Corrigendum to: Effectiveness of 3 Versus 6 ft of Physical Distancing for Controlling Spread of Coronavirus Disease 2019 Among Primary and Secondary Students and Staff: A Retrospective, Statewide Cohort Study.
    Clin Infect Dis. 2022 Feb 16. pii: 6529266. doi: 10.1093/cid/ciab1049.
    >> Share

  553. SCHUMACHER CM, Thornton N, Wagner J, Tilchin C, et al
    Sexually Transmitted Infection Transmission Dynamics During the Coronavirus Disease 2019 (COVID-19) Pandemic Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men.
    Clin Infect Dis. 2022 Feb 16. pii: 6520505. doi: 10.1093/cid/ciab1053.
    >> Share

  554. ERLANDSON KM, Fitch KV, McCallum SA, Ribaudo HJ, et al
    Geographical Differences in the Self-Reported Functional Impairment of People with HIV and Associations with Cardiometabolic Risk.
    Clin Infect Dis. 2022 Feb 15. pii: 6528571. doi: 10.1093.
    >> Share

  555. BERSHTEYN A, Dahl AM, Dong TQ, Deming ME, et al
    Self-Assessed Severity as a Determinant of COVID-19 Symptom Specificity: A Longitudinal Cohort Study.
    Clin Infect Dis. 2022 Feb 13. pii: 6527943. doi: 10.1093.
    >> Share

  556. GAO DX, Fisher LD, Miller DR, Geller AC, et al
    Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study.
    Clin Infect Dis. 2022 Feb 13. pii: 6527834. doi: 10.1093.
    >> Share

  557. HSU AL, Ohler AM, Goldstein A, Truong S, et al
    Coronavirus Disease 2019 (COVID-19) Disease Severity: Pregnant vs Nonpregnant Women at 82 Facilities.
    Clin Infect Dis. 2022;74:467-471.
    >> Share

  558. DONNELLY MAP, Chuey MR, Soto R, Schwartz NG, et al
    Household transmission of SARS-CoV-2 Alpha variant - United States, 2021.
    Clin Infect Dis. 2022 Feb 11. pii: 6526950. doi: 10.1093.
    >> Share

  559. ZAIA JA
    In the Fog of Coronavirus Disease (COVID).
    Clin Infect Dis. 2022;74:511-512.
    >> Share

  560. NIV Y, Eliakim-Raz N, Bar-Lavi Y, Green M, et al
    Comparing Covid-19 pandemic waves in hospitalized patients - a retrospective, multicenter, cohort study.
    Clin Infect Dis. 2022 Feb 10. pii: 6526377. doi: 10.1093.
    >> Share

  561. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Real-world Effectiveness of the SARS-CoV-2 mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
    Clin Infect Dis. 2022 Feb 9. pii: 6525466. doi: 10.1093.
    >> Share

  562. CONTOPOULOS-IOANNIDIS DG, Altamirano J, Maldonado Y
    Infectious Diseases-Related Hospitalizations During Oral Polio Vaccine(OPV) and non-OPV immunization periods: An Empirical Evaluation of all Hospital Discharges in California(1985-2010).
    Clin Infect Dis. 2022 Feb 9. pii: 6525447. doi: 10.1093.
    >> Share

  563. TANG W, Chen HL
    Predictors of SARS-CoV-2 infection: is there a comprehensive analysis?
    Clin Infect Dis. 2022 Feb 8. pii: 6524191. doi: 10.1093.
    >> Share

  564. BAKER MA, Rhee C, Tucker R, Badwaik A, et al
    Rapid control of hospital-based SARS-CoV-2 Omicron clusters through daily testing and universal use of N95 respirators.
    Clin Infect Dis. 2022 Feb 7. pii: 6523822. doi: 10.1093.
    >> Share

  565. DRAWZ PE, DeSilva M, Bodurtha P, Benitez GV, et al
    Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium.
    Clin Infect Dis. 2022 Feb 7. pii: 6523820. doi: 10.1093.
    >> Share

  566. LI Z, Lewis B, Berney K, Hallisey E, et al
    Social vulnerability and rurality associated with higher SARS-CoV-2 infection-induced seroprevalence: a nationwide blood donor study, United States, July 2020 - June 2021.
    Clin Infect Dis. 2022 Feb 7. pii: 6523818. doi: 10.1093.
    >> Share

  567. RISK M, Shen C, Hayek SS, Holevinski L, et al
    Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant.
    Clin Infect Dis. 2022 Feb 7. pii: 6523819. doi: 10.1093.
    >> Share

  568. PERNICIARO S, van der Linden M, Weinberger DM
    Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021.
    Clin Infect Dis. 2022 Feb 7. pii: 6523816. doi: 10.1093.
    >> Share

  569. ERAUSQUIN JT, Tan RKJ, Uhlich M, Francis JM, et al
    The International Sexual Health And Reproductive Health Survey (I-SHARE-1): A Multi-Country Analysis of Adults from 30 Countries Prior to and During the Initial COVID-19 Wave.
    Clin Infect Dis. 2022 Feb 7. pii: 6523817. doi: 10.1093.
    >> Share

  570. HELMSDAL G, Hansen OK, Moller LF, Christiansen DH, et al
    Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple-vaccinated healthcare workers.
    Clin Infect Dis. 2022 Feb 3. pii: 6520882. doi: 10.1093.
    >> Share

  571. NEUZIL KM
    Prevention and Control of COVID-19: Where do we go from here?
    Clin Infect Dis. 2022 Feb 3. pii: 6520891. doi: 10.1093.
    >> Share

  572. ONG SWX, Sutjipto S, Lee PH, Dugan C, et al
    Validation of ISARIC 4C mortality and deterioration scores in a mixed vaccination status cohort of hospitalized COVID-19 patients in Singapore.
    Clin Infect Dis. 2022 Feb 3. pii: 6520952. doi: 10.1093.
    >> Share

  573. PISCHEL L, Patel KM, Goshua G, Omer SB, et al
    Adenovirus-based vaccines and thrombosis in pregnancy: A systematic review and meta-analysis.
    Clin Infect Dis. 2022 Feb 2. pii: 6520532. doi: 10.1093.
    >> Share

  574. NOUSHAD M, Al-Awar MS, Al-Saqqaf IS, Nassani MZ, et al
    Lack of access to COVID-19 vaccines could be a greater threat than vaccine hesitancy in low-income and conflict nations: the case of Yemen.
    Clin Infect Dis. 2022 Feb 2. pii: 6520556. doi: 10.1093.
    >> Share

  575. MEIRING S, Tempia S, Bhiman JN, Buys A, et al
    Prolonged shedding of SARS-CoV-2 at high viral loads amongst hospitalised immunocompromised persons living with HIV, South Africa.
    Clin Infect Dis. 2022 Feb 2. pii: 6520530. doi: 10.1093.
    >> Share

  576. CROMER D, Reynaldi A, Steain M, Triccas JA, et al
    Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.
    Clin Infect Dis. 2022 Feb 1. pii: 6518223. doi: 10.1093.
    >> Share

  577. IMLAY H, Baum P, Brennan DC, Hanson KE, et al
    Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials.
    Clin Infect Dis. 2022 Feb 1. pii: 6518218. doi: 10.1093.
    >> Share

    January 2022
  578. FRIEDMAN N, Levy N, Kaplan O, Padeh G, et al
    Pediatric Hospitalizations after School Reopening during the SARS-CoV-2 Alpha (B.1.1.7) Variant Spread: A Multicenter Cross-sectional Study in Israel.
    Clin Infect Dis. 2022 Jan 29. pii: 6517373. doi: 10.1093.
    >> Share

  579. HOLMDAHL I, Kahn R, Slifka KJ, Dooling K, et al
    Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants.
    Clin Infect Dis. 2022 Jan 29. pii: 6517371. doi: 10.1093.
    >> Share

  580. WATKINS LKF, Mitruka K, Dorough L, Bressler SS, et al
    Characteristics of Reported Deaths Among Fully Vaccinated Persons with COVID-19 -United States, January-April 2021.
    Clin Infect Dis. 2022 Jan 29. pii: 6517385. doi: 10.1093.
    >> Share

  581. STRAHM C, Seneghini M, Gusewell S, Egger T, et al
    Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection - results of a prospective multicenter cohort.
    Clin Infect Dis. 2022 Jan 28. pii: 6516835. doi: 10.1093.
    >> Share

  582. PEROFSKY AC, Tempia S, Bingham J, Maslo C, et al
    The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 - September 2021.
    Clin Infect Dis. 2022 Jan 27. pii: 6515907. doi: 10.1093.
    >> Share

  583. MARRONE A, Nevola R, Sellitto A, Cozzolino D, et al
    Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study.
    Clin Infect Dis. 2022 Jan 27. pii: 6515763. doi: 10.1093.
    >> Share

  584. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: retrospective cohort study.
    Clin Infect Dis. 2022 Jan 27. pii: 6515675. doi: 10.1093/cid/ciab1032.
    >> Share

  585. SPAULDING AC, Zawitz C
    Vaccination in Prisons and Jails: Corrections Needed in Future Plans.
    Clin Infect Dis. 2022 Jan 27. pii: 6515673. doi: 10.1093/cid/ciab1031.
    >> Share

  586. LAWRENZ J, Xie Q, Zech F, Weil T, et al
    SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses.
    Clin Infect Dis. 2022 Jan 25. pii: 6515378. doi: 10.1093.
    >> Share

  587. MURUGESAN K, Jagannathan P, Altamirano J, Maldonado YA, et al
    Long Term Accuracy of SARS-CoV-2 Interferon-gamma Release Assay and its Application in Household Investigation.
    Clin Infect Dis. 2022 Jan 25. pii: 6515439. doi: 10.1093.
    >> Share

  588. MICHELI V, Bracchitta F, Rizzo A, Mancon A, et al
    First identification of the new SARS-CoV-2 Omicron variant (B.1.1.529) in Italy.
    Clin Infect Dis. 2022 Jan 21. pii: 6513588. doi: 10.1093/cid/ciab1044.
    >> Share

  589. ROWAN SE, McCormick DW, Wendel KA, Scott T, et al
    Lower Prevalence of SARS-CoV-2 Infection Among People Experiencing Homelessness Tested in Outdoor Encampments Compared with Overnight Shelters - Denver, Colorado, June - July 2020.
    Clin Infect Dis. 2022 Jan 18. pii: 6510919. doi: 10.1093.
    >> Share

  590. HUANG YA, Zhu W, Wiener J, Kourtis AP, et al
    Impact of COVID-19 on HIV Preexposure Prophylaxis Prescriptions in the United States - A Time Series Analysis.
    Clin Infect Dis. 2022 Jan 18. pii: 6510912. doi: 10.1093.
    >> Share

  591. PILZ S
    Contributions to the mitigation of the COVID-19 pandemic.
    Clin Infect Dis. 2022 Jan 17. pii: 6509528. doi: 10.1093.
    >> Share

  592. KRONFLI N, Dussault C, Maheu-Giroux M, Halavrezos A, et al
    Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021).
    Clin Infect Dis. 2022 Jan 17. pii: 6509066. doi: 10.1093.
    >> Share

  593. SHOJI K, Tsuzuki S, Akiyama T, Matsunaga N, et al
    Clinical characteristics and outcomes of COVID-19 in pregnant women: a propensity score matched analysis of the data from the COVID-19 Registry Japan.
    Clin Infect Dis. 2022 Jan 17. pii: 6509063. doi: 10.1093.
    >> Share

  594. LIU J, Laurie MT, Rubio L, Vazquez SE, et al
    SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons.
    Clin Infect Dis. 2022 Jan 17. pii: 6509064. doi: 10.1093.
    >> Share

  595. SEXTON ME, Waggoner JJ, Carmola LR, Nguyen PV, et al
    Rapid detection and characterization of SARS-CoV-2 omicron variant in a returning traveler.
    Clin Infect Dis. 2022 Jan 17. pii: 6509065. doi: 10.1093.
    >> Share

  596. MUSSI-PINHATA MM, Ward S, Laimon L, Pelton SI, et al
    Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jan 17. pii: 6509061. doi: 10.1093.
    >> Share

  597. SHRESTHA NK, Burke PC, Nowacki AS, Terpeluk P, et al
    Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19.
    Clin Infect Dis. 2022 Jan 13. pii: 6507165. doi: 10.1093.
    >> Share

  598. BAILIE CR, Tseng YY, Carolan L, Kirk MD, et al
    Trend in sensitivity of SARS-CoV-2 serology one year after mild and asymptomatic COVID-19: unpacking potential bias in seroprevalence studies.
    Clin Infect Dis. 2022 Jan 13. pii: 6506584. doi: 10.1093.
    >> Share

  599. WARREN BG, Nelson A, Barrett A, Addison B, et al
    SARS-CoV-2 Environmental contamination in hospital rooms is uncommon using viral culture techniques.
    Clin Infect Dis. 2022 Jan 12. pii: 6505265. doi: 10.1093.
    >> Share

  600. TODD FOJO A, Wallengren E, Schnure M, Dowdy DW, et al
    Potential Effects of the COVID-19 Pandemic on HIV Transmission: A Modeling Study in 32 US Cities.
    Clin Infect Dis. 2022 Jan 7. pii: 6500774. doi: 10.1093/cid/ciab1029.
    >> Share

  601. HEFTDAL LD, Schultz M, Lange T, Knudsen AD, et al
    Incidence of positive SARS-CoV-2 PCR after COVID-19 vaccination with up to eight months of follow-up: Real life data from the Capital Region of Denmark.
    Clin Infect Dis. 2022 Jan 7. pii: 6500168. doi: 10.1093.
    >> Share

  602. JANI IV, Peter TF
    Nucleic Acid Point-of-Care Testing to Improve Diagnostic Preparedness.
    Clin Infect Dis. 2022 Jan 7. pii: 6500010. doi: 10.1093.
    >> Share

  603. PARHIZKAR H, Dietz L, Olsen-Martinez A, Horve PF, et al
    Quantifying environmental mitigation of aerosol viral load in a controlled chamber with participants diagnosed with COVID-19.
    Clin Infect Dis. 2022 Jan 6. pii: 6498295. doi: 10.1093.
    >> Share

  604. LI X, Chan JM, Lam B, Lung DC, et al
    COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities.
    Clin Infect Dis. 2022 Jan 4. pii: 6497432. doi: 10.1093/cid/ciab1062.
    >> Share

  605. MARUKI T, Iwamoto N, Kanda K, Okumura N, et al
    Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international travelers to Japan.
    Clin Infect Dis. 2022 Jan 3. pii: 6494531. doi: 10.1093/cid/ciab1072.
    >> Share

  606. REDDY KP, Kruse GR, Lee S, Shuter J, et al
    Tobacco Use and Treatment of Tobacco Dependence Among People with HIV: A Practical Guide for Clinicians.
    Clin Infect Dis. 2022 Jan 3. pii: 6494528. doi: 10.1093/cid/ciab1069.
    >> Share

  607. JAKOBSEN A, Skov MT, Larsen L, Petersen PT, et al
    Herpes simplex virus 2 meningitis in adults: A prospective, nationwide, population-based cohort study.
    Clin Infect Dis. 2022 Jan 3. pii: 6494530. doi: 10.1093/cid/ciab1071.
    >> Share

    December 2021
  608. STEIN D, Oviedo-Orta E, Kampman WA, McGinniss J, et al
    Compassionate Use of REGEN-COV (R) in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders.
    Clin Infect Dis. 2021 Dec 31. pii: 6491226. doi: 10.1093/cid/ciab1059.
    >> Share

  609. YAMAMOTO S, Maeda K, Matsuda K, Tanaka A, et al
    COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study.
    Clin Infect Dis. 2021 Dec 24. pii: 6482345. doi: 10.1093/cid/ciab1048.
    >> Share

  610. ANDREJKO KL, Pry J, Myers JF, Openshaw J, et al
    Predictors of SARS-CoV-2 infection following high-risk exposure.
    Clin Infect Dis. 2021 Dec 21. pii: 6473597. doi: 10.1093/cid/ciab1040.
    >> Share

  611. SACHDEV DD, Chew Ng R, Sankaran M, Ernst A, et al
    Contact tracing outcomes among household contacts of fully vaccinated COVID-19 patients - San Francisco, California, January 29-July 2, 2021.
    Clin Infect Dis. 2021 Dec 20. pii: 6470866. doi: 10.1093/cid/ciab1042.
    >> Share

  612. TYNER HL, Burgess JL, Grant L, Gaglani M, et al
    Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Dec 20. pii: 6470720. doi: 10.1093/cid/ciab1038.
    >> Share

  613. PERSAD G, Peek ME, Shah SK
    Fair Allocation of Scarce Therapies for COVID-19.
    Clin Infect Dis. 2021 Dec 18. pii: 6469906. doi: 10.1093/cid/ciab1039.
    >> Share

  614. LUO CH, Morris CP, Sachithanandham J, Amadi A, et al
    Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
    Clin Infect Dis. 2021 Dec 18. pii: 6469786. doi: 10.1093.
    >> Share

  615. LU L, Mok BW, Chen LL, Chan JM, et al
    Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients.
    Clin Infect Dis. 2021 Dec 16. pii: 6463504. doi: 10.1093/cid/ciab1041.
    >> Share

  616. MUDENDA V, Mumba C, Pieciak RC, Mwananyanda L, et al
    Histopathological Evaluation of Deceased Persons in Lusaka, Zambia With or Without Coronavirus Disease 2019 (COVID-19) Infection: Results Obtained From Minimally Invasive Tissue Sampling.
    Clin Infect Dis. 2021;73.
    >> Share

  617. BASSAT Q, Varo R, Hurtado JC, Marimon L, et al
    Minimally Invasive Tissue Sampling as an Alternative to Complete Diagnostic Autopsies in the Context of Epidemic Outbreaks and Pandemics: The Example of Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2021;73.
    >> Share

  618. DUARTE-NETO AN, Ferraz da Silva LF, Monteiro RAA, Theodoro Filho J, et al
    Ultrasound-Guided Minimally Invasive Tissue Sampling: A Minimally Invasive Autopsy Strategy During the COVID-19 Pandemic in Brazil, 2020.
    Clin Infect Dis. 2021;73.
    >> Share

  619. GOCO NJ, McClure EM, Rakislova N, Bassat Q, et al
    Minimally Invasive Tissue Sampling Surveillance Alliance-Facilitating the Expansion of Pathology-Based Mortality Surveillance.
    Clin Infect Dis. 2021;73.
    >> Share

  620. RAKISLOVA N, Rodrigo-Calvo MT, Marimon L, Ribera-Cortada I, et al
    Minimally Invasive Tissue Sampling Findings in 12 Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021;73.
    >> Share

  621. GARIBALDI BT, Wang K, Robinson ML, Betz J, et al
    Real-World Effectiveness Of Remdesivir In Adults Hospitalized With Covid-19: A Retrospective, Multicenter Comparative Effectiveness Study.
    Clin Infect Dis. 2021 Dec 15. pii: 6463010. doi: 10.1093/cid/ciab1035.
    >> Share

  622. DANINO D, Ben-Shimol S, Van Der Beek BA, Givon-Lavi N, et al
    Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.
    Clin Infect Dis. 2021 Dec 14. pii: 6460745. doi: 10.1093/cid/ciab1014.
    >> Share

  623. BRUNEAU T, Wack M, Poulet G, Robillard N, et al
    Circulating ubiquitous RNA, a highly predictive and prognostic biomarker in hospitalized COVID-19 patients.
    Clin Infect Dis. 2021 Dec 11. pii: 6459561. doi: 10.1093.
    >> Share

  624. BART SM, Harizaj A, Pearson CL, Conteh T, et al
    SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021.
    Clin Infect Dis. 2021 Dec 10. pii: 6459157. doi: 10.1093/cid/ciab1025.
    >> Share

  625. KHAN K, Lustig G, Bernstein M, Archary D, et al
    Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.
    Clin Infect Dis. 2021 Dec 10. pii: 6459255. doi: 10.1093/cid/ciab1008.
    >> Share

  626. ROCCO JM, Mallarino-Haeger C, Randolph AH, Ray SM, et al
    Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation.
    Clin Infect Dis. 2021 Dec 10. pii: 6459155. doi: 10.1093/cid/ciab1024.
    >> Share

  627. FERNANDEZ-GONZALEZ M, Agullo V, Padilla S, Garcia JA, et al
    Clinical performance of a standardized SARS-CoV-2 interferon-gamma release assay for simple detection of T-cell responses after infection or vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6459152. doi: 10.1093/cid/ciab1021.
    >> Share

  628. BUTT AA, Yan P, Shaikh OS, Mayr FB, et al
    Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population.
    Clin Infect Dis. 2021 Dec 10. pii: 6459161. doi: 10.1093/cid/ciab1023.
    >> Share

  629. SHIN HS, Kim Y, Kang J, Um J, et al
    Longitudinal Analysis of Memory T cell Responses in Survivors of Middle East respiratory syndrome.
    Clin Infect Dis. 2021 Dec 10. pii: 6459149. doi: 10.1093/cid/ciab1019.
    >> Share

  630. TANG L, Cherry S, Tuomanen EI, Roubidoux EK, et al
    Host predictors of broadly cross-reactive antibodies against SARS-CoV-2 variants of concern differ between infection and vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6458694. doi: 10.1093.
    >> Share

  631. SHAW ER, Rosen LB, Cheng A, Dobbs K, et al
    Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in COVID-19 Patients.
    Clin Infect Dis. 2021 Dec 7. pii: 6455230. doi: 10.1093/cid/ciab1002.
    >> Share

  632. ENDO A
    Estimated Sensitivity Values of Severe Acute Respiratory Syndrome Coronavirus 2 Tests from Cross-sectional Data Warrant Caution Due to Unvalidated Model Assumptions.
    Clin Infect Dis. 2021;73:e3984-e3985.
    >> Share

  633. THOMAS BR
    Does Expert Opinion Trump Evidence?
    Clin Infect Dis. 2021;73:e3982-e3983.
    >> Share

  634. LOHR B, Niemann D, Verheyen J
    Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed Patient.
    Clin Infect Dis. 2021;73:2144-2145.
    >> Share

  635. SPINELLI MA, Peluso MJ, Lynch KL, Yun C, et al
    Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study.
    Clin Infect Dis. 2021 Dec 5. pii: 6453392. doi: 10.1093/cid/ciab1009.
    >> Share

  636. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2021 Dec 5. pii: 6453395. doi: 10.1093/cid/ciab1007.
    >> Share

  637. PANNUS P, Neven KY, De Craeye S, Heyndrickx L, et al
    Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naive residents of nursing homes.
    Clin Infect Dis. 2021 Dec 3. pii: 6448839. doi: 10.1093.
    >> Share

  638. KIM P, Gordon SM, Sheehan MM, Rothberg MB, et al
    Duration of SARS-CoV-2 Natural Immunity and Protection against the Delta Variant: A Retrospective Cohort Study.
    Clin Infect Dis. 2021 Dec 3. pii: 6448857. doi: 10.1093.
    >> Share

  639. JOSEPH NT, Satten GA, Williams RE, Haddad LB, et al
    The Effect of Antiretroviral Therapy for the Treatment of HIV-1 in Pregnancy on Gestational Weight Gain.
    Clin Infect Dis. 2021 Dec 3. pii: 6448917. doi: 10.1093.
    >> Share

    November 2021
  640. GRUNAU B, Asamoah-Boaheng M, Lavoie PM, Karim ME, et al
    A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
    Clin Infect Dis. 2021 Nov 30. pii: 6446287. doi: 10.1093.
    >> Share

  641. ZAVALA M, Ireland G, Amin-Chowdhury Z, Ramsay ME, et al
    Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: active, prospective, national surveillance.
    Clin Infect Dis. 2021 Nov 29. pii: 6446232. doi: 10.1093.
    >> Share

  642. BELAY ED, Godfred Cato S, Rao AK, Abrams J, et al
    Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445178. doi: 10.1093.
    >> Share

  643. CHUA GT, Kwan MYW, Chui CSL, Smith RD, et al
    Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445179. doi: 10.1093.
    >> Share

  644. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Post-vaccination SARS-CoV-2 antibody kinetics and protection duration.
    Clin Infect Dis. 2021 Nov 27. pii: 6444809. doi: 10.1093.
    >> Share

  645. SAHANIC S, Tymoszuk P, Ausserhofer D, Rass V, et al
    Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey.
    Clin Infect Dis. 2021 Nov 26. pii: 6440836. doi: 10.1093.
    >> Share

  646. CORREA H, Soslow JH, Dendy JM, Creech CB, et al
    Acute myopericarditis post intravenous injection of COVID-19 mRNA vaccine differs from viral myocarditis.
    Clin Infect Dis. 2021 Nov 26. pii: 6443709. doi: 10.1093.
    >> Share

  647. LI C, Chen Y, Zhao Y, Christopher Lung D, et al
    Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
    Clin Infect Dis. 2021 Nov 25. pii: 6438764. doi: 10.1093.
    >> Share

  648. GAZIT S, Mizrahi B, Kalkstein N, Neuberger A, et al
    BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of COVID-19 Patients.
    Clin Infect Dis. 2021 Nov 24. pii: 6437962. doi: 10.1093.
    >> Share

  649. MOLLAN KR, Eron JJ, Krajewski TJ, Painter W, et al
    Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
    Clin Infect Dis. 2021 Nov 23. pii: 6433715. doi: 10.1093.
    >> Share

  650. STRATHDEE SA, Abramovitz D, Harvey-Vera A, Vera CF, et al
    Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
    Clin Infect Dis. 2021 Nov 22. pii: 6433374. doi: 10.1093.
    >> Share

  651. CHUAH CH, Chow TS, Hor CP, Cheng JT, et al
    Efficacy of Early Treatment with Favipiravir on Disease Progression among High Risk COVID-19 Patients: A Randomized, Open-Label Clinical Trial.
    Clin Infect Dis. 2021 Nov 19. pii: 6432025. doi: 10.1093.
    >> Share

  652. CANADAY DH, Oyebanji OA, Keresztesy D, Payne M, et al
    Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
    Clin Infect Dis. 2021 Nov 19. pii: 6432026. doi: 10.1093.
    >> Share

  653. GILNER J, Kansal N, Biggio JR, Delaney S, et al
    Universal SARS-CoV-2 testing for obstetric inpatient units across the United States.
    Clin Infect Dis. 2021 Nov 17. pii: 6430425. doi: 10.1093.
    >> Share

  654. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    >> Share

  655. TEN DOESSCHATE T, Kuiper S, van Nieuwkoop C, Hassing RJ, et al
    Fosfomycin versus ciprofloxacin as oral stepdown treatment for Escherichia coli febrile urinary tract infection in women: a randomised, placebo-controlled, double blind, multicenter trial.
    Clin Infect Dis. 2021 Nov 16. pii: 6429720. doi: 10.1093.
    >> Share

  656. AKINBAMI LJ, Biggerstaff BJ, Chan PA, McGibbon E, et al
    Reinfection with SARS-CoV-2 among previously infected healthcare personnel and first responders.
    Clin Infect Dis. 2021 Nov 15. pii: 6428613. doi: 10.1093.
    >> Share

  657. LYNCH JB, Davitkov P, Anderson DJ, Bhimraj A, et al
    Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients with Suspected or Known COVID-19.
    Clin Infect Dis. 2021 Nov 15. pii: 6428563. doi: 10.1093.
    >> Share

  658. HARRIS TG, Jaszi E, Lamb MR, Laudari CA, et al
    Effects of the COVID-19 Pandemic on HIV Services: Findings from 11 Sub-Saharan African Countries.
    Clin Infect Dis. 2021 Nov 15. pii: 6428385. doi: 10.1093.
    >> Share

  659. SHEN Z, Xiao Y, Kang L, Ma W, et al
    Corrigendum to: Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021 Nov 13. pii: 6427503. doi: 10.1093.
    >> Share

  660. LI ZJ, Yu LJ, Zhang HY, Shan CX, et al
    Broad impacts of COVID-19 pandemic on acute respiratory infections in China: an observational study.
    Clin Infect Dis. 2021 Nov 12. pii: 6426178. doi: 10.1093.
    >> Share

  661. BEAN DJ, Monroe J, Turcinovic J, Moreau Y, et al
    SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies.
    Clin Infect Dis. 2021 Nov 10. pii: 6424810. doi: 10.1093.
    >> Share

  662. VIHTA KD, Pouwels KB, Peto T, Pritchard E, et al
    Symptoms and SARS-CoV-2 positivity in the general population in the UK.
    Clin Infect Dis. 2021 Nov 8. pii: 6423489. doi: 10.1093.
    >> Share

  663. LIEN CE, Kuo TY, Lin YJ, Lian WC, et al
    Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Clin Infect Dis. 2021 Nov 5. pii: 6421519. doi: 10.1093.
    >> Share

  664. PEREZ Y, Levy ER, Joshi AY, Virk A, et al
    Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
    Clin Infect Dis. 2021 Nov 3. pii: 6420408. doi: 10.1093.
    >> Share

  665. GRENINGER AL, Dien Bard J, Colgrove RC, Graf EH, et al
    Clinical and Infection Prevention Applications of SARS-CoV-2 Genotyping: An IDSA/ASM Consensus Review Document.
    Clin Infect Dis. 2021 Nov 3. pii: 6420112. doi: 10.1093.
    >> Share

  666. SHERMAN AC, Desjardins M, Cheng CA, Bausk B, et al
    SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
    Clin Infect Dis. 2021 Nov 2. pii: 6415965. doi: 10.1093.
    >> Share

  667. BOSCH W, Cowart JB, Bhakta S, Carter RE, et al
    COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.
    Clin Infect Dis. 2021 Nov 2. pii: 6415962. doi: 10.1093.
    >> Share

  668. LIU K, Ai S, Song S, Zhu G, et al
    Corrigendum to: Population Movement, City Closure in Wuhan, and Geographical Expansion of the COVID-19 Infection in China in January 2020.
    Clin Infect Dis. 2021 Nov 1. pii: 6414998. doi: 10.1093.
    >> Share

    October 2021
  669. CONWAY MORRIS A, Sharrocks K, Bousfield R, Kermack L, et al
    The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units.
    Clin Infect Dis. 2021 Oct 30. pii: 6414657. doi: 10.1093.
    >> Share

  670. DOUGAN M, Azizad M, Mocherla B, Gottlieb RL, et al
    A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic value of persistently high viral load.
    Clin Infect Dis. 2021 Oct 28. pii: 6413724. doi: 10.1093.
    >> Share

  671. LEDNICKY JA, Tagliamonte MS, White SK, Blohm GM, et al
    Isolation of a Novel Recombinant Canine Coronavirus from a Visitor to Haiti: Further Evidence of Transmission of Coronaviruses of Zoonotic Origin to Humans.
    Clin Infect Dis. 2021 Oct 28. pii: 6413759. doi: 10.1093.
    >> Share

  672. YANG B, Tsang TK, Gao H, Lau EHY, et al
    Universal community nucleic acid testing for COVID-19 in Hong Kong reveals insights into transmission dynamics: a cross-sectional and modelling study.
    Clin Infect Dis. 2021 Oct 28. pii: 6413763. doi: 10.1093.
    >> Share

  673. HORITA N, Kato H, Watanabe K, Hara Y, et al
    Declined mortality due to seasonal influenza in Japan during the coronavirus disease 2019 pandemic.
    Clin Infect Dis. 2021 Oct 28. pii: 6413653. doi: 10.1093.
    >> Share

  674. WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
    Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
    Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
    >> Share

  675. MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
    Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
    Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
    >> Share

  676. DE CASTILHOS J, Zamir E, Hippchen T, Rohrbach R, et al
    Severe dysbiosis and specific Haemophilus and Neisseria signatures as hallmarks of the oropharyngeal microbiome in critically ill COVID-19 patients.
    Clin Infect Dis. 2021 Oct 25. pii: 6409876. doi: 10.1093.
    >> Share

  677. WOLDEMESKEL BA, Garliss CC, Blankson JN
    mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
    Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
    >> Share

  678. WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
    Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
    Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
    >> Share

  679. BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
    Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords.
    Clin Infect Dis. 2021 Oct 20. pii: 6398590. doi: 10.1093.
    >> Share

  680. BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
    Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatment guideline panel.
    Clin Infect Dis. 2021 Oct 20. pii: 6398589. doi: 10.1093.
    >> Share

  681. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Severity, criticality, and fatality of the SARS-CoV-2 Beta variant.
    Clin Infect Dis. 2021 Oct 17. pii: 6398699. doi: 10.1093.
    >> Share

  682. BROSSEAU LM, Escandon K, Ulrich AK, Rasmussen AL, et al
    SARS-CoV-2 Dose, Infection, and Disease Outcomes for COVID-19 - A Review.
    Clin Infect Dis. 2021 Oct 15. pii: 6397523. doi: 10.1093.
    >> Share

  683. ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
    Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
    Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
    >> Share

  684. PELUSO MJ, Thomas IJ, Munter SE, Deeks SG, et al
    Lack of Antinuclear Antibodies in Convalescent COVID-19 Patients with Persistent Symptoms.
    Clin Infect Dis. 2021 Oct 7. pii: 6383256. doi: 10.1093.
    >> Share

  685. ZHANG J, Lin H, Ye B, Zhao M, et al
    One-year sustained cellular and humoral immunities of COVID-19 convalescents.
    Clin Infect Dis. 2021 Oct 5. pii: 6381561. doi: 10.1093.
    >> Share

  686. KLOMPAS M, Ye S, Vaidya V, Ochoa A, et al
    Association between Airborne Infection Isolation Room Utilization Rates and Healthcare Worker COVID-19 Infections in Two Academic Hospitals.
    Clin Infect Dis. 2021 Oct 2. pii: 6380290. doi: 10.1093.
    >> Share

  687. BAILLY B, Pere H, Veyer D, Berceanu A, et al
    Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies.
    Clin Infect Dis. 2021 Oct 1. pii: 6379055. doi: 10.1093.
    >> Share

  688. MOZAFFARI E, Chandak A, Zhang Z, Liang S, et al
    Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort.
    Clin Infect Dis. 2021 Oct 1. pii: 6378778. doi: 10.1093.
    >> Share

  689. ZHU N, Rawson TM, Mookerjee S, Price JR, et al
    Changing patterns of bloodstream infections in the community and acute care across two COVID-19 epidemic waves: a retrospective analysis using data linkage.
    Clin Infect Dis. 2021 Oct 1. pii: 6378783. doi: 10.1093.
    >> Share

    September 2021
  690. JAAFAR R, Aherfi S, Wurtz N, Grimaldier C, et al
    Corrigendum to: Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates.
    Clin Infect Dis. 2021 Sep 29. pii: 6377803. doi: 10.1093.
    >> Share

  691. FORD N, Vitoria M, Doherty M
    WHO guidance to support HIV care models during the Covid-19 era.
    Clin Infect Dis. 2021 Sep 24. pii: 6374892. doi: 10.1093.
    >> Share

  692. STAUFT CB, Tegenge M, Khurana S, Lee Y, et al
    Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters.
    Clin Infect Dis. 2021 Sep 23. pii: 6374486. doi: 10.1093.
    >> Share

  693. LESIEUR E, Torrents J, Fina F, Zandotti C, et al
    Congenital infection of SARS-CoV-2 with intrauterine foetal death: a clinicopathological study with molecular analysis.
    Clin Infect Dis. 2021 Sep 23. pii: 6374309. doi: 10.1093.
    >> Share

  694. ZHU F, Jin P, Zhu T, Wang W, et al
    Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial.
    Clin Infect Dis. 2021 Sep 22. pii: 6374123. doi: 10.1093.
    >> Share

  695. FRALEY E, LeMaster C, Khanal S, Banerjee D, et al
    Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine.
    Clin Infect Dis. 2021 Sep 22. pii: 6373987. doi: 10.1093.
    >> Share

  696. HASAN ALI O, Bomze D, Risch L, Brugger SD, et al
    Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
    Clin Infect Dis. 2021 Sep 22. pii: 6373914. doi: 10.1093.
    >> Share

  697. HU M, Wang J, Lin H, Ruktanonchai CW, et al
    Risk of SARS-CoV-2 Transmission among Air Passengers in China.
    Clin Infect Dis. 2021 Sep 21. pii: 6373518. doi: 10.1093.
    >> Share

  698. CHAUHAN L, Pattee J, Ford J, Thomas C, et al
    A Multi-center, Prospective, Observational-cohort controlled study of Clinical Outcomes following COVID-19 Convalescent plasma therapy in hospitalized COVID-19 patients.
    Clin Infect Dis. 2021 Sep 21. pii: 6373512. doi: 10.1093.
    >> Share

  699. WHITTAKER C, Watson OJ, Alvarez-Moreno C, Angkasekwinai N, et al
    Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis.
    Clin Infect Dis. 2021 Sep 21. pii: 6373521. doi: 10.1093.
    >> Share

  700. BUENO SM, Abarca K, Gonzalez PA, Galvez NMS, et al
    Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in a Subgroup of Healthy Adults in Chile.
    Clin Infect Dis. 2021 Sep 19. pii: 6372423. doi: 10.1093.
    >> Share

  701. CHAN JF, Poon VK, Chan CC, Chik KK, et al
    Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters.
    Clin Infect Dis. 2021 Sep 18. pii: 6372264. doi: 10.1093.
    >> Share

  702. MAN NIU M, Cao Y, Li RX, Fan GZ, et al
    Outcome heterogeneity in COVID-19 patients receiving tocilizumab.
    Clin Infect Dis. 2021 Sep 17. pii: 6371851. doi: 10.1093.
    >> Share

  703. MOON RC, Mackey RH, Cao Z, Emont S, et al
    Is COVID-19 Less Deadly Now? -- Trends of In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States.
    Clin Infect Dis. 2021 Sep 17. pii: 6371824. doi: 10.1093.
    >> Share

  704. ANANWORANICH J, Mogg R, Dunne MW, Bassyouni M, et al
    Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19.
    Clin Infect Dis. 2021 Sep 15. pii: 6370549. doi: 10.1093.
    >> Share

  705. STRUTNER J, Ramchandar N, Dubey S, Gamboa M, et al
    Comparison of RT-PCR Cycle Threshold Values from Respiratory Specimens in Symptomatic and Asymptomatic Children with SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Sep 15. pii: 6370557. doi: 10.1093.
    >> Share

  706. PECHTER E, Lessin N, Brosseau L
    Schools and Coronavirus Disease 2019 Prevention.
    Clin Infect Dis. 2021;73:e1403-e1404.
    >> Share

  707. ADENAIYE OO, Lai J, de Mesquita PJB, Hong F, et al
    Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection.
    Clin Infect Dis. 2021 Sep 14. pii: 6370149. doi: 10.1093.
    >> Share

  708. PAMPA-ESPINOZA L, Silva-Valencia J, Fernandez M, Padilla-Rojas C, et al
    Reinfections are more frequent than currently considered in countries with high incidence of COVID-19 cases due to stringent definitions.
    Clin Infect Dis. 2021 Sep 11. pii: 6368494. doi: 10.1093.
    >> Share

  709. BAROCAS JA, Savinkina A, Lodi S, Epstein RL, et al
    Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study.
    Clin Infect Dis. 2021 Sep 9. pii: 6367757. doi: 10.1093.
    >> Share

  710. TO KK, Li X, Lung DC, Ip JD, et al
    False COVID-19 cases due to contamination by inactivated virus vaccine.
    Clin Infect Dis. 2021 Sep 9. pii: 6367446. doi: 10.1093.
    >> Share

  711. LEE M
    Lack of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Antibodies to Seasonal Coronaviruses: Making Sense of the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2021;73:e1212-e1213.
    >> Share

  712. KULKARNI O, Narreddy S, Zaveri L, Kalal IG, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein.
    Clin Infect Dis. 2021;73:e1239-e1241.
    >> Share

  713. GUARALDI G, Milic J, Martinez E, Kamarulzaman A, et al
    Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era.
    Clin Infect Dis. 2021;73:e1222-e1227.
    >> Share

  714. GRINT DJ, Wing K, Houlihan C, Gibbs HP, et al
    Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England.
    Clin Infect Dis. 2021 Sep 6. pii: 6365124. doi: 10.1093.
    >> Share

  715. WYNBERG E, van Willigen HDG, Dijkstra M, Boyd A, et al
    Evolution of COVID-19 symptoms during the first 12 months after illness onset.
    Clin Infect Dis. 2021 Sep 2. pii: 6362727. doi: 10.1093.
    >> Share

  716. FEDER KA, Patel A, Vepachedu VR, Dominguez C, et al
    Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
    Clin Infect Dis. 2021 Sep 2. pii: 6362726. doi: 10.1093.
    >> Share

  717. SNYMAN J, Hwa SH, Krause R, Muema D, et al
    Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave.
    Clin Infect Dis. 2021 Sep 2. pii: 6362722. doi: 10.1093.
    >> Share

  718. TAGLIAMONTE MS, Mavian C, Zainabadi K, Cash MN, et al
    Rapid emergence and spread of SARS-CoV-2 gamma (P.1) variant in Haiti.
    Clin Infect Dis. 2021 Sep 2. pii: 6359631. doi: 10.1093.
    >> Share

  719. STRICH JR, Tian X, Samour M, King CS, et al
    Fostamatinib for the treatment of hospitalized adults with COVD-19 A randomized trial.
    Clin Infect Dis. 2021 Sep 1. pii: 6358811. doi: 10.1093.
    >> Share

  720. SHAW J, Hanley S, Stewart T, Salmon DA, et al
    Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization.
    Clin Infect Dis. 2021 Sep 1. pii: 6357694. doi: 10.1093.
    >> Share

    August 2021
  721. MARTINEZ DA, Klein EY, Parent C, Prieto D, et al
    Latino Household Transmission of SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 31. pii: 6360016. doi: 10.1093.
    >> Share

  722. CARAZO S, Talbot D, Boulianne N, Brisson M, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
    Clin Infect Dis. 2021 Aug 30. pii: 6359881. doi: 10.1093.
    >> Share

  723. XIN H, Li Y, Wu P, Li Z, et al
    Estimating the latent period of coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2021 Aug 28. pii: 6359063. doi: 10.1093.
    >> Share

  724. KNOWLTON KU
    Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
    Clin Infect Dis. 2021 Aug 28. pii: 6359059. doi: 10.1093.
    >> Share

  725. GOTTLIEB L, Fridkin SK
    It's hard to measure success while caring for surges in COVID-19 hospitalizations.
    Clin Infect Dis. 2021 Aug 28. pii: 6359066. doi: 10.1093.
    >> Share

  726. MACK CD, Tai C, Sikka R, Grad YH, et al
    SARS-CoV-2 Reinfection: A Case Series from a 12-Month Longitudinal Occupational Cohort.
    Clin Infect Dis. 2021 Aug 28. pii: 6359055. doi: 10.1093.
    >> Share

  727. ONG SWX, Chiew CJ, Ang LW, Mak TM, et al
    Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta).
    Clin Infect Dis. 2021 Aug 23. pii: 6356459. doi: 10.1093.
    >> Share

  728. NARAYANAN S, Chua JV, Baddley JW
    COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease.
    Clin Infect Dis. 2021 Aug 22. pii: 6356215. doi: 10.1093.
    >> Share

  729. WONG CKH, Lau KTK, Au ICH, Xiong X, et al
    Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone.
    Clin Infect Dis. 2021 Aug 22. pii: 6356217. doi: 10.1093.
    >> Share

  730. PETTI S
    Undetected and relatively sustained SARS-CoV-2 circulation worldwide during the year 2019.
    Clin Infect Dis. 2021 Aug 22. pii: 6356216. doi: 10.1093.
    >> Share

  731. MARR LC, Tang JW
    A Paradigm Shift to Align Transmission Routes with Mechanisms.
    Clin Infect Dis. 2021 Aug 20. pii: 6355601. doi: 10.1093.
    >> Share

  732. MAIER HE, Kuan G, Saborio S, Bustos Carrillo FA, et al
    Clinical spectrum of SARS-CoV-2 infection and protection from symptomatic re-infection.
    Clin Infect Dis. 2021 Aug 19. pii: 6354980. doi: 10.1093.
    >> Share

  733. BALTAS I, Boshier FAT, Williams CA, Bayzid N, et al
    Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals.
    Clin Infect Dis. 2021 Aug 19. pii: 6354928. doi: 10.1093.
    >> Share

  734. DUNAY MA, McClain SL, Holloway RL, Norris SLW, et al
    Pre-Hospital Administration of Remdesivir during a SARS-CoV-2 Outbreak in a Skilled Nursing Facility.
    Clin Infect Dis. 2021 Aug 19. pii: 6354937. doi: 10.1093.
    >> Share

  735. DAWOOD FS, Varner M, Tita A, Newes-Adeyi G, et al
    Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States.
    Clin Infect Dis. 2021 Aug 19. pii: 6354856. doi: 10.1093.
    >> Share

  736. FINTZI J, Bonnett T, Sweeney DA, Huprikar NA, et al
    Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization.
    Clin Infect Dis. 2021 Aug 19. pii: 6354746. doi: 10.1093.
    >> Share

  737. DIAZ GA, Christensen AB, Pusch T, Goulet D, et al
    Remdesivir and Mortality in Patients with COVID-19.
    Clin Infect Dis. 2021 Aug 19. pii: 6352176. doi: 10.1093.
    >> Share

  738. LI C, Chen Y, Zhao Y, Lung DC, et al
    Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model.
    Clin Infect Dis. 2021 Aug 18. pii: 6353927. doi: 10.1093.
    >> Share

  739. LIU T, Wu D, Yan W, Wang X, et al
    Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: a prospective cohort study in Wuhan, China.
    Clin Infect Dis. 2021 Aug 14. pii: 6352408. doi: 10.1093.
    >> Share

  740. DIMEGLIO C, Herin F, Da-Silva I, Jougla I, et al
    Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 12. pii: 6349304. doi: 10.1093.
    >> Share

  741. CERAMI C, Popkin-Hall ZR, Rapp T, Tompkins K, et al
    Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color.
    Clin Infect Dis. 2021 Aug 12. pii: 6349288. doi: 10.1093.
    >> Share

  742. CALDERON-PARRA J, Munez-Rubio E, Fernandez-Cruz A, Garcia Sanchez MC, et al
    Incidence, clinical presentation, relapses and outcome of SARS-CoV-2 infection in patients treated with anti-CD20 monoclonal antibodies.
    Clin Infect Dis. 2021 Aug 12. pii: 6348942. doi: 10.1093.
    >> Share

  743. PAULES CI, Gallagher SK, Rapaka RR, Davey RT, et al
    Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
    Clin Infect Dis. 2021 Aug 11. pii: 6348134. doi: 10.1093.
    >> Share

  744. JACOBS JL, Bain W, Naqvi A, Staines B, et al
    SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes.
    Clin Infect Dis. 2021 Aug 10. pii: 6347519. doi: 10.1093.
    >> Share

  745. CLIPMAN SJ, Wesolowski A, Mehta SH, Cobey S, et al
    Improvements in SARS-CoV-2 Testing Cascade in the US: Data from Serial Cross-sectional Assessments.
    Clin Infect Dis. 2021 Aug 10. pii: 6347429. doi: 10.1093.
    >> Share

  746. BAKER MA, Sands KE, Huang SS, Kleinman K, et al
    The Impact of COVID-19 on Healthcare-Associated Infections.
    Clin Infect Dis. 2021 Aug 9. pii: 6346721. doi: 10.1093.
    >> Share

  747. NORTH CM, Barczak A, Goldstein RH, Healy BC, et al
    Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19].
    Clin Infect Dis. 2021 Aug 7. pii: 6345339. doi: 10.1093.
    >> Share

  748. TENFORDE MW, Patel MM, Ginde AA, Douin DJ, et al
    Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    Clin Infect Dis. 2021 Aug 6. pii: 6343399. doi: 10.1093.
    >> Share

  749. BANNO M, Tsujimoto Y, Ishikane M
    Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease.
    Clin Infect Dis. 2021 Aug 6. pii: 6343415. doi: 10.1093.
    >> Share

  750. COLEMAN KK, Tay DJW, Sen Tan K, Ong SWX, et al
    Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing.
    Clin Infect Dis. 2021 Aug 6. pii: 6343417. doi: 10.1093.
    >> Share

  751. PADHI S, Pati A, Panda AK
    Effect of ivermectin in the treatment of COVID-19: A trial sequential analysis highlighted the requirement of additional randomized controlled trials.
    Clin Infect Dis. 2021 Aug 6. pii: 6343157. doi: 10.1093.
    >> Share

  752. LAWANDI A, Warner S, Sun J, Demirkale CY, et al
    Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities, June 1, 2020- February 28, 2021.
    Clin Infect Dis. 2021 Aug 5. pii: 6342166. doi: 10.1093.
    >> Share

  753. BIGGERSTAFF M, Slayton RB, Johansson MA, Butler JC, et al
    Improving Pandemic Response: Employing Mathematical Modeling to Confront COVID-19.
    Clin Infect Dis. 2021 Aug 3. pii: 6338173. doi: 10.1093.
    >> Share

  754. FOURATI S, Bailly B, Le Bouter A, Guilpain L, et al
    Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
    Clin Infect Dis. 2021 Aug 3. pii: 6338175. doi: 10.1093.
    >> Share

  755. XIANG F, Sun J, Chen PH, Han P, et al
    Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021;73:e594-e601.
    >> Share

  756. LI P, Ikram A, Peppelenbosch MP, Ma Z, et al
    Systematically Mapping Clinical Features of Infections With Classical Endemic Human Coronaviruses.
    Clin Infect Dis. 2021;73:554-555.
    >> Share

  757. CASADEVALL A, Joyner MJ, Pirofski LA
    Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Clin Infect Dis. 2021;73:e540-e542.
    >> Share

  758. GIL E, Martyn E, Rokadiya S, Jain S, et al
    Bacterial Coinfection in COVID-19.
    Clin Infect Dis. 2021;73:e843-e845.
    >> Share

    July 2021
  759. CHOW K, Aslam A, McClure T, Singh J, et al
    Risk of Healthcare-Associated Transmission of SARS-CoV-2 in Hospitalized Cancer Patients.
    Clin Infect Dis. 2021 Jul 30. pii: 6331919. doi: 10.1093.
    >> Share

  760. MACCANNELL T, Batson J, Bonin B, Kc A, et al
    Genomic epidemiology and transmission dynamics of SARS-CoV-2 in congregate healthcare facilities in Santa Clara County, California.
    Clin Infect Dis. 2021 Jul 30. pii: 6330915. doi: 10.1093.
    >> Share

  761. SCHOOLEY RT
    Introduction to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Supplement.
    Clin Infect Dis. 2021;73.
    >> Share

  762. TSUBOI M, Hachiya M, Ohtsu H, Akashi H, et al
    Epidemiology and risk of COVID-19 among travelers at airport and port quarantine stations across Japan: a nationwide descriptive analysis and an individually matched case-control study.
    Clin Infect Dis. 2021 Jul 28. pii: 6329456. doi: 10.1093.
    >> Share

  763. HERSTEIN JJ, Lowe JJ, Wolf T, Vasoo S, et al
    Leveraging a preexisting global infectious disease network for local decision-making during a pandemic.
    Clin Infect Dis. 2021 Jul 28. pii: 6329401. doi: 10.1093.
    >> Share

  764. CHEN LL, Lu L, Choi CY, Cai JP, et al
    Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.
    Clin Infect Dis. 2021 Jul 26. pii: 6328361. doi: 10.1093.
    >> Share

  765. CORVOL H, Alimi A, Prevost B, Schnuriger A, et al
    Atypical severe organizing pneumonia following COVID-19 in an immunocompromised teenager.
    Clin Infect Dis. 2021 Jul 26. pii: 6328309. doi: 10.1093.
    >> Share

  766. CHEN X, Chen Z, Azman AS, Sun R, et al
    Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.
    Clin Infect Dis. 2021 Jul 24. pii: 6327511. doi: 10.1093.
    >> Share

  767. SUHS T, Gerlach D, Garfin J, Lorentz A, et al
    COVID-19 Outbreak Associated with a Fitness Center - Minnesota, September-November 2020.
    Clin Infect Dis. 2021 Jul 23. pii: 6326825. doi: 10.1093.
    >> Share

  768. GHARBHARAN A, GeurtsvanKessel CH, Jordans CCE, Blaauw M, et al
    Effects of treatment of COVID-19 with convalescent plasma in 25 B-cell depleted patients.
    Clin Infect Dis. 2021 Jul 22. pii: 6325623. doi: 10.1093.
    >> Share

  769. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
    The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV.
    Clin Infect Dis. 2021 Jul 22. pii: 6325617. doi: 10.1093.
    >> Share

  770. HALBROOK M, Gadoth A, Martin-Blais R, Gray AN, et al
    Longitudinal assessment of COVID-19 vaccine acceptance and uptake among frontline medical workers in Los Angeles, California.
    Clin Infect Dis. 2021 Jul 22. pii: 6325325. doi: 10.1093.
    >> Share

  771. ANDREJKO KL, Pry J, Myers JF, Jewell NP, et al
    Prevention of COVID-19 by mRNA-based vaccines within the general population of California.
    Clin Infect Dis. 2021 Jul 20. pii: 6324500. doi: 10.1093.
    >> Share

  772. MORRIS CP, Luo CH, Amadi A, Schwartz M, et al
    An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern.
    Clin Infect Dis. 2021 Jul 17. pii: 6323262. doi: 10.1093.
    >> Share

  773. ALBHAISI S, Wenzel RP
    The Value of Medical Registries and Observational Studies Early in Pandemics: The COVID-19 Experience.
    Clin Infect Dis. 2021 Jul 16. pii: 6322561. doi: 10.1093.
    >> Share

  774. TRAM KH, Saeed S, Bradley C, Fox B, et al
    Deliberation, Dissent, and Distrust: Understanding distinct drivers of COVID-19 vaccine hesitancy in the United States.
    Clin Infect Dis. 2021 Jul 16. pii: 6323151. doi: 10.1093.
    >> Share

  775. GOSWAMI ND, Fiore AE, Walke HT
    Evidence, Experience, Expertise, and the US Coronavirus Disease 2019 Public Health Response.
    Clin Infect Dis. 2021;73.
    >> Share

  776. MCCARTY T
    Candidemia and Severe COVID-19 - Which Risk Factors are Modifiable?
    Clin Infect Dis. 2021 Jul 15. pii: 6322064. doi: 10.1093.
    >> Share

  777. WONG CKH, Lau KTK, Au ICH, Xiong X, et al
    Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.
    Clin Infect Dis. 2021 Jul 15. pii: 6321803. doi: 10.1093.
    >> Share

  778. LIN DY, Gu Y, Zeng D, Janes HE, et al
    Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Jul 14. pii: 6321290. doi: 10.1093.
    >> Share

  779. DAS ADHIKARI U, Eng G, Farcasanu M, Avena LE, et al
    Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival.
    Clin Infect Dis. 2021 Jul 10. pii: 6318824. doi: 10.1093.
    >> Share

  780. TORRES JR
    Sequential Dengue and Covid-19. A case of viral Dr. Jekyll or Mr. Hyde?
    Clin Infect Dis. 2021 Jul 10. pii: 6318742. doi: 10.1093.
    >> Share

  781. SULLIVAN PS, Siegler AJ, Shioda K, Hall EW, et al
    SARS-CoV-2 cumulative incidence, United States, August-December 2020.
    Clin Infect Dis. 2021 Jul 10. pii: 6318822. doi: 10.1093.
    >> Share

  782. DAWOOD FS, Naleway AL, Flannery B, Levine MZ, et al
    Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
    Clin Infect Dis. 2021 Jul 10. pii: 6318730. doi: 10.1093.
    >> Share

  783. SKOWRONSKI DM, Setayeshgar S, Zou M, Prystajecky N, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada.
    Clin Infect Dis. 2021 Jul 9. pii: 6318435. doi: 10.1093.
    >> Share

  784. WILLIAMS C, Al-Bargash D, Macalintal C, Stuart R, et al
    COVID-19 Outbreak Associated with a SARS-CoV-2 P.1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program - Ontario, April-May 2021.
    Clin Infect Dis. 2021 Jul 8. pii: 6317716. doi: 10.1093.
    >> Share

  785. SEESSLE J, Waterboer T, Hippchen T, Simon J, et al
    Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.
    Clin Infect Dis. 2021 Jul 5. pii: 6315216. doi: 10.1093.
    >> Share

  786. GRANDJEAN L, Saso A, Ortiz AT, Lam T, et al
    Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.
    Clin Infect Dis. 2021 Jul 4. pii: 6314536. doi: 10.1093.
    >> Share

  787. LUMLEY SF, Rodger G, Constantinides B, Sanderson N, et al
    An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.
    Clin Infect Dis. 2021 Jul 3. pii: 6314286. doi: 10.1093.
    >> Share

  788. BERBENYUK A, Bobkova P, Bordyugov S, Borisenko A, et al
    Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.
    Clin Infect Dis. 2021;73:174.
    >> Share

  789. ROTHENBERG R
    Death and the Virus.
    Clin Infect Dis. 2021;73:e86-e87.
    >> Share

    June 2021
  790. DARCIS G, Meuris C, Kremer C, Faes C, et al
    The risk of underestimating the contribution of children to SARS-CoV-2 pandemic.
    Clin Infect Dis. 2021 Jun 30. pii: 6311795. doi: 10.1093.
    >> Share

  791. SAGARA I, Woodford J, Kone M, Assadou MH, et al
    Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study.
    Clin Infect Dis. 2021 Jun 29. pii: 6311302. doi: 10.1093.
    >> Share

  792. ROMAN YM, Burela PA, Pasupuleti V, Piscoya A, et al
    Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
    Clin Infect Dis. 2021 Jun 28. pii: 6310839. doi: 10.1093.
    >> Share

  793. WALKER A, Houwaart T, Finzer P, Ehlkes L, et al
    Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.
    Clin Infect Dis. 2021 Jun 28. pii: 6310838. doi: 10.1093.
    >> Share

  794. COLEBUNDERS R, Kenyon C
    Extensive SARS-CoV-2 transmission associated with low mortality in Kinshasa, Democratic Republic of Congo. For how long?
    Clin Infect Dis. 2021 Jun 28. pii: 6310791. doi: 10.1093.
    >> Share

  795. VERDERESE JP, Stepanova M, Lam B, Racila A, et al
    Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.
    Clin Infect Dis. 2021 Jun 24. pii: 6309036. doi: 10.1093.
    >> Share

  796. MAZZOLA A, Todesco E, Drouin S, Hazan F, et al
    Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.
    Clin Infect Dis. 2021 Jun 24. pii: 6309017. doi: 10.1093.
    >> Share

  797. MCEWEN AE, Cohen S, Bryson-Cahn C, Liu C, et al
    Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.
    Clin Infect Dis. 2021 Jun 24. pii: 6309019. doi: 10.1093.
    >> Share

  798. HANSON KE, Altayar O, Caliendo AM, Arias CA, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing.
    Clin Infect Dis. 2021 Jun 23. pii: 6308396. doi: 10.1093.
    >> Share

  799. ANTONIO-VILLA NE, Fernandez-Chirino L, Pisanty-Alatorre J, Mancilla-Galindo J, et al
    Comprehensive evaluation of the impact of sociodemographic inequalities on adverse outcomes and excess mortality during the COVID-19 pandemic in Mexico City.
    Clin Infect Dis. 2021 Jun 22. pii: 6308070. doi: 10.1093.
    >> Share

  800. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine.
    Clin Infect Dis. 2021 Jun 22. pii: 6307902. doi: 10.1093.
    >> Share

  801. LODI L, Moriondo M, Pucci A, Pisano L, et al
    Chronic asymptomatic SARS-CoV-2 infection in the immunocompromised patient: new challenges and urgent needs.
    Clin Infect Dis. 2021 Jun 22. pii: 6307947. doi: 10.1093.
    >> Share

  802. BUONSENSO D, Valentini P
    Children and SARS-CoV-2 transmission: a step closer to better understanding and evidence-based interventions?
    Clin Infect Dis. 2021 Jun 18. pii: 6305136. doi: 10.1093.
    >> Share

  803. SEAGLE EE, Jackson BR, Lockhart SR, Georgacopoulos O, et al
    The landscape of candidemia during the COVID-19 pandemic.
    Clin Infect Dis. 2021 Jun 18. pii: 6305138. doi: 10.1093.
    >> Share

  804. KARAN A, Klompas M, Tucker R, Baker M, et al
    The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center.
    Clin Infect Dis. 2021 Jun 18. pii: 6305137. doi: 10.1093.
    >> Share

  805. JACOBSON KB, Pinsky BA, Montez Rath ME, Wang H, et al
    Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
    Clin Infect Dis. 2021 Jun 17. pii: 6303032. doi: 10.1093.
    >> Share

  806. MANICA M, Pancheri S, Poletti P, Giovanazzi G, et al
    The risk of symptomatic infection during a second COVID-19 wave, in SARS-CoV-2 seropositive individuals.
    Clin Infect Dis. 2021 Jun 16. pii: 6301134. doi: 10.1093.
    >> Share

  807. STANKOV MV, Cossmann A, Bonifacius A, Dopfer-Jablonka A, et al
    Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.
    Clin Infect Dis. 2021 Jun 16. pii: 6301133. doi: 10.1093.
    >> Share

  808. ALTHOFF KN, Schlueter DJ, Anton-Culver H, Cherry J, et al
    Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020.
    Clin Infect Dis. 2021 Jun 15. pii: 6294073. doi: 10.1093.
    >> Share

  809. MALGIE J, Schoones JW, Pijls BG
    Reply to Tleyjeh.
    Clin Infect Dis. 2021;72:e1155-e1156.
    >> Share

  810. WANG M, Hu K
    Reply to DeVito.
    Clin Infect Dis. 2021;72:e1165-e1166.
    >> Share

  811. DEVITO NJ
    Concerning Trials Registration.
    Clin Infect Dis. 2021;72:e1164-e1165.
    >> Share

  812. MUNBLIT D, Nekliudov NA, Bugaeva P, Blyuss O, et al
    Reply to Russo et al.
    Clin Infect Dis. 2021;72:e1159-e1160.
    >> Share

  813. MALGIE J, Schoones JW, Pijls BG
    Reply to Huang et al.
    Clin Infect Dis. 2021;72:e1157-e1158.
    >> Share

  814. GU S, Lv L, Wu Z, Li L, et al
    Reply to Klann et al.
    Clin Infect Dis. 2021;72:2248-2249.
    >> Share

  815. GU S, Chen Y, Lv L, Li L, et al
    Reply to Marcialis et al.
    Clin Infect Dis. 2021;72:2246-2247.
    >> Share

  816. POLLETT SD, Richard SA, Fries AC, Simons MP, et al
    The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity.
    Clin Infect Dis. 2021 Jun 12. pii: 6297424. doi: 10.1093.
    >> Share

  817. XIN H, Wong JY, Murphy C, Yeung A, et al
    The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
    Clin Infect Dis. 2021 Jun 12. pii: 6297425. doi: 10.1093.
    >> Share

  818. KLOMPAS M, Rhee C, Baker M
    Universal Use of N95s in Healthcare Settings when Community Covid-19 Rates are High.
    Clin Infect Dis. 2021 Jun 11. pii: 6296401. doi: 10.1093.
    >> Share

  819. BENFIELD T, Bodilsen J, Brieghel C, Harboe ZB, et al
    Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study.
    Clin Infect Dis. 2021 Jun 10. pii: 6296026. doi: 10.1093.
    >> Share

  820. STONE M, Di Germanio C, Wright DJ, Sulaeman H, et al
    Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
    Clin Infect Dis. 2021 Jun 10. pii: 6296028. doi: 10.1093.
    >> Share

  821. ZHANG AW, Morjaria S, Kaltsas A, Hohl TM, et al
    The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection.
    Clin Infect Dis. 2021 Jun 10. pii: 6296025. doi: 10.1093.
    >> Share

  822. BUCHAN SA, Tibebu S, Daneman N, Whelan M, et al
    Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases.
    Clin Infect Dis. 2021 Jun 9. pii: 6295404. doi: 10.1093.
    >> Share

  823. CRANE MA, Popovic A, Panaparambil R, Stolbach AI, et al
    Reporting of Infectious Diseases in the United States During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 Jun 7. pii: 6294158. doi: 10.1093.
    >> Share

  824. VANKER A, McGeer A, O'Byrne G, Snyder ECR, et al
    Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada.
    Clin Infect Dis. 2021 Jun 6. pii: 6294072. doi: 10.1093.
    >> Share

  825. JENKS JD, Aslam S, Horton LE, Law N, et al
    Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients with COVID-19.
    Clin Infect Dis. 2021 Jun 6. pii: 6294071. doi: 10.1093.
    >> Share

  826. NKUBA AN, Makiala SM, Guichet E, Tshiminyi PM, et al
    High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey.
    Clin Infect Dis. 2021 Jun 5. pii: 6293985. doi: 10.1093.
    >> Share

  827. JACOBSON MA, Zakaria A, Maung Z, Hart C, et al
    Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees.
    Clin Infect Dis. 2021 Jun 4. pii: 6291929. doi: 10.1093.
    >> Share

  828. LESHO E, Corey B, Lebreton F, Ong AC, et al
    Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.345 in Upstate New York.
    Clin Infect Dis. 2021 Jun 4. pii: 6292251. doi: 10.1093.
    >> Share

  829. KAHN R, Holmdahl I, Reddy S, Jernigan J, et al
    Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes.
    Clin Infect Dis. 2021 Jun 4. pii: 6292250. doi: 10.1093.
    >> Share

  830. YEH HF
    The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake.
    Clin Infect Dis. 2021 Jun 3. pii: 6291428. doi: 10.1093.
    >> Share

  831. ROUSSEL Y, Million M, Chabriere E, Lagier JC, et al
    Be Careful With Big Data: Reanalysis of Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 Hospitalized Across the United States.
    Clin Infect Dis. 2021;72:e928.
    >> Share

  832. VAUGHN VM, Flanders SA
    Reply to Stevenson et al.
    Clin Infect Dis. 2021;72:e927.
    >> Share

    May 2021
  833. MAROT S, Malet I, Leducq V, Abdi B, et al
    Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers.
    Clin Infect Dis. 2021 May 29. pii: 6288468. doi: 10.1093.
    >> Share

  834. TALBOT HK, Martin ET, Gaglani M, Middleton DB, et al
    Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.
    Clin Infect Dis. 2021 May 29. pii: 6288408. doi: 10.1093.
    >> Share

  835. COHEN MS, Wohl DA, Fischer WA, Smith DJ, et al
    Outpatient Treatment of SARS-CoV-2 Infection to Prevent COVID-19 Progression.
    Clin Infect Dis. 2021 May 28. pii: 6287650. doi: 10.1093.
    >> Share

  836. CANTERINO JE, Wang K, Golden M
    Provider Satisfaction with Infectious Diseases Telemedicine Consults for Hospitalized Patients During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 May 28. pii: 6287628. doi: 10.1093.
    >> Share

  837. ZHANG Y, Luo W, Li Q, Wang X, et al
    Risk Factors for Death Among the First 80 543 COVID-19 Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region.
    Clin Infect Dis. 2021 May 27. pii: 6287117. doi: 10.1093.
    >> Share

  838. LEIDI A, Koegler F, Dumont R, Dubos R, et al
    Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study.
    Clin Infect Dis. 2021 May 27. pii: 6287116. doi: 10.1093.
    >> Share

  839. MEHRAVARAN S, Ahmed H, Chen YC
    Disparities in COVID-19 outcomes for African Americans: more studies are warranted.
    Clin Infect Dis. 2021 May 26. pii: 6285195. doi: 10.1093.
    >> Share

  840. ALI ST, Yeung A, Shan S, Wang L, et al
    Serial intervals and case isolation delays for COVID-19: a systematic review and meta-analysis.
    Clin Infect Dis. 2021 May 26. pii: 6284329. doi: 10.1093.
    >> Share

  841. KLOPFENSTEIN T, Gerazime A, Puyraveau M, Kadiane-Oussou NJ, et al
    It is time to determine Tocilizumab place in COVID-19.
    Clin Infect Dis. 2021 May 24. pii: 6283696. doi: 10.1093.
    >> Share

  842. YADAV PD, Sapkal GN, Abraham P, Deshpande G, et al
    Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1.
    Clin Infect Dis. 2021 May 24. pii: 6283706. doi: 10.1093.
    >> Share

  843. GALANG RR, Newton SM, Woodworth KR, Griffin I, et al
    Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection - Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 -March 5, 2021.
    Clin Infect Dis. 2021 May 22. pii: 6280195. doi: 10.1093.
    >> Share

  844. VERNA EC, Landis C, Brown RS Jr, Mospan AR, et al
    Factors Associated with Readmission in the US Following Hospitalization with COVID-19.
    Clin Infect Dis. 2021 May 20. pii: 6279074. doi: 10.1093.
    >> Share

  845. OGATA AF, Cheng CA, Desjardins M, Senussi Y, et al
    Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
    Clin Infect Dis. 2021 May 20. pii: 6279075. doi: 10.1093.
    >> Share

  846. KARABA AH, Zhou W, Hsieh LL, Figueroa A, et al
    Differential Cytokine Signatures of SARS-CoV-2 and Influenza Infection Highlight Key Differences in Pathobiology.
    Clin Infect Dis. 2021 May 20. pii: 6278486. doi: 10.1093.
    >> Share

  847. VLASOVA AN, Diaz A, Damtie D, Xiu L, et al
    Novel Canine Coronavirus Isolated from a Hospitalized Pneumonia Patient, East Malaysia.
    Clin Infect Dis. 2021 May 20. pii: 6278597. doi: 10.1093.
    >> Share

  848. HIRSCHTICK JL, Titus AR, Slocum E, Power LE, et al
    Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics.
    Clin Infect Dis. 2021 May 19. pii: 6276644. doi: 10.1093.
    >> Share

  849. FURUKAWA D, Graber CJ
    Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
    Clin Infect Dis. 2021;72:e542-e544.
    >> Share

  850. PISCHEL L, Goshua G
    Cost-effectiveness of tocilizumab in severe COVID-19: to see or not to see.
    Clin Infect Dis. 2021 May 17. pii: 6277058. doi: 10.1093.
    >> Share

  851. CHODICK G, Tene L, Rotem RS, Patalon T, et al
    The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data.
    Clin Infect Dis. 2021 May 17. pii: 6276888. doi: 10.1093.
    >> Share

  852. HENSLEY KS, Jordans CCE, van Kampen JJA, Mollema FPN, et al
    Significant impact of COVID-19 on HIV care in hospitals affecting the first pillar of the HIV care continuum.
    Clin Infect Dis. 2021 May 16. pii: 6276393. doi: 10.1093.
    >> Share

  853. BAILLY B, Guilpain L, Bouiller K, Chirouze C, et al
    BNT162b2 mRNA vaccination did not prevent an outbreak of SARS COV-2 variant 501Y.V2 in an elderly nursing home but reduced transmission and disease severity.
    Clin Infect Dis. 2021 May 16. pii: 6276392. doi: 10.1093.
    >> Share

  854. CANADAY DH, Carias L, Oyebanji OA, Keresztesy D, et al
    Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.
    Clin Infect Dis. 2021 May 16. pii: 6276391. doi: 10.1093.
    >> Share

  855. RENNERT L, McMahan C
    Risk of SARS-CoV-2 reinfection in a university student population.
    Clin Infect Dis. 2021 May 16. pii: 6276528. doi: 10.1093.
    >> Share

  856. HARRIS DA, Sobers M, Greenwald ZR, Simmons AE, et al
    Is 3 feet of physical distancing enough?
    Clin Infect Dis. 2021 May 14. pii: 6275593. doi: 10.1093.
    >> Share

  857. MASSO-SILVA JA, Moshensky A, Lam MTY, Odish M, et al
    Increased peripheral blood neutrophil activation phenotypes and NETosis in critically ill COVID-19 patients: a case series and review of the literature.
    Clin Infect Dis. 2021 May 14. pii: 6275596. doi: 10.1093.
    >> Share

  858. BRANCH-ELLIMAN W, Jack RS, Schechter-Perkins EM, van den Berg P, et al
    Reply to Author.
    Clin Infect Dis. 2021 May 14. pii: 6275594. doi: 10.1093.
    >> Share

  859. LUTGRING JD, Tobolowsky FA, Hatfield KM, Lehnertz NB, et al
    Evaluating the Presence of Replication-Competent SARS-CoV-2 from Nursing Home Residents with Persistently Positive RT-PCR Results.
    Clin Infect Dis. 2021 May 14. pii: 6275595. doi: 10.1093.
    >> Share

  860. VANIJCHAROENKARN K, Lee FE, Martin L, Shih J, et al
    Immediate reactions following the first dose of the SARS-CoV2 mRNA vaccines do not preclude second dose administration.
    Clin Infect Dis. 2021 May 14. pii: 6275836. doi: 10.1093.
    >> Share

  861. GUAGLIARDO SAJ, Prasad PV, Rodriguez A, Fukunaga R, et al
    Cruise ship travel in the era of COVID-19: A summary of outbreaks and a model of public health interventions.
    Clin Infect Dis. 2021 May 12. pii: 6274545. doi: 10.1093.
    >> Share

  862. SAMI S, Tenforde MW, Talbot HK, Lindsell CJ, et al
    Adults Hospitalized with COVID-19 -United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
    Clin Infect Dis. 2021 May 12. pii: 6270754. doi: 10.1093.
    >> Share

  863. FOX MD, Leiszler MS, Seamon MD, Garmin BL, et al
    Results of a Shortened Quarantine Protocol on a Midwestern College Campus.
    Clin Infect Dis. 2021 May 12. pii: 6274299. doi: 10.1093.
    >> Share

  864. KO JY, DeSisto CL, Simeone RM, Ellington S, et al
    Adverse pregnancy outcomes, maternal complications, and severe illness among U.S. delivery hospitalizations with and without a COVID-19 diagnosis.
    Clin Infect Dis. 2021 May 12. pii: 6274300. doi: 10.1093.
    >> Share

  865. MARKS SM, Clara A, Fiebelkorn AP, Le X, et al
    Influenza Vaccination in Health Centers during the COVID-19 Pandemic-United States, November 7-27, 2020.
    Clin Infect Dis. 2021 May 12. pii: 6274304. doi: 10.1093.
    >> Share

  866. MORENO GK, Braun KM, Pray IW, Segaloff HE, et al
    SARS-CoV-2 transmission in intercollegiate athletics not fully mitigated with daily antigen testing.
    Clin Infect Dis. 2021 May 12. pii: 6274297. doi: 10.1093.
    >> Share

  867. IOANNOU GN, O'Hare AM, Berry K, Fan VS, et al
    Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2021 May 11. pii: 6273415. doi: 10.1093.
    >> Share

  868. LEE LYW, Rozmanowski S, Pang M, Charlett A, et al
    SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission.
    Clin Infect Dis. 2021 May 11. pii: 6273394. doi: 10.1093.
    >> Share

  869. FITZGERALD KC, Mecoli CA, Douglas M, Harris S, et al
    Risk Factors For Infection And Health Impacts Of The Covid-19 Pandemic In People With Autoimmune Diseases.
    Clin Infect Dis. 2021 May 6. pii: 6270948. doi: 10.1093.
    >> Share

  870. NICOLETE VC, Rodrigues PT, Johansen IC, Corder RM, et al
    Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated with Increased COVID-19 Risk in a Population-Based Cohort Study.
    Clin Infect Dis. 2021 May 6. pii: 6270997. doi: 10.1093.
    >> Share

  871. SINHA P, Linas BP
    Combination therapy with tocilizumab and dexamethasone cost-effectively reduces Coronavirus disease 2019 mortality.
    Clin Infect Dis. 2021 May 6. pii: 6270961. doi: 10.1093.
    >> Share

  872. HUI KP, Cheung MC, Lai KL, Ng KC, et al
    Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection.
    Clin Infect Dis. 2021 May 6. pii: 6270945. doi: 10.1093.
    >> Share

  873. NARITA M, Hatt G, Toren KG, Vuong K, et al
    Delayed Tuberculosis Diagnoses During the COVID-19 Pandemic in 2020 - King County, Washington.
    Clin Infect Dis. 2021 May 6. pii: 6270740. doi: 10.1093.
    >> Share

  874. SCHRODT CA, Malenfant JH, Hunter JC, Slifka KJ, et al
    Investigation of a Suspect SARS-CoV-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide.
    Clin Infect Dis. 2021 May 6. pii: 6270741. doi: 10.1093.
    >> Share

  875. WILSON K, Dennison C, Struminger B, Armistad A, et al
    Building a Virtual Global Knowledge Network during COVID-19: The Infection Prevention and Control Global Webinar Series.
    Clin Infect Dis. 2021 May 6. pii: 6270763. doi: 10.1093.
    >> Share

  876. HANDBERRY M, Bull-Otterson L, Dai M, Mann CN, et al
    Changes in Emergency Medical Services before and during COVID-19 in the United States, January 2018-December 2020.
    Clin Infect Dis. 2021 May 6. pii: 6270742. doi: 10.1093.
    >> Share

  877. NUNES MC, Baillie VL, Kwatra G, Bhikha S, et al
    SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study.
    Clin Infect Dis. 2021 May 5. pii: 6265294. doi: 10.1093.
    >> Share

  878. RAM-MOHAN N, Kim D, Zudock EJ, Hashemi MM, et al
    SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19.
    Clin Infect Dis. 2021 May 5. pii: 6265285. doi: 10.1093.
    >> Share

  879. ROSE K, Grant-Kels JM, Striano P, Neubauer D, et al
    Warp speed for COVID-19 drugs and vaccines - time to re-consider how we use the term 'children'.
    Clin Infect Dis. 2021 May 5. pii: 6265295. doi: 10.1093.
    >> Share

  880. BELLON M, Baggio S, Bausch FJ, Spechbach H, et al
    SARS-CoV-2 viral load kinetics in symptomatic children, adolescents and adults.
    Clin Infect Dis. 2021 May 5. pii: 6265276. doi: 10.1093.
    >> Share

  881. ANDERSON EJ, Kamidani S, Orenstein W, Campbell JD, et al
    COVID-19 Vaccines Have Moved Out of Neutral, but Still Gearing Up in Children.
    Clin Infect Dis. 2021 May 5. pii: 6265296. doi: 10.1093.
    >> Share

  882. HAIDAR G, Mellors JW
    Improving the Outcomes of Immunocompromised Patients with COVID-19.
    Clin Infect Dis. 2021 May 5. pii: 6265293. doi: 10.1093.
    >> Share

  883. STRUTNER J, Ramchandar N, Dubey S, Gamboa M, et al
    Comparison of Reverse-Transcription Polymerase Chain Reaction Cycle Threshold Values From Respiratory Specimens in Symptomatic and Asymptomatic Children With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Clin Infect Dis. 2021 May 5. pii: 6266745. doi: 10.1093.
    >> Share

  884. MARTINEZ-URBISTONDO D, Costa Segovia R, Suarez Del Villar Carrero R, Risco Risco C, et al
    Early Combination of Tocilizumab and Corticosteroids: An Upgrade in Anti-inflammatory Therapy for Severe Coronavirus Disease (COVID).
    Clin Infect Dis. 2021;72:1682-1683.
    >> Share

  885. RAN L, Tan X
    Reply to Belingheri et al.
    Clin Infect Dis. 2021;72:1676-1677.
    >> Share

  886. MILLION M, Chaudet H, Raoult D
    Hydroxychloroquine Failure: The End Does Not Justify the Means.
    Clin Infect Dis. 2021;72:e439.
    >> Share

  887. HAJAGE D, Pourcher V, Paccoud O, Bleibtreu A, et al
    Reply to Million et al.
    Clin Infect Dis. 2021;72:e440-e441.
    >> Share

  888. ROSENBERG ES, Hall EW, Rosenthal EM, Maxted AM, et al
    Reply to Flannery et al.
    Clin Infect Dis. 2021;72:e429.
    >> Share

  889. ZHANG M, Yao X, Cui C, Liu X, et al
    Reply to Wolowich and Kwon.
    Clin Infect Dis. 2021;72:1678-1680.
    >> Share

  890. WOLOWICH WR, Kwon YM
    Simulation of Drug in the Lung Can Be Misleading.
    Clin Infect Dis. 2021;72:1677-1678.
    >> Share

  891. HILT EE, Boocock J, Trejo M, Le CQ, et al
    Retrospective Detection of SARS-CoV-2 in Symptomatic Patients prior to Widespread Diagnostic Testing in Southern California.
    Clin Infect Dis. 2021 May 3. pii: 6262672. doi: 10.1093.
    >> Share

    April 2021
  892. BEALL RF, Kesselheim AS, Hollis A
    Pre-market development times for innovative vaccines - to what extent are the COVID-19 vaccines outliers?
    Clin Infect Dis. 2021 Apr 29. pii: 6259217. doi: 10.1093.
    >> Share

  893. MARX GE, Biggerstaff BJ, Nawrocki CC, Totten SE, et al
    SARS-CoV-2 detection on self-collected saliva or anterior nasal specimens compared with healthcare personnel-collected nasopharyngeal specimens.
    Clin Infect Dis. 2021 Apr 29. pii: 6257585. doi: 10.1093.
    >> Share

  894. LAWS RL, Biraro S, Kirungi W, Gianetti B, et al
    COVID-19 Mitigation Efforts and Testing During an In-Person Training Event - Uganda, October 12-29, 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257593. doi: 10.1093.
    >> Share

  895. CARTER RJ, Rose D, Sabo R, Clayton J, et al
    Widespread SARS-CoV-2 Transmission Among Attendees at a Large Motorcycle Rally and their Contacts, 30 US Jurisdictions, August-September, 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257584. doi: 10.1093.
    >> Share

  896. TRAN VT, Riveros C, Clepier B, Desvarieux M, et al
    Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients' lived experience.
    Clin Infect Dis. 2021 Apr 29. pii: 6252414. doi: 10.1093.
    >> Share

  897. RODGERS L, Sheppard M, Smith A, Dietz S, et al
    Changes in Seasonal Respiratory Illnesses in the United States During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 Apr 29. pii: 6257582. doi: 10.1093.
    >> Share

  898. BUSHMAN D, Sekaran J, Jeffery N, Rath C, et al
    COVID-19 Outbreaks at Two Construction Sites - New York City, October-November 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257583. doi: 10.1093.
    >> Share

  899. CHEVINSKY JR, Tao G, Lavery AM, Kukielka EA, et al
    Late conditions diagnosed 1-4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data - United States, March 1-June 30, 2020.
    Clin Infect Dis. 2021 Apr 28. pii: 6257082. doi: 10.1093.
    >> Share

  900. SHAH MM, Salvatore PP, Ford L, Kamitani E, et al
    Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020.
    Clin Infect Dis. 2021 Apr 28. pii: 6257223. doi: 10.1093.
    >> Share

  901. GABLE P, Huang JY, Gilbert SE, Bollinger S, et al
    A Comparison of Less Invasive SARS-CoV-2 Diagnostic Specimens in Nursing Home Residents - Arkansas, June-August 2020.
    Clin Infect Dis. 2021 Apr 28. pii: 6257222. doi: 10.1093.
    >> Share

  902. TENG JLL, Fok KMN, Lin KPK, Chan E, et al
    Substantial decline in invasive pneumococcal disease (IPD) during COVID-19 pandemic in Hong Kong.
    Clin Infect Dis. 2021 Apr 27. pii: 6255967. doi: 10.1093.
    >> Share

  903. MULLER L, Andree M, Moskorz W, Drexler I, et al
    Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination.
    Clin Infect Dis. 2021 Apr 27. pii: 6255965. doi: 10.1093.
    >> Share

  904. DEAR N, Duff E, Esber A, Parikh A, et al
    Transient reductions in HIV clinic attendance and food security during the COVID-19 pandemic for people living with HIV in four African countries.
    Clin Infect Dis. 2021 Apr 27. pii: 6255964. doi: 10.1093.
    >> Share

  905. CHOUDHARY MC, Crain CR, Qiu X, Hanage W, et al
    SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection.
    Clin Infect Dis. 2021 Apr 27. pii: 6255966. doi: 10.1093.
    >> Share

  906. PAPAYANNI PG, Chasiotis D, Koukoulias K, Georgakopoulou A, et al
    Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients.
    Clin Infect Dis. 2021 Apr 27. pii: 6255711. doi: 10.1093.
    >> Share

  907. PIROFSKI LA
    Disease severity and durability of the SARS-CoV-2 antibody response: A view through the lens of the second year of the pandemic.
    Clin Infect Dis. 2021 Apr 27. pii: 6255716. doi: 10.1093.
    >> Share

  908. BASTOS RH, Blos PK, Rodrigues VD, da S Miranda B, et al
    One in every three COVID-19 reinfections result in hospitalization in the US.
    Clin Infect Dis. 2021 Apr 26. pii: 6253740. doi: 10.1093.
    >> Share

  909. SWIFT MD, Breeher LE, Tande AJ, Tommaso CP, et al
    Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel.
    Clin Infect Dis. 2021 Apr 26. pii: 6253721. doi: 10.1093.
    >> Share

  910. ALANGADEN G, Ramesh MS
    Reply to Fernandez Cruz, et al.
    Clin Infect Dis. 2021;72:1487.
    >> Share

  911. YU F, Yan L, Wang N, Guo Y, et al
    Reply to Aquino-Jarquin.
    Clin Infect Dis. 2021;72:1490-1491.
    >> Share

  912. AQUINO-JARQUIN G
    The Raw Cycle Threshold Values From Reverse-transcription Polymerase Chain Reaction Detection Are Not Viral Load Quantitation Units.
    Clin Infect Dis. 2021;72:1489-1490.
    >> Share

  913. LYNCH RM, Favata E, Gochfeld M
    Assess Ventilation When Determining Safe Distancing in Schools to Control COVID-19 Transmission.
    Clin Infect Dis. 2021 Apr 25. pii: 6250101. doi: 10.1093.
    >> Share

  914. QURESHI AI, Baskett WI, Huang W, Lobanova I, et al
    Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing.
    Clin Infect Dis. 2021 Apr 25. pii: 6251701. doi: 10.1093.
    >> Share

  915. BRANCH-ELLIMAN W, Schechter-Perkins EM, Jack RS, van den Berg P, et al
    Reply to authors.
    Clin Infect Dis. 2021 Apr 25. pii: 6250099. doi: 10.1093.
    >> Share

  916. GOSWAMI ND, Fiore AE, Walke HT
    Evidence, Experience, Expertise, and the U.S. COVID-19 Public Health Response.
    Clin Infect Dis. 2021 Apr 24. pii: 6248544. doi: 10.1093.
    >> Share

  917. ETYANG AO, Lucinde R, Karanja H, Kalu C, et al
    Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya.
    Clin Infect Dis. 2021 Apr 24. pii: 6248493. doi: 10.1093.
    >> Share

  918. BROCCIA MM, de Knegt VEVE, Mills EHAEHA, Moller ALAL, et al
    Household exposure to SARS-CoV-2 and association with COVID-19 severity: a Danish nationwide cohort study.
    Clin Infect Dis. 2021 Apr 24. pii: 6248492. doi: 10.1093.
    >> Share

  919. FINSTERER J, Scorza FA
    COVID-19 can be complicated by immune-encephalopathy rather than encephalitis.
    Clin Infect Dis. 2021 Apr 24. pii: 6248513. doi: 10.1093.
    >> Share

  920. GAUTAM N, Madathil S, Tahani N, Bolton S, et al
    Medium-term outcome of severe to critically ill patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2021 Apr 24. pii: 6248543. doi: 10.1093.
    >> Share

  921. LILLIE PJ, O'Brien P, Lawtie M, Jessop S, et al
    First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection.
    Clin Infect Dis. 2021 Apr 24. pii: 6248435. doi: 10.1093.
    >> Share

  922. JONES LD, Chan ER, Zabarsky TF, Cadnum JL, et al
    Transmission of SARS-CoV-2 on a Patient Transport Van.
    Clin Infect Dis. 2021 Apr 24. pii: 6248519. doi: 10.1093.
    >> Share

  923. TOVAR M, Peinado J, Palomino S, Llanos F, et al
    Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru.
    Clin Infect Dis. 2021 Apr 21. pii: 6243873. doi: 10.1093.
    >> Share

  924. GETTINGS JR, Gold JAW, Kimball A, Forsberg K, et al
    SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021.
    Clin Infect Dis. 2021 Apr 17. pii: 6232104. doi: 10.1093.
    >> Share

  925. TANG J, Grubbs G, Lee Y, Golding H, et al
    Impact of convalescent plasma therapy on SARS CoV-2 antibody profile in COVID-19 patients.
    Clin Infect Dis. 2021 Apr 16. pii: 6228549. doi: 10.1093.
    >> Share

  926. BRAUN KM, Moreno GK, Buys A, Somsen ED, et al
    Viral sequencing reveals US healthcare personnel rarely become infected with SARS-CoV-2 through patient contact.
    Clin Infect Dis. 2021 Apr 15. pii: 6226897. doi: 10.1093.
    >> Share

  927. BETTON M, Livrozet M, Planas D, Fayol A, et al
    Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19.
    Clin Infect Dis. 2021 Apr 14. pii: 6225251. doi: 10.1093.
    >> Share

  928. CHENG VC, Fung KS, Siu GK, Wong SC, et al
    Nosocomial outbreak of COVID-19 by possible airborne transmission leading to a superspreading event.
    Clin Infect Dis. 2021 Apr 14. pii: 6225253. doi: 10.1093.
    >> Share

  929. KUMAR RN, Wu EL, Stosor V, Moore WJ, et al
    Real-World Experience of Bamlanivimab for COVID-19: A Case-Control Study.
    Clin Infect Dis. 2021 Apr 13. pii: 6224410. doi: 10.1093.
    >> Share

  930. FORD L, Lee C, Pray IW, Cole D, et al
    Epidemiologic characteristics associated with SARS-CoV-2 antigen-based test results, rRT-PCR cycle threshold values, subgenomic RNA, and viral culture results from university testing.
    Clin Infect Dis. 2021 Apr 13. pii: 6224406. doi: 10.1093.
    >> Share

  931. BOSSLET GT, Pollak M, Jang JH, Roll R, et al
    The effect of in-person primary and secondary school instruction on county-level SARS-CoV-2 spread in Indiana.
    Clin Infect Dis. 2021 Apr 13. pii: 6224418. doi: 10.1093.
    >> Share

  932. WANG H, Hogan CA, Verghese M, Solis D, et al
    Ultra-sensitive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection for the Diagnosis of Coronavirus Disease 2019 (COVID-19) in Upper Respiratory Samples.
    Clin Infect Dis. 2021 Apr 8. pii: 6217390. doi: 10.1093.
    >> Share

  933. CHEN Y, Li L
    Influence of Corticosteroid Dose on Viral Shedding Duration in Patients With COVID-19.
    Clin Infect Dis. 2021;72:1298-1300.
    >> Share

  934. GUO L, Ren L, Sharma L, Wang J, et al
    Reply to Yamaoka, et al.
    Clin Infect Dis. 2021;72:1293.
    >> Share

  935. VAN PRAET JT, Vandecasteele S, De Roo A, De Vriese AS, et al
    Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents.
    Clin Infect Dis. 2021 Apr 7. pii: 6213866. doi: 10.1093.
    >> Share

  936. WESTHOLTER D, Taube C
    SARS-CoV-2 outbreak in a long-term care facility after vaccination with BNT162b2.
    Clin Infect Dis. 2021 Apr 7. pii: 6213878. doi: 10.1093.
    >> Share

  937. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Zigron R, et al
    Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination.
    Clin Infect Dis. 2021 Apr 3. pii: 6209876. doi: 10.1093.
    >> Share

  938. WILEY Z, Ross-Driscoll K, Wang Z, Smothers L, et al
    Racial and Ethnic Differences and Clinical Outcomes of COVID-19 Patients Presenting to the Emergency Department.
    Clin Infect Dis. 2021 Apr 2. pii: 6209403. doi: 10.1093.
    >> Share

  939. REUKERS DFM, van Boven M, Meijer A, Rots N, et al
    High infection secondary attack rates of SARS-CoV-2 in Dutch households revealed by dense sampling.
    Clin Infect Dis. 2021 Apr 2. pii: 6209401. doi: 10.1093.
    >> Share

    March 2021
  940. PENG J, Liu J, Mann SA, Mitchell AM, et al
    Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco.
    Clin Infect Dis. 2021 Mar 31. pii: 6206738. doi: 10.1093.
    >> Share

  941. DEGRAZIA D, Miller FG
    SARS-CoV-2 Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective.
    Clin Infect Dis. 2021 Mar 31. pii: 6205379. doi: 10.1093.
    >> Share

  942. FWOLOSHI S, Hines JZ, Barradas DT, Yingst S, et al
    Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Health Care Workers-Zambia, July 2020.
    Clin Infect Dis. 2021 Mar 30. pii: 6204763. doi: 10.1093.
    >> Share

  943. WU P, Liu F, Chang Z, Lin Y, et al
    Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2.
    Clin Infect Dis. 2021 Mar 27. pii: 6193430. doi: 10.1093.
    >> Share

  944. VOS ERA, van Boven M, den Hartog G, Backer JA, et al
    Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands.
    Clin Infect Dis. 2021 Mar 27. pii: 6189768. doi: 10.1093.
    >> Share

  945. CHAILLON A, Smith DM
    Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution.
    Clin Infect Dis. 2021 Mar 27. pii: 6189784. doi: 10.1093.
    >> Share

  946. MCELLISTREM MC, Clancy CJ, Buehrle DJ, Lucas A, et al
    Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19.
    Clin Infect Dis. 2021 Mar 26. pii: 6188727. doi: 10.1093.
    >> Share

  947. ECKSTEIN L, Rid A, Kamuya D, Shah SK, et al
    The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19.
    Clin Infect Dis. 2021 Mar 24. pii: 6184613. doi: 10.1093.
    >> Share

  948. ESCANDON K, Ulrich AK, Chou R
    Concerns with and recommendations for COVID-19 research related to asymptomatic infection and mask wearing.
    Clin Infect Dis. 2021 Mar 23. pii: 6180410. doi: 10.1093.
    >> Share

  949. BADDLEY JW
    COVID-19 Associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?
    Clin Infect Dis. 2021 Mar 23. pii: 6180413. doi: 10.1093.
    >> Share

  950. CUMMINS NW
    Remdesivir: An antiviral still seeking a raison d'etre.
    Clin Infect Dis. 2021 Mar 22. pii: 6179767. doi: 10.1093.
    >> Share


  951. Corrigendum to: A Case of 2019 Novel Coronavirus in a Pregnant Woman With Preterm Delivery.
    Clin Infect Dis. 2021 Mar 19. pii: 6178940. doi: 10.1093.
    >> Share

  952. MCNAB S, Ha Do LA, Clifford V, Crawford NW, et al
    Changing Epidemiology of Respiratory Syncytial Virus in Australia - delayed re-emergence in Victoria compared to WA/NSW after prolonged lock-down for COVID-19.
    Clin Infect Dis. 2021 Mar 18. pii: 6178344. doi: 10.1093.
    >> Share

  953. POLAND GA
    Antibody Dynamics, Seroreversion, and Persistence After SARS-CoV-2: Another Answer.
    Clin Infect Dis. 2021 Mar 17. pii: 6175316. doi: 10.1093.
    >> Share

  954. SLUGGETT JK, Dinh YH, Wesselingh SL, Inacio MC, et al
    National Changes in Outpatient Systemic Antibiotic Use During the Coronavirus Disease 2019 Pandemic in Australia.
    Clin Infect Dis. 2021 Mar 17. pii: 6175263. doi: 10.1093.
    >> Share


  955. Corrigendum to: Changing Disease Epidemiology to Inform Expanded Coronavirus Disease 2019 Testing.
    Clin Infect Dis. 2021;72:1108.
    >> Share

  956. SHEEHAN MM, Reddy AJ, Rothberg MB
    Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study.
    Clin Infect Dis. 2021 Mar 15. pii: 6170939. doi: 10.1093.
    >> Share

  957. JORDAN I, de Sevilla MF, Fumado V, Bassat Q, et al
    Transmission of SARS-CoV-2 infection among children in summer schools applying stringent control measures in Barcelona, Spain.
    Clin Infect Dis. 2021 Mar 12. pii: 6168543. doi: 10.1093.
    >> Share

  958. SORIANO-ARANDES A, Gatell A, Serrano P, Biosca M, et al
    Household SARS-CoV-2 transmission and children: a network prospective study.
    Clin Infect Dis. 2021 Mar 12. pii: 6168547. doi: 10.1093.
    >> Share

  959. KLOMPAS M, Baker MA, Griesbach D, Tucker R, et al
    Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals in healthcare settings despite medical masks and eye protection.
    Clin Infect Dis. 2021 Mar 11. pii: 6168040. doi: 10.1093.
    >> Share

  960. TANDE AJ, Pollock BD, Shah ND, Farrugia G, et al
    Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening.
    Clin Infect Dis. 2021 Mar 10. pii: 6167855. doi: 10.1093.
    >> Share

  961. VAN DEN BERG P, Schechter-Perkins EM, Jack RS, Epshtein I, et al
    Effectiveness of three versus six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff: A retrospective, state-wide cohort study.
    Clin Infect Dis. 2021 Mar 10. pii: 6167856. doi: 10.1093.
    >> Share

  962. GOUIN KA, Creasy S, Beckerson M, Wdowicki M, et al
    Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 Mar 10. pii: 6167836. doi: 10.1093.
    >> Share

  963. LIN DY, Zeng D, Gilbert PB
    Evaluating the Long-Term Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2021 Mar 10. pii: 6167839. doi: 10.1093.
    >> Share

  964. PERMPALUNG N, Chiang TP, Massie AB, Zhang SX, et al
    COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
    Clin Infect Dis. 2021 Mar 9. pii: 6164950. doi: 10.1093.
    >> Share

  965. PIANTADOSI A
    SARS-CoV-2 Episode 2? A sequel nobody wants to see.
    Clin Infect Dis. 2021 Mar 9. pii: 6164969. doi: 10.1093.
    >> Share

  966. VAN ELSLANDE J, Gruwier L, Godderis L, Vermeersch P, et al
    Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers.
    Clin Infect Dis. 2021 Mar 8. pii: 6162856. doi: 10.1093.
    >> Share

  967. CAPETTI AF, Stangalini CA, Borgonovo F, Mileto D, et al
    Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.
    Clin Infect Dis. 2021 Mar 6. pii: 6159798. doi: 10.1093.
    >> Share

  968. RAPAKA RR, Hammershaimb EA, Neuzil KM
    Are some COVID vaccines better than others? Interpreting and comparing estimates of efficacy in trials of COVID-19 vaccines.
    Clin Infect Dis. 2021 Mar 6. pii: 6159795. doi: 10.1093.
    >> Share

  969. PAUL LA, Daneman N, Brown KA, Johnson J, et al
    Characteristics associated with household transmission of SARS-CoV-2 in Ontario, Canada: A cohort study.
    Clin Infect Dis. 2021 Mar 5. pii: 6159706. doi: 10.1093.
    >> Share

  970. TSE H, Lung DC, Wong SC, Ip KF, et al
    Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 virus variant with novel genomic architecture in Hong Kong.
    Clin Infect Dis. 2021 Mar 2. pii: 6155931. doi: 10.1093.
    >> Share

  971. VAN LOON W, Hommes F, Theuring S, von der Haar A, et al
    Renewed absence of SARS-CoV-2 infections in the day care context in Berlin, January 2021.
    Clin Infect Dis. 2021 Mar 2. pii: 6155930. doi: 10.1093.
    >> Share

  972. RAWSON TM, Moore LSP, Zhu N, Ranganathan N, et al
    Reply to Dudoignon et al.
    Clin Infect Dis. 2021;72:906-908.
    >> Share

    February 2021
  973. EYAL N, Lipsitch M
    How to test SARS-CoV-2 vaccines ethically even after one is available.
    Clin Infect Dis. 2021 Feb 26. pii: 6152007. doi: 10.1093.
    >> Share

  974. LIM T, Delorey M, Bestul N, Johannsen M, et al
    Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020.
    Clin Infect Dis. 2021 Feb 26. pii: 6152134. doi: 10.1093.
    >> Share

  975. HYDE Z
    Difference in SARS-CoV-2 attack rate between children and adults may reflect bias.
    Clin Infect Dis. 2021 Feb 26. pii: 6150026. doi: 10.1093.
    >> Share

  976. GROOTHOF D, Post A, Gans ROB, Bakker SJL, et al
    Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function?
    Clin Infect Dis. 2021 Feb 25. pii: 6149918. doi: 10.1093.
    >> Share

  977. SAFE IP, Lacerda MVG, Almeida Val FF, Sampaio VS, et al
    Severe Hypoxemia With Normal Heart and Respiratory Rate in Early-stage Coronavirus Disease 2019 Patients: The "Happy Hypoxemia Phenomenon".
    Clin Infect Dis. 2021 Feb 24. pii: 6149031. doi: 10.1093.
    >> Share

  978. DEN HARTOG G, Vos ERA, van den Hoogen LL, van Boven M, et al
    Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study.
    Clin Infect Dis. 2021 Feb 24. pii: 6149064. doi: 10.1093.
    >> Share

  979. REIMER JR, Ahmed SM, Brintz B, Shah RU, et al
    Using a clinical prediction rule to prioritize diagnostic testing leads to reduced transmission and hospital burden: A modeling example of early SARS-CoV-2.
    Clin Infect Dis. 2021 Feb 23. pii: 6148743. doi: 10.1093.
    >> Share

  980. DAI CL, Kornilov SA, Roper RT, Cohen-Cline H, et al
    Characteristics and Factors Associated with COVID-19 Infection, Hospitalization, and Mortality Across Race and Ethnicity.
    Clin Infect Dis. 2021 Feb 20. pii: 6145124. doi: 10.1093.
    >> Share

  981. LEE JT, Hesse EM, Paulin HN, Datta D, et al
    Clinical and Laboratory Findings in Patients with Potential SARS-CoV-2 Reinfection, May-July 2020.
    Clin Infect Dis. 2021 Feb 18. pii: 6142945. doi: 10.1093.
    >> Share

  982. XU J, Zhou M, Luo P, Yin Z, et al
    Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge.
    Clin Infect Dis. 2021 Feb 17. pii: 6141511. doi: 10.1093.
    >> Share

  983. FOLEY DA, Yeoh DK, Minney-Smith CA, Martin AC, et al
    The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019-Related Public Health Measures.
    Clin Infect Dis. 2021 Feb 17. pii: 6140790. doi: 10.1093/cid/ciaa1906.
    >> Share

  984. JACKSON ML, Starita L, Kiniry E, Phillips CH, et al
    Incidence of medically attended acute respiratory illnesses due to respiratory viruses across the life course during the 2018/19 influenza season.
    Clin Infect Dis. 2021 Feb 16. pii: 6137552. doi: 10.1093.
    >> Share

  985. KULKARNI O, Narreddy S, Zaveri L, Kalal IG, et al
    Evidence of SARS-CoV-2 reinfection without mutations in Spike protein.
    Clin Infect Dis. 2021 Feb 16. pii: 6137553. doi: 10.1093.
    >> Share

  986. WESTREICH D, Jenness SM, Marcus JL
    To Contact Tracing... and Beyond!
    Clin Infect Dis. 2021;72:724-725.
    >> Share

  987. SAM-AGUDU NA, Rabie H, Pipo MT, Byamungu LN, et al
    The Critical Need for Pooled Data on COVID-19 in African Children: An AFREhealth Call for Action through Multi-Country Research Collaboration.
    Clin Infect Dis. 2021 Feb 13. pii: 6134449. doi: 10.1093.
    >> Share

  988. BELL N, Bracchi M, Dalla Pria A, Nelson M, et al
    Indirect HIV morbidity and mortality due to COVID-19.
    Clin Infect Dis. 2021 Feb 13. pii: 6134310. doi: 10.1093.
    >> Share

  989. FELDMAN AG, O'Leary ST, Isakov LD
    The Risk of Resurgence in Vaccine Preventable Infections Due to COVID-Related Gaps in Immunization.
    Clin Infect Dis. 2021 Feb 13. pii: 6134309. doi: 10.1093.
    >> Share

  990. ZUCMAN N, Uhel F, Descamps D, Roux D, et al
    Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report.
    Clin Infect Dis. 2021 Feb 10. pii: 6132402. doi: 10.1093.
    >> Share

  991. SEE I, Paul P, Slayton RB, Steele MK, et al
    Modeling effectiveness of testing strategies to prevent COVID-19 in nursing homes -United States, 2020.
    Clin Infect Dis. 2021 Feb 10. pii: 6132104. doi: 10.1093.
    >> Share

  992. DUGDALE CM, Rubins DM, Lee H, McCluskey SM, et al
    COVID-19 Diagnostic Clinical Decision Support: a Pre-Post Implementation Study of CORAL (COvid Risk cALculator).
    Clin Infect Dis. 2021 Feb 10. pii: 6132091. doi: 10.1093.
    >> Share

  993. THOMPSON HA, Mousa A, Dighe A, Fu H, et al
    SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis.
    Clin Infect Dis. 2021 Feb 9. pii: 6131730. doi: 10.1093.
    >> Share

  994. MOMPLAISIR F, Haynes N, Nkwihoreze H, Nelson M, et al
    Understanding Drivers of COVID-19 Vaccine Hesitancy Among Blacks.
    Clin Infect Dis. 2021 Feb 9. pii: 6131729. doi: 10.1093.
    >> Share

  995. CROVETTO F, Crispi F, Llurba E, Pascal R, et al
    Impact of SARS-CoV-2 Infection on Pregnancy Outcomes: A Population-Based Study.
    Clin Infect Dis. 2021 Feb 8. pii: 6131375. doi: 10.1093.
    >> Share

  996. REBEIRO PF, Aronoff DM, Smith MK
    The Impact of State Mask-Wearing Requirements on the Growth of COVID-19 Cases in the United States.
    Clin Infect Dis. 2021 Feb 7. pii: 6129930. doi: 10.1093.
    >> Share

  997. JACOBSON KB, Rao M, Bonilla H, Subramanian A, et al
    Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic.
    Clin Infect Dis. 2021 Feb 7. pii: 6129932. doi: 10.1093.
    >> Share

  998. CONNORS JM, Iba T, Gandhi RT
    Thrombosis and COVID-19: Controversies and (Tentative) Conclusions.
    Clin Infect Dis. 2021 Feb 4. pii: 6128795. doi: 10.1093.
    >> Share

  999. ARNAOUT R, Lee RA, Lee GR, Callahan C, et al
    The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing.
    Clin Infect Dis. 2021 Feb 3. pii: 6127024. doi: 10.1093/cid/ciaa1382.
    >> Share

  1000. PATEL MR, Carroll D, Ussery E, Whitham H, et al
    Performance of Oropharyngeal Swab Testing Compared With Nasopharyngeal Swab Testing for Diagnosis of Coronavirus Disease 2019-United States, January 2020-February 2020.
    Clin Infect Dis. 2021;72:403-410.
    >> Share

  1001. CANADAY DH, Gravenstein S
    On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Clin Infect Dis. 2021;72:513-514.
    >> Share

  1002. KAO CM, Orenstein WA, Anderson EJ
    The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children.
    Clin Infect Dis. 2021;72:515-518.
    >> Share

  1003. MANDONNET E, Molina JM
    Household Coronavirus Disease 2019 (COVID-19) Prevalence.
    Clin Infect Dis. 2021;72:539.
    >> Share

  1004. HAN L, Li N, Peng M, Yang L, et al
    Reply to Chen.
    Clin Infect Dis. 2021;72:538-539.
    >> Share

  1005. CHEN HJ
    It Is Not a Case-control Study.
    Clin Infect Dis. 2021;72:538.
    >> Share

    January 2021
  1006. LI C, Chen YX, Liu FF, Lee AC, et al
    Absence of vaccine-enhanced disease with unexpected positive protection against SARS-CoV-2 by inactivated vaccine given within three days of virus challenge in Syrian hamster model.
    Clin Infect Dis. 2021 Jan 30. pii: 6124512. doi: 10.1093.
    >> Share

  1007. GOTTLIEB RL, Spak CW
    The Olympiad of SARS-CoV-2 vaccinology: Fundamentals to Complement Technical Frontiers.
    Clin Infect Dis. 2021 Jan 30. pii: 6124447. doi: 10.1093.
    >> Share

  1008. RICHIER Q, Placais L, Lacombe K, Hermine O, et al
    Tocilizumab in COVID-19: Give it time!
    Clin Infect Dis. 2021 Jan 30. pii: 6124471. doi: 10.1093.
    >> Share

  1009. MOGHADAS SM, Vilches TN, Zhang K, Wells CR, et al
    The impact of vaccination on COVID-19 outbreaks in the United States.
    Clin Infect Dis. 2021 Jan 30. pii: 6124429. doi: 10.1093.
    >> Share

  1010. AKINBAMI LJ, Petersen LR, Sami S, Vuong N, et al
    COVID-19 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel, May-July 2020.
    Clin Infect Dis. 2021 Jan 30. pii: 6124470. doi: 10.1093.
    >> Share

  1011. HENSLEY MK, Bain WG, Jacobs J, Nambulli S, et al
    Intractable COVID-19 and Prolonged SARS-CoV-2 Replication in a CAR-T-cell Therapy Recipient: A Case Study.
    Clin Infect Dis. 2021 Jan 28. pii: 6122591. doi: 10.1093.
    >> Share

  1012. LANE MA, Brownsword EA, Babiker A, Ingersoll JM, et al
    Bioaerosol sampling for SARS-CoV-2 in a referral center with critically ill COVID-19 patients March-May 2020.
    Clin Infect Dis. 2021 Jan 28. pii: 6121685. doi: 10.1093/cid/ciaa1880.
    >> Share

  1013. BIENIASZ P
    The case against delaying SARS-CoV-2 mRNA vaccine boosting doses.
    Clin Infect Dis. 2021 Jan 27. pii: 6121510. doi: 10.1093.
    >> Share

  1014. LAPENNA D
    Antioxidant therapy in COVID-19: The crucial role of early treatment and antioxidant typology.
    Clin Infect Dis. 2021 Jan 27. pii: 6121547. doi: 10.1093.
    >> Share

  1015. DIMEGLIO C, Herin F, Miedouge M, Martin-Blondel G, et al
    Protection of healthcare workers against SARS-CoV-2 reinfection.
    Clin Infect Dis. 2021 Jan 27. pii: 6121509. doi: 10.1093.
    >> Share

  1016. PLOTKIN SA, Halsey N
    Accelerate COVID-19 Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.
    Clin Infect Dis. 2021 Jan 27. pii: 6121304. doi: 10.1093.
    >> Share

  1017. FUNG M, Babik JM
    COVID-19 in Immunocompromised Hosts: What We Know So Far.
    Clin Infect Dis. 2021;72:340-350.
    >> Share

  1018. ERIKSTRUP C, Hother CE, Pedersen OBV, Molbak K, et al
    Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
    Clin Infect Dis. 2021;72:249-253.
    >> Share

  1019. ANGOULVANT F, Ouldali N, Yang DD, Filser M, et al
    Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-a Time Series Analysis.
    Clin Infect Dis. 2021;72:319-322.
    >> Share

  1020. NACHEGA JB, Grimwood A, Mahomed H, Fatti G, et al
    From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa-Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.
    Clin Infect Dis. 2021;72:327-331.
    >> Share

  1021. SCHWIERZECK V, Konig JC, Kuhn J, Mellmann A, et al
    First Reported Nosocomial Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Dialysis Unit.
    Clin Infect Dis. 2021;72:265-270.
    >> Share

  1022. CHAMILOS G, Lionakis MS, Kontoyiannis DP
    Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
    Clin Infect Dis. 2021;72:351-356.
    >> Share

  1023. BUSCH MP, Stone M
    Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations.
    Clin Infect Dis. 2021;72:254-256.
    >> Share

  1024. CONTEJEAN A, Leporrier J, Canoui E, Alby-Laurent F, et al
    Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
    Clin Infect Dis. 2021;72:257-264.
    >> Share

  1025. LYNCH KL, Whitman JD, Lacanienta NP, Beckerdite EW, et al
    Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
    Clin Infect Dis. 2021;72:301-308.
    >> Share

  1026. LONG DR, Gombar S, Hogan CA, Greninger AL, et al
    Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.
    Clin Infect Dis. 2021;72:323-326.
    >> Share

  1027. ZHOU L, Wu Z, Li Z, Zhang Y, et al
    One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.
    Clin Infect Dis. 2021;72:332-339.
    >> Share

  1028. LYNCH KL, Whitman JD, Lacanienta NP, Beckerdite EW, et al
    Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
    Clin Infect Dis. 2021;72:301-308.
    >> Share

  1029. ZHOU L, Wu Z, Li Z, Zhang Y, et al
    One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.
    Clin Infect Dis. 2021;72:332-339.
    >> Share

  1030. CONTEJEAN A, Leporrier J, Canoui E, Alby-Laurent F, et al
    Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
    Clin Infect Dis. 2021;72:257-264.
    >> Share

  1031. BUSCH MP, Stone M
    Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations.
    Clin Infect Dis. 2021;72:254-256.
    >> Share

  1032. LONG DR, Gombar S, Hogan CA, Greninger AL, et al
    Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.
    Clin Infect Dis. 2021;72:323-326.
    >> Share

  1033. MAVES RC
    Making sense of contradictory evidence in Covid-19 trials.
    Clin Infect Dis. 2021 Jan 25. pii: 6119538. doi: 10.1093.
    >> Share

  1034. SHAW J, Stewart T, Anderson KB, Hanley S, et al
    Assessment of U.S. health care personnel (HCP) attitudes towards COVID-19 vaccination in a large university health care system.
    Clin Infect Dis. 2021 Jan 25. pii: 6118651. doi: 10.1093.
    >> Share

  1035. BRANCH-ELLIMAN W, Safdar N, Nelson R
    Economic Considerations in Infectious Diseases Emergency Response Preparedness: It's All About the Point of View.
    Clin Infect Dis. 2021;72:148-152.
    >> Share

  1036. JI D, Qin E, Zhang D, Cheng G, et al
    Reply to Grifoni et al.
    Clin Infect Dis. 2021;72:183.
    >> Share

  1037. HANSON KE, Caliendo AM, Arias CA, Hayden MK, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing.
    Clin Infect Dis. 2021 Jan 22. pii: 6106562. doi: 10.1093.
    >> Share

  1038. PEKOSZ A, Parvu V, Li M, Andrews JC, et al
    Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture.
    Clin Infect Dis. 2021 Jan 20. pii: 6105729. doi: 10.1093/cid/ciaa1706.
    >> Share

  1039. GOYAL R, Hotchkiss J, Schooley RT, De Gruttola V, et al
    Evaluation of SARS-CoV-2 transmission mitigation strategies on a university campus using an agent-based network model.
    Clin Infect Dis. 2021 Jan 19. pii: 6104139. doi: 10.1093.
    >> Share

  1040. SOMEKH I, Shohat T, Boker LK, Simoes EAF, et al
    Reopening Schools and the Dynamics of SARS-CoV-2 Infections in Israel: A Nationwide Study.
    Clin Infect Dis. 2021 Jan 18. pii: 6103916. doi: 10.1093.
    >> Share

  1041. SAMET JM, Prather K, Benjamin G, Lakdawala S, et al
    Airborne Transmission of SARS-CoV-2: What We Know.
    Clin Infect Dis. 2021 Jan 18. pii: 6103221. doi: 10.1093.
    >> Share

  1042. ALROY KA, Crossa A, Dominianni C, Sell J, et al
    Population-based Estimates of COVID-19-like Illness, COVID-19 Illness, and Rates of Case Ascertainment, Hospitalizations, and Deaths - Non-Institutionalized New York City Residents, March-April 2020.
    Clin Infect Dis. 2021 Jan 18. pii: 6103212. doi: 10.1093.
    >> Share

  1043. HARRINGTON D, Kele B, Pereira S, Couto-Parada X, et al
    Confirmed Reinfection with SARS-CoV-2 Variant VOC-202012/01.
    Clin Infect Dis. 2021 Jan 9. pii: 6076528. doi: 10.1093.
    >> Share

  1044. LEE M
    Lack of SARS-CoV2 neutralization by antibodies to seasonal coronaviruses: making sense of the COVID-19 pandemic.
    Clin Infect Dis. 2021 Jan 8. pii: 6071008. doi: 10.1093.
    >> Share

  1045. BOYD S, Martin-Loeches I
    Rates of Aspergillus Co-infection in COVID patients in ICU not as high as previously reported.
    Clin Infect Dis. 2021 Jan 8. pii: 6071009. doi: 10.1093.
    >> Share

  1046. ANDERSEN KM, Mehta HB, Palamuttam N, Ford D, et al
    Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System.
    Clin Infect Dis. 2021 Jan 7. pii: 6067567. doi: 10.1093/cid/ciaa1488.
    >> Share

  1047. YANG B, Wu P, Lau EHY, Wong JY, et al
    Changing disparities in COVID-19 burden in the ethnically homogeneous population of Hong Kong through pandemic waves: an observational study.
    Clin Infect Dis. 2021 Jan 6. pii: 6066577. doi: 10.1093.
    >> Share

  1048. LUMLEY SF, Wei J, O'Donnell D, Stoesser NE, et al
    The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers.
    Clin Infect Dis. 2021 Jan 6. pii: 6064824. doi: 10.1093.
    >> Share

  1049. DALAGER-PEDERSEN M, Lund LC, Mariager T, Winther R, et al
    Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study.
    Clin Infect Dis. 2021 Jan 5. pii: 6064643. doi: 10.1093.
    >> Share

  1050. PILOTTO A, Masciocchi S, Volonghi I, De Giuli V, et al
    SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.
    Clin Infect Dis. 2021 Jan 4. pii: 6062486. doi: 10.1093/cid/ciaa1933.
    >> Share

  1051. TRIANT VA, Gandhi RT
    When Epidemics Collide: Why People with HIV May Have Worse COVID-19 Outcomes and Implications for Vaccination.
    Clin Infect Dis. 2021 Jan 4. pii: 6062462. doi: 10.1093/cid/ciaa1946.
    >> Share

  1052. WEINBERGER T, Steffen J, Osterman A, Mueller TT, et al
    Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany.
    Clin Infect Dis. 2021 Jan 3. pii: 6060065. doi: 10.1093/cid/ciaa1935.
    >> Share

  1053. ZHANG Z, Guo L, Huang L, Zhang C, et al
    Distinct disease severity between children and older adults with COVID-19: Impacts of ACE2 expression, distribution, and lung progenitor cells.
    Clin Infect Dis. 2021 Jan 3. pii: 6059779. doi: 10.1093/cid/ciaa1911.
    >> Share

  1054. HOEHL S, Kreutzer E, Schenk B, Westhaus S, et al
    Longitudinal testing for respiratory and gastrointestinal shedding of SARS-CoV-2 in day care centres in Hesse, Germany.
    Clin Infect Dis. 2021 Jan 3. pii: 6059778. doi: 10.1093/cid/ciaa1912.
    >> Share

  1055. DAN J, Mehta S
    SARS-CoV-2 immunity and reinfection.
    Clin Infect Dis. 2021 Jan 2. pii: 6058751. doi: 10.1093/cid/ciaa1936.
    >> Share

    December 2020
  1056. GRANICH R, Gupta S
    European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV Pandemic.
    Clin Infect Dis. 2020;71:2917-2919.
    >> Share

  1057. TAYLOR SP, Kowalkowski MA, Beidas RS
    Where Is the Implementation Science? An Opportunity to Apply Principles During the COVID-19 Pandemic.
    Clin Infect Dis. 2020;71:2993-2995.
    >> Share

  1058. SKURNIK D, Rybak A, Yang DD, Pons S, et al
    Unexpected lessons from the COVID-19 lockdowns in France: Low impact of school opening on common communicable pediatric airborne diseases.
    Clin Infect Dis. 2020 Dec 29. pii: 6054992. doi: 10.1093/cid/ciaa1899.
    >> Share

  1059. KING LM, Lovegrove MC, Shehab N, Tsay S, et al
    Trends in U.S. outpatient antibiotic prescriptions during the COVID-19 pandemic.
    Clin Infect Dis. 2020 Dec 29. pii: 6054971. doi: 10.1093/cid/ciaa1896.
    >> Share

  1060. SILVESTRE OM, Costa LR, Lopes BVR, Barbosa MR, et al
    Previous dengue infection and mortality in COVID-19.
    Clin Infect Dis. 2020 Dec 29. pii: 6054970. doi: 10.1093/cid/ciaa1895.
    >> Share

  1061. PILAROWSKI G, Marquez C, Rubio L, Peng J, et al
    Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing.
    Clin Infect Dis. 2020 Dec 26. pii: 6052342. doi: 10.1093/cid/ciaa1890.
    >> Share

  1062. HIRSCHFELD G, von Glischinski M, Thiele C
    Optimal cycle thresholds for COVID-19 screening - ROC-based methods highlight between-study differences.
    Clin Infect Dis. 2020 Dec 23. pii: 6044731. doi: 10.1093/cid/ciaa1883.
    >> Share

  1063. GILES ML, Wallace EM, Alpren C, Brady N, et al
    Suppression of SARS-CoV-2 after a second wave in Victoria, Australia.
    Clin Infect Dis. 2020 Dec 23. pii: 6044730. doi: 10.1093/cid/ciaa1882.
    >> Share

  1064. KIES KD, Thomas AS, Binnicker MJ, Bashynski KL, et al
    Decrease in Enteroviral Meningitis - An Unexpected Benefit of COVID-19 Mitigation?
    Clin Infect Dis. 2020 Dec 23. pii: 6044729. doi: 10.1093/cid/ciaa1881.
    >> Share

  1065. LIN DY, Zeng D, Mehrotra DV, Corey L, et al
    Evaluating the Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2020 Dec 19. pii: 6042236. doi: 10.1093/cid/ciaa1863.
    >> Share

  1066. GUARALDI G, Milic J, Martinez E, Kamarulzaman A, et al
    HIV care models during the COVID-19 era.
    Clin Infect Dis. 2020 Dec 19. pii: 6041857. doi: 10.1093/cid/ciaa1864.
    >> Share

  1067. BOYCE RM, Shook-Sa BE, Aiello AE
    A tale of two studies: Study design and our understanding of SARS-CoV-2 seroprevalence.
    Clin Infect Dis. 2020 Dec 18. pii: 6041690. doi: 10.1093/cid/ciaa1868.
    >> Share

  1068. COHEN JI, Burbelo PD
    Reinfection with SARS-CoV-2: Implications for Vaccines.
    Clin Infect Dis. 2020 Dec 18. pii: 6041697. doi: 10.1093/cid/ciaa1866.
    >> Share

  1069. GOODMAN KE, Magder LS, Baghdadi JD, Pineles L, et al
    Impact of Sex and Metabolic Comorbidities on COVID-19 Mortality Risk Across Age Groups: 66,646 Inpatients Across 613 U.S. Hospitals.
    Clin Infect Dis. 2020 Dec 18. pii: 6041643. doi: 10.1093/cid/ciaa1787.
    >> Share

  1070. HANSON KE, Azar MM, Banerjee R, Chou A, et al
    Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee.
    Clin Infect Dis. 2020;71:2744-2751.
    >> Share

  1071. HUANG J, Liu F, Teng Z, Chen J, et al
    Care for the Psychological Status of Frontline Medical Staff Fighting Against Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2020;71:3268-3269.
    >> Share

  1072. MODY A, Pfeifauf K, Bradley C, Fox B, et al
    Understanding Drivers of COVID-19 Racial Disparities: A Population-Level Analysis of COVID-19 Testing among Black and White Populations.
    Clin Infect Dis. 2020 Dec 14. pii: 6033727. doi: 10.1093/cid/ciaa1848.
    >> Share

  1073. PETTIT NN, Pisano J, Nguyen CT, Lew AK, et al
    Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?
    Clin Infect Dis. 2020 Dec 14. pii: 6033734. doi: 10.1093/cid/ciaa1851.
    >> Share

  1074. ABU-RADDAD LJ, Chemaitelly H, Malek JA, Ahmed AA, et al
    Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting.
    Clin Infect Dis. 2020 Dec 14. pii: 6033728. doi: 10.1093/cid/ciaa1846.
    >> Share

  1075. SELHORST P, Van Ierssel S, Michiels J, Marien J, et al
    Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response.
    Clin Infect Dis. 2020 Dec 14. pii: 6033730. doi: 10.1093/cid/ciaa1850.
    >> Share

  1076. COSTA SF, Giavina-Bianchi P, Buss L, Mesquita Peres CH, et al
    SARS-CoV-2 seroprevalence and risk factors among oligo/asymptomatic healthcare workers(HCW): estimating the impact of community transmission.
    Clin Infect Dis. 2020 Dec 13. pii: 6032715. doi: 10.1093/cid/ciaa1845.
    >> Share

  1077. MOEHRING RW, Holland TL
    Compiling Observational Research During a Pandemic: A Necessary Bridge.
    Clin Infect Dis. 2020 Dec 11. pii: 6030989. doi: 10.1093/cid/ciaa1705.
    >> Share

  1078. COOK AR, Dickens BL, Wilder-Smith A
    Differential household attack rates mirror the ability to control Covid-19.
    Clin Infect Dis. 2020 Dec 11. pii: 6030927. doi: 10.1093/cid/ciaa1842.
    >> Share

  1079. BAJEMA KL, Dahlgren FS, Lim TW, Bestul N, et al
    Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey.
    Clin Infect Dis. 2020 Dec 10. pii: 6029296. doi: 10.1093/cid/ciaa1804.
    >> Share

  1080. KAISER L, Vu-Cantero DL, Eberhardt CS
    Paradoxes and uncertainties of immunomodulatory treatments in the fight against COVID-19.
    Clin Infect Dis. 2020 Dec 8. pii: 6025515. doi: 10.1093/cid/ciaa1837.
    >> Share

  1081. ZHU Y, Bloxham CJ, Hulme KD, Sinclair JE, et al
    A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters.
    Clin Infect Dis. 2020 Dec 6. pii: 6024998. doi: 10.1093/cid/ciaa1825.
    >> Share

  1082. COVIN S, Rutherford GW
    Co-infection, SARS-CoV-2 and influenza: an evolving puzzle.
    Clin Infect Dis. 2020 Dec 5. pii: 6024509. doi: 10.1093/cid/ciaa1810.
    >> Share

  1083. DOSHI P, Powers JH
    Determining the infectious potential of individuals with positive RT-PCR SARS-CoV-2 tests.
    Clin Infect Dis. 2020 Dec 4. pii: 6024448. doi: 10.1093/cid/ciaa1819.
    >> Share

  1084. ZHANG N, Jia W, Lei H, Wang P, et al
    Effects of human behaviour changes during the COVID-19 pandemic on influenza spread in Hong Kong.
    Clin Infect Dis. 2020 Dec 4. pii: 6024447. doi: 10.1093/cid/ciaa1818.
    >> Share

  1085. ROSENBERG ES, Bradley HM
    Improving surveillance estimates of COVID-19 incidence in the United States.
    Clin Infect Dis. 2020 Dec 4. pii: 6020000. doi: 10.1093/cid/ciaa1813.
    >> Share

  1086. HOWARD LM
    Is there an association between SARS-CoV-2 and Streptococcus pneumoniae?
    Clin Infect Dis. 2020 Dec 4. pii: 6020002. doi: 10.1093/cid/ciaa1812.
    >> Share

  1087. NEVES FS
    Dose-response effects of hydroxychloroquine on prophylaxis against SARS-CoV-2 / COVID-19 infection.
    Clin Infect Dis. 2020 Dec 3. pii: 6018203. doi: 10.1093/cid/ciaa1807.
    >> Share

  1088. OWUSU D, Kim L, O'Halloran A, Whitaker M, et al
    Characteristics of Adults aged 18-49 Years without Underlying Conditions Hospitalized with Laboratory-Confirmed COVID-19 in the United States, COVID-NET - March-August 2020.
    Clin Infect Dis. 2020 Dec 3. pii: 6017811. doi: 10.1093/cid/ciaa1806.
    >> Share

  1089. POSTON D, Weisblum Y, Wise H, Templeton K, et al
    Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection.
    Clin Infect Dis. 2020 Dec 3. pii: 6017810. doi: 10.1093/cid/ciaa1803.
    >> Share

  1090. JEFFERSON T, Spencer EA, Brassey J, Heneghan C, et al
    Viral cultures for COVID-19 infectious potential assessment - a systematic review.
    Clin Infect Dis. 2020 Dec 3. pii: 6018217. doi: 10.1093/cid/ciaa1764.
    >> Share

  1091. WADHWA A, Fisher KA, Silver R, Koh M, et al
    Identification of presymptomatic and asymptomatic cases using cohort-based testing approaches at a large correctional facility - Chicago, Illinois, USA, May 2020.
    Clin Infect Dis. 2020 Dec 3. pii: 6017809. doi: 10.1093/cid/ciaa1802.
    >> Share

  1092. CHAN JF, Zhang AJ, Yuan S, Poon VK, et al
    Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
    Clin Infect Dis. 2020;71:2428-2446.
    >> Share

  1093. LEDNICKY JA
    A practical and economic approach for assessing potential SARS-CoV-2 transmission risk in COVID-19 patients.
    Clin Infect Dis. 2020 Dec 1. pii: 6015519. doi: 10.1093/cid/ciaa1789.
    >> Share

    November 2020
  1094. PETERSEN MS, Kristiansen MF, Hanusson KD, Danielsen ME, et al
    Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients.
    Clin Infect Dis. 2020 Nov 30. pii: 6012625. doi: 10.1093/cid/ciaa1792.
    >> Share

  1095. BASAVARAJU SV, Patton ME, Grimm K, Rasheed MAU, et al
    Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020.
    Clin Infect Dis. 2020 Nov 30. pii: 6012472. doi: 10.1093/cid/ciaa1785.
    >> Share

  1096. BRAUNSTEIN SL, Lazar R, Wahnich A, Daskalakis DC, et al
    COVID-19 infection among people with HIV in New York City: A population-level analysis of linked surveillance data.
    Clin Infect Dis. 2020 Nov 30. pii: 6012626. doi: 10.1093/cid/ciaa1793.
    >> Share

  1097. KUIPER VP, Rosendaal FR, Kamerling IMC, Visser LG, et al
    Assessment of risks associated with SARS-CoV-2 experimental human infection studies.
    Clin Infect Dis. 2020 Nov 29. pii: 6009505. doi: 10.1093/cid/ciaa1784.
    >> Share

  1098. PADMANABHAN S
    The COVID-19 Pan-Syndemic - will we ever learn?
    Clin Infect Dis. 2020 Nov 29. pii: 6009406. doi: 10.1093/cid/ciaa1797.
    >> Share

  1099. NGUYEN TV, Frost SA
    Effect of steroids on Covid-19 mortality risk: a Bayesian interpretation.
    Clin Infect Dis. 2020 Nov 29. pii: 6009383. doi: 10.1093/cid/ciaa1783.
    >> Share

  1100. JIA R, Wang H
    How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?
    Clin Infect Dis. 2020 Nov 27. pii: 6007043. doi: 10.1093/cid/ciaa1325.
    >> Share

  1101. HUGHES G, Merry C, Geary U, Noonan N, et al
    Changing Disease Epidemiology to Inform Expanded Coronavirus Disease 2019 Testing.
    Clin Infect Dis. 2020 Nov 26. pii: 6006321. doi: 10.1093/cid/ciaa1677.
    >> Share

  1102. REESE H, Iuliano AD, Patel NN, Garg S, et al
    Estimated incidence of COVID-19 illness and hospitalization - United States, February-September, 2020.
    Clin Infect Dis. 2020 Nov 25. pii: 6000389. doi: 10.1093/cid/ciaa1780.
    >> Share

  1103. VAN DEN BORST B, Peters JB, Brink M, Schoon Y, et al
    Comprehensive health assessment three months after recovery from acute COVID-19.
    Clin Infect Dis. 2020 Nov 21. pii: 5998118. doi: 10.1093/cid/ciaa1750.
    >> Share

  1104. LEE JS, Kim SY, Kim TS, Hong KH, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Clin Infect Dis. 2020 Nov 21. pii: 5997517. doi: 10.1093/cid/ciaa1421.
    >> Share

  1105. ZELNER J, Trangucci R, Naraharisetti R, Cao A, et al
    Racial disparities in COVID-19 mortality are driven by unequal infection risks.
    Clin Infect Dis. 2020 Nov 21. pii: 5998295. doi: 10.1093/cid/ciaa1723.
    >> Share

  1106. BHATT PJ, Shiau S, Brunetti L, Xie Y, et al
    Risk Factors and Outcomes of Hospitalized Patients with Severe COVID-19 and Secondary Bloodstream Infections: A Multicenter, Case-Control Study.
    Clin Infect Dis. 2020 Nov 20. pii: 5995838. doi: 10.1093/cid/ciaa1748.
    >> Share

  1107. MEYEROWITZ EA, Sen P, Schoenfeld SR, Neilan TG, et al
    Immunomodulation as Treatment for Severe COVID-19: a systematic review of current modalities and future directions.
    Clin Infect Dis. 2020 Nov 20. pii: 5996142. doi: 10.1093/cid/ciaa1759.
    >> Share

  1108. ZHANG AJ, Lee AC, Chan JF, Liu F, et al
    Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters.
    Clin Infect Dis. 2020 Nov 20. pii: 5995847. doi: 10.1093/cid/ciaa1747.
    >> Share

  1109. MCLAUGHLIN JM, Khan F, Pugh S, Angulo FJ, et al
    County-Level Predictors of COVID-19 Cases and Deaths in the United States: What Happened, and Where Do We Go from Here?
    Clin Infect Dis. 2020 Nov 19. pii: 5992242. doi: 10.1093/cid/ciaa1729.
    >> Share

  1110. PELUSO MJ, Bakkour S, Busch MP, Deeks SG, et al
    A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19.
    Clin Infect Dis. 2020 Nov 19. pii: 5991913. doi: 10.1093/cid/ciaa1754.
    >> Share

  1111. SULLIVAN SG
    The Need for Robust Epidemiological Evidence During a Pandemic.
    Clin Infect Dis. 2020;71:2289-2290.
    >> Share

  1112. LORENTZEN HF, Schmidt S, Benfield T
    PCR Test Caveats After Discharge Following COVID-19.
    Clin Infect Dis. 2020;71:2302-2303.
    >> Share

  1113. JAIN MK, Rollins N, Jain R
    Access to Coronavirus Disease 2019 Clinical Trials by English and Non-English Speakers Is Needed.
    Clin Infect Dis. 2020;71:2298-2299.
    >> Share

  1114. POLONI C, Tsoukas C
    Evaluating Immune Dysregulation in Patients With COVID-19 Requires a More Accurate Definition of the CD45RA+ T-cell Phenotype.
    Clin Infect Dis. 2020;71:2306-2307.
    >> Share

  1115. DOAN T, Hinterwirth A, Arzika AM, Worden L, et al
    Reduction of Coronavirus Burden With Mass Azithromycin Distribution.
    Clin Infect Dis. 2020;71:2282-2284.
    >> Share

  1116. POLLETT S, Rivers C
    Social Media and the New World of Scientific Communication During the COVID-19 Pandemic.
    Clin Infect Dis. 2020;71:2184-2186.
    >> Share

  1117. OUYANG Y, Yin J, Wang W, Shi H, et al
    Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19.
    Clin Infect Dis. 2020;71:2052-2060.
    >> Share

  1118. LI N, Han L, Peng M, Lv Y, et al
    Maternal and Neonatal Outcomes of Pregnant Women With Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case-Control Study.
    Clin Infect Dis. 2020;71:2035-2041.
    >> Share

  1119. SANVILLE B, Corbett R, Pidcock W, Hardin K, et al
    A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States.
    Clin Infect Dis. 2020;71:2222-2226.
    >> Share

  1120. RUSSO A, Bellelli V, Ceccarelli G, Marincola Cattaneo F, et al
    Comparison between hospitalized patients affected or not by COVID-19 (RESILIENCY study).
    Clin Infect Dis. 2020 Nov 18. pii: 5989494. doi: 10.1093/cid/ciaa1745.
    >> Share

  1121. STAPLETON JT
    SARS-CoV-2 Antibody Testing: Important but Imperfect.
    Clin Infect Dis. 2020 Nov 18. pii: 5989218. doi: 10.1093/cid/ciaa1755.
    >> Share

  1122. TLEYJEH IM
    The misleading "pooled effect estimate" of crude data from observational studies at critical risk of bias: The case of Tocilizumab in COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985641. doi: 10.1093/cid/ciaa1735.
    >> Share

  1123. LADHANI SN, Andrews N, Aiano F, Baawuah F, et al
    Secondary attack rate and family clustering of SARS-CoV-2 infection in children of healthcare workers with confirmed COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985642. doi: 10.1093/cid/ciaa1737.
    >> Share

  1124. HUANG YT, Chao CM, Lai CC
    The impact of tocilizumab on the mortality of patients with COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985678. doi: 10.1093/cid/ciaa1738.
    >> Share

  1125. EMANUELS A, Heimonen J, O'Hanlon J, Kim AE, et al
    Remote Household Observation for Non-influenza Respiratory Viral Illness.
    Clin Infect Dis. 2020 Nov 17. pii: 5983780. doi: 10.1093/cid/ciaa1719.
    >> Share

  1126. AMIN-CHOWDHURY Z, Aiano F, Mensah A, Sheppard C, et al
    Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection with SARS-CoV-2: prospective national cohort study, England.
    Clin Infect Dis. 2020 Nov 16. pii: 5983410. doi: 10.1093/cid/ciaa1728.
    >> Share

  1127. MARAIS BJ
    COVID-19 disease spectrum in children - first insights from Africa.
    Clin Infect Dis. 2020 Nov 14. pii: 5981678. doi: 10.1093/cid/ciaa1731.
    >> Share

  1128. BROTONS P, Launes C, Buetas E, Fumado V, et al
    Susceptibility to Sars-COV-2 Infection Among Children And Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain.
    Clin Infect Dis. 2020 Nov 12. pii: 5979490. doi: 10.1093/cid/ciaa1721.
    >> Share

  1129. LUM BX, Liu EH, Archuleta S, Somani J, et al
    Establishing a New Normal for Hospital Care: A Whole of Hospital Approach to COVID-19.
    Clin Infect Dis. 2020 Nov 12. pii: 5974991. doi: 10.1093/cid/ciaa1722.
    >> Share

  1130. VAN DER ZALM MM, Lishman J, Verhagen LM, Redfern A, et al
    Clinical experience with SARS CoV-2 related illness in children - hospital experience in Cape Town, South Africa.
    Clin Infect Dis. 2020 Nov 10. pii: 5973899. doi: 10.1093/cid/ciaa1666.
    >> Share

  1131. CHE Y, Liu X, Pu Y, Zhou M, et al
    Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.
    Clin Infect Dis. 2020 Nov 9. pii: 5962856. doi: 10.1093/cid/ciaa1703.
    >> Share

  1132. COLLINS LF
    Persons with HIV and the COVID-19 Pandemic: A Viral Synergy of Biology and Sociology.
    Clin Infect Dis. 2020 Nov 8. pii: 5960297. doi: 10.1093/cid/ciaa1715.
    >> Share

  1133. POSFAY-BARBE KM, Andrey DO, Virzi J, Cohen P, et al
    Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care.
    Clin Infect Dis. 2020 Nov 8. pii: 5960295. doi: 10.1093/cid/ciaa1702.
    >> Share

  1134. SHERMAN AC, Babiker A, Sieben AJ, Pyden A, et al
    The Effect of SARS-CoV-2 Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of Two Large Metropolitan Centers in the United States.
    Clin Infect Dis. 2020 Nov 8. pii: 5960296. doi: 10.1093/cid/ciaa1704.
    >> Share

  1135. GOLDMAN JD
    Hydroxychloroquine for Prevention of SARS-CoV-2 Infection: challenges to trial conduct during the global pandemic.
    Clin Infect Dis. 2020 Nov 7. pii: 5959847. doi: 10.1093/cid/ciaa1707.
    >> Share

  1136. HUH K, Jung J, Hong J, Kim M, et al
    Impact of non-pharmaceutical interventions on the incidence of respiratory infections during the COVID-19 outbreak in Korea: a nationwide surveillance study.
    Clin Infect Dis. 2020 Nov 5. pii: 5956267. doi: 10.1093/cid/ciaa1682.
    >> Share

  1137. SIMS MD, Maine GN, Childers KL, Podolsky RH, et al
    COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking.
    Clin Infect Dis. 2020 Nov 5. pii: 5956266. doi: 10.1093/cid/ciaa1684.
    >> Share

  1138. LEI JH, Xu Y, Jiang YF, Shi ZH, et al
    Clustering cases of Chlamydia psittaci pneumonia in COVID-19 screening ward staff.
    Clin Infect Dis. 2020 Nov 5. pii: 5956268. doi: 10.1093/cid/ciaa1681.
    >> Share

  1139. QIN G, Zhang L, Yu CJ
    Nonpharmaceutical Interventions and Epidemic Intensity During the 2019 Novel Coronavirus Disease Pandemic.
    Clin Infect Dis. 2020;71:2019-2020.
    >> Share

  1140. HTUN HL, Lim DW, Kyaw WM, Loh WJ, et al
    Responding to the COVID-19 Outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems.
    Clin Infect Dis. 2020;71:1947-1952.
    >> Share

  1141. PETERSEN LR, Sami S, Vuong N, Pathela P, et al
    Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons.
    Clin Infect Dis. 2020 Nov 4. pii: 5956137. doi: 10.1093/cid/ciaa1685.
    >> Share

  1142. ARVISAIS-ANHALT S, Lehmann CU, Park JY, Araj E, et al
    What the COVID-19 Pandemic Has Reinforced: The Need for Accurate Data.
    Clin Infect Dis. 2020 Nov 4. pii: 5956084. doi: 10.1093/cid/ciaa1686.
    >> Share

  1143. HURST JH, Heston SM, Chambers HN, Cunningham HM, et al
    SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.
    Clin Infect Dis. 2020 Nov 3. pii: 5952826. doi: 10.1093/cid/ciaa1693.
    >> Share

  1144. VIJAYAN T, Shin M, Adamson PC, Harris C, et al
    Beyond the 405 and the 5: Geographic variations and factors associated with SARS-CoV-2 positivity rates in Los Angeles County.
    Clin Infect Dis. 2020 Nov 3. pii: 5952808. doi: 10.1093/cid/ciaa1692.
    >> Share

    October 2020
  1145. MASTRANGELO A, Germinario BN, Ferrante M, Frangi C, et al
    Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls.
    Clin Infect Dis. 2020 Oct 30. pii: 5943480. doi: 10.1093/cid/ciaa1594.
    >> Share

  1146. ZHANG X, Wang J
    Dose-response Relation Deduced for Coronaviruses from COVID-19, SARS and MERS Meta-analysis Results and its Application for Infection Risk Assessment of Aerosol Transmission.
    Clin Infect Dis. 2020 Oct 29. pii: 5943160. doi: 10.1093/cid/ciaa1675.
    >> Share

  1147. VOETEN HACM, Sikkema RS, Damen M, Oude Munnink BB, et al
    Unravelling the modes of transmission of SARS-CoV-2 during a nursing home outbreak: looking beyond the church super-spread event.
    Clin Infect Dis. 2020 Oct 29. pii: 5943000. doi: 10.1093/cid/ciaa1664.
    >> Share

  1148. HOFFMANN C, Wolf E
    The Low Case Fatality Rate of COVID-19 in Hong Kong Could Be Deceptive.
    Clin Infect Dis. 2020 Oct 29. pii: 5942945. doi: 10.1093/cid/ciaa1676.
    >> Share

  1149. MARQUEZ H, Ramers C, Northrup A, Tam A, et al
    Response to the COVID-19 pandemic among people experiencing homelessness in congregant living settings in San Diego, CA.
    Clin Infect Dis. 2020 Oct 28. pii: 5942619. doi: 10.1093/cid/ciaa1668.
    >> Share

  1150. YANG HC
    Isolation or De-isolation: Measuring the Infectivity of SARS-CoV-2?
    Clin Infect Dis. 2020 Oct 28. pii: 5942612. doi: 10.1093/cid/ciaa1671.
    >> Share

  1151. FAN VS, Dominitz JA, Eastment MC, Locke E, et al
    Risk Factors for testing positive for SARS-CoV-2 in a national US healthcare system.
    Clin Infect Dis. 2020 Oct 27. pii: 5940590. doi: 10.1093/cid/ciaa1624.
    >> Share

  1152. PREMACHANDRAN KP, Senthur Nambi P, Ramasubramanian V, Gopalakrishnan R, et al
    Avifavir in Treating Patients with Moderate Covid 19.
    Clin Infect Dis. 2020 Oct 27. pii: 5940577. doi: 10.1093/cid/ciaa1601.
    >> Share

  1153. GNIAZDOWSKI V, Morris CP, Wohl S, Mehoke T, et al
    Repeat COVID-19 Molecular Testing: Correlation of SARS-CoV-2 Culture with Molecular Assays and Cycle Thresholds.
    Clin Infect Dis. 2020 Oct 27. pii: 5940589. doi: 10.1093/cid/ciaa1616.
    >> Share

  1154. IWATA K, Yoshimura K
    A concern regarding estimated sensitivities and specificities of nasopharyngeal and saliva specimens for SARS-CoV-2 infection.
    Clin Infect Dis. 2020 Oct 26. pii: 5940522. doi: 10.1093/cid/ciaa1655.
    >> Share

  1155. GUHAROY R, Krenzelok EP
    FDA Emergency Use Authorization: Glass Half Empty?
    Clin Infect Dis. 2020 Oct 26. pii: 5940147. doi: 10.1093/cid/ciaa1653.
    >> Share

  1156. FANG FC, Benson CA, Del Rio C, Edwards KM, et al
    COVID-19 - Lessons Learned and Questions Remaining.
    Clin Infect Dis. 2020 Oct 26. pii: 5940148. doi: 10.1093/cid/ciaa1654.
    >> Share

  1157. RHEE C, Kanjilal S, Baker M, Klompas M, et al
    Reply to Cimolai: Even With Variable Viral Culture Methods, Culturing SARS-CoV-2 After 10 Days Appears to be Rare and Has Unclear Implications for Transmission.
    Clin Infect Dis. 2020 Oct 26. pii: 5940146. doi: 10.1093/cid/ciaa1634.
    >> Share

  1158. KOBAYASHI T, Trannel A, Holley SA, Alsuhaibani M, et al
    COVID-19 Serial Testing among Hospitalized Patients in a Midwest Tertiary Medical Center, July-September 2020.
    Clin Infect Dis. 2020 Oct 26. pii: 5939900. doi: 10.1093/cid/ciaa1630.
    >> Share

  1159. MALSY J, Veletzky L, Heide J, Hennigs A, et al
    Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19.
    Clin Infect Dis. 2020 Oct 26. pii: 5939946. doi: 10.1093/cid/ciaa1637.
    >> Share

  1160. ANDERSON L, Caniza M
    COVID-19 and preventative medicine for HIV infected children.
    Clin Infect Dis. 2020 Oct 26. pii: 5939859. doi: 10.1093/cid/ciaa1626.
    >> Share

  1161. HAGE R, Schuurmans MM
    COVID-19 in solid organ transplant recipients.
    Clin Infect Dis. 2020 Oct 26. pii: 5939886. doi: 10.1093/cid/ciaa1629.
    >> Share

  1162. PEDERSEN OB, Nissen J, Dinh KM, Schwinn M, et al
    SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors - A cross-sectional study.
    Clin Infect Dis. 2020 Oct 26. pii: 5939898. doi: 10.1093/cid/ciaa1627.
    >> Share

  1163. CHIN ET, Huynh BQ, Chapman LAC, Murrill M, et al
    Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce Outbreaks.
    Clin Infect Dis. 2020 Oct 26. pii: 5939986. doi: 10.1093/cid/ciaa1383.
    >> Share

  1164. SANTORO F, Monitillo F, Raimondo P, Lopizzo A, et al
    QTc interval prolongation and life-threatening arrhythmias during hospitalization in patients with COVID-19. Results from a multi-center prospective registry.
    Clin Infect Dis. 2020 Oct 24. pii: 5938528. doi: 10.1093/cid/ciaa1578.
    >> Share

  1165. BASILE K, McPhie K, Carter I, Alderson S, et al
    Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19.
    Clin Infect Dis. 2020 Oct 24. pii: 5937368. doi: 10.1093/cid/ciaa1579.
    >> Share

  1166. GERETTI AM, Stockdale AJ, Kelly SH, Cevik M, et al
    Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study.
    Clin Infect Dis. 2020 Oct 23. pii: 5937133. doi: 10.1093/cid/ciaa1605.
    >> Share

  1167. OLDONI E, van Gool A, Garcia Bermejo L, Scherer A, et al
    Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination.
    Clin Infect Dis. 2020 Oct 22. pii: 5935756. doi: 10.1093/cid/ciaa1250.
    >> Share

  1168. ASLAM A, Singh J, Robilotti E, Chow K, et al
    SARS CoV-2 Surveillance and Exposure in the Perioperative Setting with Universal testing and Personal Protective Equipment (PPE) Policies.
    Clin Infect Dis. 2020 Oct 22. pii: 5934921. doi: 10.1093/cid/ciaa1607.
    >> Share

  1169. DU P, Song C, Li R, Song Y, et al
    Specific re-distribution of SARS-CoV-2 variants in the respiratory system and intestinal tract.
    Clin Infect Dis. 2020 Oct 22. pii: 5934821. doi: 10.1093/cid/ciaa1617.
    >> Share

  1170. AHMAD MF, Mahakkanukrauh P, Das S
    The detection of SARS-CoV-2 virus in the vaginal fluid of females with severe COVID-19 infection: scientific facts.
    Clin Infect Dis. 2020 Oct 21. pii: 5934738. doi: 10.1093/cid/ciaa1608.
    >> Share

  1171. AZZI L
    Saliva is the Key Element for SARS-CoV-2 Mass Screening.
    Clin Infect Dis. 2020 Oct 21. pii: 5933821. doi: 10.1093/cid/ciaa1440.
    >> Share

  1172. LEI H, Wu X, Wang X, Xu M, et al
    Different transmission dynamics of COVID-19 and influenza suggest the relative efficiency of isolation/quarantine and social distancing against COVID-19 in China.
    Clin Infect Dis. 2020 Oct 20. pii: 5932276. doi: 10.1093/cid/ciaa1584.
    >> Share

  1173. O'DRISCOLL M, Harry C, Donnelly CA, Cori A, et al
    A comparative analysis of statistical methods to estimate the reproduction number in emerging epidemics with implications for the current COVID-19 pandemic.
    Clin Infect Dis. 2020 Oct 20. pii: 5932264. doi: 10.1093/cid/ciaa1599.
    >> Share

  1174. XU J, Teng Y, Shang L, Gu X, et al
    The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2020 Oct 20. pii: 5932274. doi: 10.1093/cid/ciaa1592.
    >> Share

  1175. YANG B, Fulcher JA, Ahn J, Berro M, et al
    Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab.
    Clin Infect Dis. 2020 Oct 20. pii: 5932277. doi: 10.1093/cid/ciaa1583.
    >> Share

  1176. KOJIMA N, Turner F, Slepnev V, Bacelar A, et al
    Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Oct 19. pii: 5930814. doi: 10.1093/cid/ciaa1589.
    >> Share

  1177. DAUBY N
    Favipiravir as an antiviral agent in COVID-19: same script, different cast?
    Clin Infect Dis. 2020 Oct 19. pii: 5930653. doi: 10.1093/cid/ciaa1600.
    >> Share

  1178. ANESI GL
    Hospital transfers across U.S. regions to address the "space" shortage in a pandemic: a public good.
    Clin Infect Dis. 2020 Oct 18. pii: 5929668. doi: 10.1093/cid/ciaa1596.
    >> Share

  1179. PIMENOFF VN, Elfstrom M, Baussano I, Bjornstedt M, et al
    Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden.
    Clin Infect Dis. 2020 Oct 18. pii: 5929661. doi: 10.1093/cid/ciaa1593.
    >> Share

  1180. CONOVER CS
    Transmission of SARS-CoV-2 via Contaminated Surfaces: What is to be Done?
    Clin Infect Dis. 2020 Oct 18. pii: 5929662. doi: 10.1093/cid/ciaa1586.
    >> Share

  1181. RODRIGUEZ JY, Le Pape P, Lopez O, Esquea K, et al
    Candida auris: a latent threat to critically ill patients with COVID-19.
    Clin Infect Dis. 2020 Oct 18. pii: 5929667. doi: 10.1093/cid/ciaa1595.
    >> Share

  1182. WHITE PL, Dhillon R, Healy B, Wise MP, et al
    Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures?
    Clin Infect Dis. 2020 Oct 18. pii: 5929669. doi: 10.1093/cid/ciaa1597.
    >> Share

  1183. RAJASINGHAM R, Bangdiwala AS, Nicol MR, Skipper CP, et al
    Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial.
    Clin Infect Dis. 2020 Oct 17. pii: 5929230. doi: 10.1093/cid/ciaa1571.
    >> Share

  1184. LESSLER J
    An overlooked role for fecal transmission of SARS-CoV-2?
    Clin Infect Dis. 2020 Oct 16. pii: 5925219. doi: 10.1093/cid/ciaa1575.
    >> Share

  1185. YOSHIOKA T, Funada S, Luo Y
    The inherent problems with the generalizability of the CALL score: towards reliable clinical prediction models for COVID-19.
    Clin Infect Dis. 2020 Oct 16. pii: 5925185. doi: 10.1093/cid/ciaa1564.
    >> Share

  1186. MCCAW ZR, Tian L, Kim DH, Localio AR, et al
    Survival analysis of treatment efficacy in comparative COVID-19 studies.
    Clin Infect Dis. 2020 Oct 14. pii: 5923375. doi: 10.1093/cid/ciaa1563.
    >> Share

  1187. ZENG HL, Lu QB, Yang Q, Wang X, et al
    Longitudinal Profile of Laboratory Parameters and Their Application in the Prediction for Fatal Outcome Among Patients Infected With SARS-CoV-2: A Retrospective Cohort Study.
    Clin Infect Dis. 2020 Oct 13. pii: 5922241. doi: 10.1093.
    >> Share

  1188. ZANG X, Krebs E, Chen S, Piske M, et al
    The potential epidemiological impact of COVID-19 on the HIV/AIDS epidemic and the cost-effectiveness of linked, opt-out HIV testing: A modeling study in six US cities.
    Clin Infect Dis. 2020 Oct 12. pii: 5921245. doi: 10.1093/cid/ciaa1547.
    >> Share

  1189. FUNG HF, Martinez L, Alarid-Escudero F, Salomon JA, et al
    The household secondary attack rate of SARS-CoV-2: A rapid review.
    Clin Infect Dis. 2020 Oct 12. pii: 5921151. doi: 10.1093/cid/ciaa1558.
    >> Share

  1190. YUAN J, Chen Z, Gong C, Liu H, et al
    Sewage as a Possible Transmission Vehicle During a Coronavirus Disease 2019 Outbreak in a Densely populated Community: Guangzhou, China, April 2020.
    Clin Infect Dis. 2020 Oct 12. pii: 5920983. doi: 10.1093/cid/ciaa1494.
    >> Share

  1191. STEVENSON DR, Sahemey M, Cevallos Morales J, Martin-Lazaro J, et al
    Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19.
    Clin Infect Dis. 2020 Oct 11. pii: 5920705. doi: 10.1093/cid/ciaa1559.
    >> Share

  1192. ROGERS R, Shehadeh F, Mylona EK, Rich J, et al
    Convalescent plasma for patients with severe COVID-19: a matched cohort study.
    Clin Infect Dis. 2020 Oct 10. pii: 5920703. doi: 10.1093/cid/ciaa1548.
    >> Share

  1193. EDWARDS KM
    The Impact of Social Distancing for SARS-CoV-2 on Respiratory Syncytial Virus and Influenza Burden.
    Clin Infect Dis. 2020 Oct 10. pii: 5920710. doi: 10.1093/cid/ciaa1543.
    >> Share

  1194. MICHELSON KA, Rees CA, Sarathy J, VonAchen P, et al
    Inter-Region Transfers for Pandemic Surges.
    Clin Infect Dis. 2020 Oct 10. pii: 5920707. doi: 10.1093/cid/ciaa1549.
    >> Share

  1195. KIM AY, Gandhi RT
    Re-infection with SARS-CoV-2: What Goes Around May Come Back Around.
    Clin Infect Dis. 2020 Oct 9. pii: 5920338. doi: 10.1093/cid/ciaa1541.
    >> Share

  1196. MUNBLIT D, Nekliudov NA, Bugaeva P, Blyuss O, et al
    StopCOVID cohort: An observational study of 3,480 patients admitted to the Sechenov University hospital network in Moscow city for suspected COVID-19 infection.
    Clin Infect Dis. 2020 Oct 9. pii: 5920244. doi: 10.1093/cid/ciaa1535.
    >> Share

  1197. MURUGESAN K, Jagannathan P, Pham TD, Pandey S, et al
    Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response.
    Clin Infect Dis. 2020 Oct 9. pii: 5920279. doi: 10.1093/cid/ciaa1537.
    >> Share

  1198. MCCAULEY BD, Ortega-Legaspi JM
    Learning more about what can make COVID-19 deadly: Insights from the Atlanta Metropolitan Area.
    Clin Infect Dis. 2020 Oct 9. pii: 5920339. doi: 10.1093/cid/ciaa1540.
    >> Share

  1199. ARMSTRONG WS, Agwu AL, Barrette EP, Ignacio RB, et al
    Innovations in HIV care delivery during the COVID-19 pandemic: Policies to strengthen the Ending the Epidemic Initiative - A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
    Clin Infect Dis. 2020 Oct 9. pii: 5920317. doi: 10.1093/cid/ciaa1532.
    >> Share

  1200. WOOD BR, Young JD, Abdel-Massih RC, McCurdy L, et al
    Advancing Digital Health Equity: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
    Clin Infect Dis. 2020 Oct 9. pii: 5919799. doi: 10.1093/cid/ciaa1525.
    >> Share

  1201. MULDER M, van der Vegt DSJM, Oude Munnink BB, GeurtsvanKessel CH, et al
    Reinfection of SARS-CoV-2 in an immunocompromised patient: a case report.
    Clin Infect Dis. 2020 Oct 9. pii: 5920950. doi: 10.1093/cid/ciaa1538.
    >> Share

  1202. BURWICK RM, Yawetz S, Stephenson KE, Collier AY, et al
    Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19.
    Clin Infect Dis. 2020 Oct 8. pii: 5919737. doi: 10.1093/cid/ciaa1466.
    >> Share

  1203. HIROSE R, Ikegaya H, Naito Y, Watanabe N, et al
    Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19.
    Clin Infect Dis. 2020 Oct 3. pii: 5917611. doi: 10.1093/cid/ciaa1517.
    >> Share

  1204. ROSENBERG ES, Holtgrave DR
    Widespread and frequent testing is essential to controlling COVID-19 in the United States.
    Clin Infect Dis. 2020 Oct 3. pii: 5917595. doi: 10.1093/cid/ciaa1508.
    >> Share

  1205. TSAI AC, Harling G, Reynolds Z, Gilbert RF, et al
    COVID-19 transmission in the U.S. before vs. after relaxation of statewide social distancing measures.
    Clin Infect Dis. 2020 Oct 3. pii: 5917573. doi: 10.1093/cid/ciaa1502.
    >> Share

  1206. JESPERSEN S, Mikkelsen S, Greve T, Kaspersen KA, et al
    SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region.
    Clin Infect Dis. 2020 Oct 3. pii: 5917713. doi: 10.1093/cid/ciaa1471.
    >> Share

  1207. LUI GC, Yip TC, Wong VW, Chow VC, et al
    Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study.
    Clin Infect Dis. 2020 Oct 1. pii: 5917130. doi: 10.1093/cid/ciaa1187.
    >> Share

    September 2020
  1208. FOCOSI D, Iorio MC, Lanza M
    ABO Blood Group Correlations With COVID-19: Cohort Choice Makes A Difference.
    Clin Infect Dis. 2020 Sep 30. pii: 5913429. doi: 10.1093/cid/ciaa1495.
    >> Share

  1209. HASAN ALI O, Bomze D, Risch L, Brugger SD, et al
    Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies.
    Clin Infect Dis. 2020 Sep 30. pii: 5913451. doi: 10.1093/cid/ciaa1496.
    >> Share

  1210. LI H, Sun K, Persing DH, Tang YW, et al
    Real-time Screening of Specimen Pools for Coronavirus Disease 2019 (COVID-19) Infection at Sanya Airport, Hainan Island, China.
    Clin Infect Dis. 2020 Sep 30. pii: 5913344. doi: 10.1093/cid/ciaa1074.
    >> Share

  1211. SACHITHANANDHAM J, Thio CL, Balagopal A
    The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Composite But Incomplete Picture.
    Clin Infect Dis. 2020 Sep 29. pii: 5912956. doi: 10.1093/cid/ciaa1413.
    >> Share

  1212. LINAS BP, Cunningham CO
    Coronavirus Disease 2019 (COVID-19) Disparities: A Call for Equity in Health Outcomes and Clinical Research.
    Clin Infect Dis. 2020 Sep 29. pii: 5912957. doi: 10.1093/cid/ciaa1460.
    >> Share

  1213. ANTONIO-VILLA NE, Bello-Chavolla OY, Vargas-Vazquez A, Fermin-Martinez CA, et al
    Health-care workers with COVID-19 living in Mexico City: clinical characterization and related outcomes.
    Clin Infect Dis. 2020 Sep 28. pii: 5912602. doi: 10.1093/cid/ciaa1487.
    >> Share

  1214. FRIEDRICH F, Ongaratto R, Scotta MC, Veras TN, et al
    Early Impact of social distancing in response to COVID-19 on hospitalizations for acute bronchiolitis in infants in Brazil.
    Clin Infect Dis. 2020 Sep 28. pii: 5912563. doi: 10.1093/cid/ciaa1458.
    >> Share

  1215. MARTINOT M, Jary A, Fafi-Kremer S, Leducq V, et al
    Remdesivir failure with SARS-CoV-2 RNA-dependent RNA-polymerase mutation in a B-cell immunodeficient patient with protracted Covid-19.
    Clin Infect Dis. 2020 Sep 28. pii: 5912587. doi: 10.1093/cid/ciaa1474.
    >> Share

  1216. YEOH DK, Foley DA, Minney-Smith CA, Martin AC, et al
    The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter.
    Clin Infect Dis. 2020 Sep 28. pii: 5912591. doi: 10.1093/cid/ciaa1475.
    >> Share

  1217. DELANGHE JR, De Buyzere ML, Speeckaert MM
    ABO blood groups and COVID-19.
    Clin Infect Dis. 2020 Sep 28. pii: 5912552. doi: 10.1093/cid/ciaa1472.
    >> Share

  1218. JAAFAR R, Aherfi S, Wurtz N, Grimaldier C, et al
    Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates.
    Clin Infect Dis. 2020 Sep 28. pii: 5912603. doi: 10.1093/cid/ciaa1491.
    >> Share

  1219. BOUDIN L, Dutasta F
    Relationship between ABO blood groups and COVID-19: study design matters.
    Clin Infect Dis. 2020 Sep 28. pii: 5912554. doi: 10.1093/cid/ciaa1473.
    >> Share

  1220. MATSUNAGA N, Hayakawa K, Terada M, Ohtsu H, et al
    Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN.
    Clin Infect Dis. 2020 Sep 28. pii: 5912544. doi: 10.1093/cid/ciaa1470.
    >> Share

  1221. CLARK AE, Lee FM
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Screening With Specimen Pools: Time to Swim, or Too Deep for Comfort?
    Clin Infect Dis. 2020 Sep 28. pii: 5912416. doi: 10.1093/cid/ciaa1145.
    >> Share

  1222. SALVATORE PP, Dawson P, Wadhwa A, Rabold EM, et al
    Epidemiological Correlates of PCR Cycle Threshold Values in the Detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Sep 28. pii: 5912493. doi: 10.1093/cid/ciaa1469.
    >> Share

  1223. GUERRERO-TORRES L, Caro-Vega Y, Crabtree-Ramirez B, Sierra-Madero JG, et al
    Clinical Characteristics and Mortality of Healthcare Workers with SARS-CoV-2 infection in Mexico City.
    Clin Infect Dis. 2020 Sep 28. pii: 5912498. doi: 10.1093/cid/ciaa1465.
    >> Share

  1224. BHARGAVA A, Sharma M, Riederer K, Fukushima EA, et al
    Risk Factors for In-hospital Mortality from COVID-19 Infection among Black Patients - An Urban Center Experience.
    Clin Infect Dis. 2020 Sep 28. pii: 5912353. doi: 10.1093/cid/ciaa1468.
    >> Share

  1225. KANAMORI H, Weber DJ, Rutala WA
    The role of the healthcare surface environment in SARS-CoV-2 transmission and potential control measures.
    Clin Infect Dis. 2020 Sep 28. pii: 5912347. doi: 10.1093/cid/ciaa1467.
    >> Share

  1226. CLARK KEN, Nevin WD, Mahungu T, Lachmann H, et al
    Assessment of the Haemophagocytic lymphohistiocytosis HScore in patients with COVID-19.
    Clin Infect Dis. 2020 Sep 28. pii: 5912317. doi: 10.1093/cid/ciaa1463.
    >> Share

  1227. TOOR J, Adams ER, Aliee M, Amoah B, et al
    Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation.
    Clin Infect Dis. 2020 Sep 28. pii: 5912106. doi: 10.1093.
    >> Share

  1228. YOKOTA I, Shane PY, Okada K, Unoki Y, et al
    Mass screening of asymptomatic persons for SARS-CoV-2 using saliva.
    Clin Infect Dis. 2020 Sep 25. pii: 5911780. doi: 10.1093/cid/ciaa1388.
    >> Share

  1229. JACKSON BR, Gold JAW, Natarajan P, Rossow J, et al
    Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19.
    Clin Infect Dis. 2020 Sep 24. pii: 5911241. doi: 10.1093/cid/ciaa1459.
    >> Share

  1230. IBRAHIM Y, Raut A, Varney J, Sidhu A, et al
    Lessons Learned from the Re-emergent COVID-19 Cases in Areas of Long Reported No Community Transmission.
    Clin Infect Dis. 2020 Sep 24. pii: 5911203. doi: 10.1093/cid/ciaa1438.
    >> Share

  1231. GERSH F, Lavie CJ, O'Keefe JH
    Menopause status and COVID-19.
    Clin Infect Dis. 2020 Sep 23. pii: 5910673. doi: 10.1093/cid/ciaa1447.
    >> Share

  1232. TO KK, Hung IF, Chan KH, Yuan S, et al
    Serum antibody profile of a patient with COVID-19 reinfection.
    Clin Infect Dis. 2020 Sep 23. pii: 5910650. doi: 10.1093/cid/ciaa1368.
    >> Share

  1233. HOGAN CA, Stevens BA, Sahoo MK, Huang C, et al
    High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease.
    Clin Infect Dis. 2020 Sep 23. pii: 5910434. doi: 10.1093/cid/ciaa1054.
    >> Share

  1234. GUPTA V, Bhoyar RC, Jain A, Srivastava S, et al
    Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2.
    Clin Infect Dis. 2020 Sep 23. pii: 5910388. doi: 10.1093/cid/ciaa1451.
    >> Share

  1235. CEVIK M, Marcus JL, Buckee C, Smith TC, et al
    SARS-CoV-2 transmission dynamics should inform policy.
    Clin Infect Dis. 2020 Sep 23. pii: 5910315. doi: 10.1093/cid/ciaa1442.
    >> Share

  1236. DE ALENCAR JCG, Moreira CL, Muller AD, Chaves CE, et al
    Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19.
    Clin Infect Dis. 2020 Sep 23. pii: 5910353. doi: 10.1093/cid/ciaa1443.
    >> Share

  1237. MALGIE J, Schoones JW, Pijls BG
    Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies.
    Clin Infect Dis. 2020 Sep 23. pii: 5910379. doi: 10.1093/cid/ciaa1445.
    >> Share

  1238. WANG M, Zhao Y, Hu W, Zhao D, et al
    Treatment of COVID-19 Patients with Prolonged Post-Symptomatic Viral Shedding with Leflunomide -- a Single-Center, Randomized, Controlled Clinical Trial.
    Clin Infect Dis. 2020 Sep 21. pii: 5909448. doi: 10.1093/cid/ciaa1417.
    >> Share

  1239. LUCEY M, Macori G, Mullane N, Sutton-Fitzpatrick U, et al
    Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks.
    Clin Infect Dis. 2020 Sep 19. pii: 5909421. doi: 10.1093/cid/ciaa1433.
    >> Share

  1240. LARSON D, Brodniak SL, Voegtly LJ, Cer RZ, et al
    A Case of Early Re-infection with SARS-CoV-2.
    Clin Infect Dis. 2020 Sep 19. pii: 5908892. doi: 10.1093/cid/ciaa1436.
    >> Share

  1241. RYBICKI FJ
    3D Printing in Medicine: COVID-19 Testing with 3D Printed Nasopharyngeal Swabs.
    Clin Infect Dis. 2020 Sep 19. pii: 5908885. doi: 10.1093/cid/ciaa1437.
    >> Share

  1242. KOW CS, Hasan SS
    Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19?
    Clin Infect Dis. 2020 Sep 18. pii: 5908741. doi: 10.1093/cid/ciaa1423.
    >> Share

  1243. ROLDAN-SANTIAGO E, Benito-Berlinches A, Martinez-Garcia L, Quereda C, et al
    SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19.
    Clin Infect Dis. 2020 Sep 18. pii: 5908740. doi: 10.1093/cid/ciaa1422.
    >> Share

  1244. FLAHERMAN VJ, Afshar Y, Boscardin J, Keller RL, et al
    Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study.
    Clin Infect Dis. 2020 Sep 18. pii: 5908705. doi: 10.1093/cid/ciaa1411.
    >> Share

  1245. MILLER J, Fadel RA, Tang A, Perrotta G, et al
    The Impact of Sociodemographic Factors, Comorbidities and Physiologic Response on 30-day Mortality in COVID-19 Patients in Metropolitan Detroit.
    Clin Infect Dis. 2020 Sep 18. pii: 5908303. doi: 10.1093/cid/ciaa1420.
    >> Share

  1246. KO JY, Danielson ML, Town M, Derado G, et al
    Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System.
    Clin Infect Dis. 2020 Sep 18. pii: 5908300. doi: 10.1093/cid/ciaa1419.
    >> Share

  1247. NEILAN AM, Losina E, Bangs AC, Flanagan C, et al
    Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts.
    Clin Infect Dis. 2020 Sep 18. pii: 5908298. doi: 10.1093/cid/ciaa1418.
    >> Share

  1248. BAHL P, de Silva C, Bhattacharjee S, Stone H, et al
    Droplets and Aerosols generated by singing and the risk of COVID-19 for choirs.
    Clin Infect Dis. 2020 Sep 18. pii: 5908276. doi: 10.1093/cid/ciaa1241.
    >> Share

  1249. ANDERSON EJ, Campbell JD, Creech CB, Frenck R, et al
    Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral?
    Clin Infect Dis. 2020 Sep 18. pii: 5908283. doi: 10.1093/cid/ciaa1425.
    >> Share

  1250. PINSKY BA, Hogan CA
    Carving out a niche for SARS-CoV-2 plasma RNA testing.
    Clin Infect Dis. 2020 Sep 17. pii: 5907919. doi: 10.1093/cid/ciaa1412.
    >> Share

  1251. WASFY JH
    American Politics and the Spread of SARS-CoV-2.
    Clin Infect Dis. 2020 Sep 17. pii: 5907812. doi: 10.1093/cid/ciaa1414.
    >> Share

  1252. BRAHIER T, Meuwly JY, Pantet O, Brochu Vez MJ, et al
    Lung ultrasonography for risk stratification in patients with COVID-19: a prospective observational cohort study.
    Clin Infect Dis. 2020 Sep 17. pii: 5907893. doi: 10.1093/cid/ciaa1408.
    >> Share

  1253. COLLINS GS, Riley RD, van Smeden M
    Flaws in the development and validation of a covid-19 prediction model.
    Clin Infect Dis. 2020 Sep 16. pii: 5906588. doi: 10.1093/cid/ciaa1406.
    >> Share

  1254. POON KS, Wen-Sim Tee N
    Caveats of Reporting Cycles Threshold from SARS-CoV-2 Qualitative PCR Assays: A Molecular Diagnostic Laboratory Perspective.
    Clin Infect Dis. 2020 Sep 15. pii: 5905681. doi: 10.1093/cid/ciaa1399.
    >> Share

  1255. KASLOW NJ, White DT, Cook SC
    A Psychological Perspective on the Association between Critical Care Resource Availability and Emotional Wellness during the COVID-19 Pandemic.
    Clin Infect Dis. 2020 Sep 15. pii: 5905679. doi: 10.1093/cid/ciaa1398.
    >> Share

  1256. LUO YR, Chakraborty I, Yun C, Wu AHB, et al
    Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity.
    Clin Infect Dis. 2020 Sep 14. pii: 5905578. doi: 10.1093/cid/ciaa1389.
    >> Share

  1257. WHYLER NCA, Sherry NL, Lane CR, Seemann T, et al
    Viral genomics to inform infection control response in occupational COVID-19 transmission.
    Clin Infect Dis. 2020 Sep 14. pii: 5905584. doi: 10.1093/cid/ciaa1385.
    >> Share

  1258. DOOKIE N, Padayatchi N, Naidoo K
    Tuberculosis Elimination in the Era of COVID-19: A Moving Target.
    Clin Infect Dis. 2020 Sep 14. pii: 5905579. doi: 10.1093/cid/ciaa1400.
    >> Share

  1259. CHONG CY, Kam KQ, Li J, Maiwald M, et al
    Saliva is not a useful diagnostic specimen in children with Coronavirus Disease 2019.
    Clin Infect Dis. 2020 Sep 14. pii: 5905581. doi: 10.1093/cid/ciaa1376.
    >> Share

  1260. HANSON KE, Caliendo AM, Arias CA, Englund JA, et al
    Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:Serologic Testing.
    Clin Infect Dis. 2020 Sep 12. pii: 5904785. doi: 10.1093/cid/ciaa1343.
    >> Share

  1261. CHAN JF, To KK, Yuen KY
    A Case Series of Children With Coronavirus Disease 2019: What Have We Learned?
    Clin Infect Dis. 2020;71:1552-1553.
    >> Share

  1262. JIEHAO C, Jin X, Daojiong L, Zhi Y, et al
    A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features.
    Clin Infect Dis. 2020;71:1547-1551.
    >> Share

  1263. CANTOS VD, Rebolledo PA
    Structural vulnerability to COVID-19 among Latinx communities in the United States.
    Clin Infect Dis. 2020 Sep 11. pii: 5904342. doi: 10.1093/cid/ciaa1378.
    >> Share

  1264. MOURAD A, Turner NA, Baker AW, Okeke NL, et al
    Social Disadvantage, Politics, and SARS-CoV-2 Trends: A County-Level Analysis of United States Data.
    Clin Infect Dis. 2020 Sep 11. pii: 5904339. doi: 10.1093/cid/ciaa1374.
    >> Share

  1265. DECKER SJ, Goldstein TA, Ford JM, Teng MN, et al
    3D Printed Alternative to the Standard Synthetic Flocked Nasopharyngeal Swabs Used for COVID-19 testing.
    Clin Infect Dis. 2020 Sep 10. pii: 5903830. doi: 10.1093/cid/ciaa1366.
    >> Share

  1266. DANDACHI D, Geiger G, Montgomery MW, Karmen-Tuohy S, et al
    Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19.
    Clin Infect Dis. 2020 Sep 9. pii: 5903368. doi: 10.1093/cid/ciaa1339.
    >> Share

  1267. WALKER J, Fleece ME, Griffin RL, Leal SM, et al
    Decreasing High Risk Exposures for Healthcare-workers through Universal Masking and Universal SARS-CoV-2 Testing upon entry to a Tertiary Care Facility.
    Clin Infect Dis. 2020 Sep 8. pii: 5903054. doi: 10.1093/cid/ciaa1358.
    >> Share

  1268. YOON JC, Montgomery MP, Buff AM, Boyd AT, et al
    COVID-19 Prevalence among People Experiencing Homelessness and Homelessness Service Staff during Early Community Transmission in Atlanta, Georgia, April-May 2020.
    Clin Infect Dis. 2020 Sep 8. pii: 5902935. doi: 10.1093/cid/ciaa1340.
    >> Share

  1269. JACOBS JL, Mellors JW
    Detection of SARS-CoV-2 RNA in Blood of Patients with COVID-19: What Does It Mean?
    Clin Infect Dis. 2020 Sep 8. pii: 5902941. doi: 10.1093/cid/ciaa1316.
    >> Share

  1270. KIM YS, Aigerim A, Park U, Kim Y, et al
    Sustained responses of neutralizing antibodies against MERS-CoV in recovered patients and their therapeutic applicability.
    Clin Infect Dis. 2020 Sep 8. pii: 5902973. doi: 10.1093/cid/ciaa1345.
    >> Share

  1271. YANG DD, Ouldali N, Gajdos V, Thomas-Sertillanges R, et al
    Common pediatric respiratory infectious diseases may serve as an early predictor for SARS-CoV-2 new wave of infections.
    Clin Infect Dis. 2020 Sep 7. pii: 5902551. doi: 10.1093/cid/ciaa1359.
    >> Share

  1272. GUILAMO-RAMOS V, Benzekri A, Thimm-Kaiser M, Hidalgo A, et al
    Reconsidering assumptions of adolescent and young adult SARS-CoV-2 transmission dynamics.
    Clin Infect Dis. 2020 Sep 7. pii: 5902518. doi: 10.1093/cid/ciaa1348.
    >> Share

  1273. NOLEN LD, Seeman S, Bruden D, Klejka J, et al
    Impact of Social Distancing and Travel Restrictions on non-COVID-19 Respiratory Hospital Admissions in Young Children in Rural Alaska.
    Clin Infect Dis. 2020 Sep 5. pii: 5901658. doi: 10.1093/cid/ciaa1328.
    >> Share

  1274. PREBENSEN C, Hre PLM, Jonassen C, Rangberg A, et al
    SARS-CoV-2 RNA in plasma is associated with ICU admission and mortality in patients hospitalized with COVID-19.
    Clin Infect Dis. 2020 Sep 5. pii: 5901727. doi: 10.1093/cid/ciaa1338.
    >> Share

  1275. HOENIGL M
    Invasive Fungal Disease complicating COVID-19: when it rains it pours.
    Clin Infect Dis. 2020 Sep 5. pii: 5901729. doi: 10.1093/cid/ciaa1342.
    >> Share

  1276. RILEY ED, Hickey MD, Imbert E, Clemenzi-Allen AA, et al
    COVID-19 and HIV spotlight the U.S. imperative for permanent affordable housing.
    Clin Infect Dis. 2020 Sep 5. pii: 5901720. doi: 10.1093/cid/ciaa1327.
    >> Share

  1277. VAN ELSLANDE J, Vermeersch P, Vandervoort K, Wawina-Bokalanga T, et al
    Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain.
    Clin Infect Dis. 2020 Sep 5. pii: 5901661. doi: 10.1093/cid/ciaa1330.
    >> Share

  1278. SQUILLACE N, Pozzi MR, Gustinetti G, Ricci E, et al
    Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment?
    Clin Infect Dis. 2020 Sep 4. pii: 5901570. doi: 10.1093/cid/ciaa1282.
    >> Share

  1279. DE OLIVEIRA B, Mallat J
    Efficacy of Tocilizumab for treatment of severe COVID-19 Pneumonia: more evidence is needed.
    Clin Infect Dis. 2020 Sep 4. pii: 5901587. doi: 10.1093/cid/ciaa1284.
    >> Share

  1280. BROUWER AF, Myers JL, Martin ET, Konopka KE, et al
    SARS-CoV-2 surveillance in decedents in a large, urban medical examiner's office.
    Clin Infect Dis. 2020 Sep 2. pii: 5900757. doi: 10.1093/cid/ciaa1312.
    >> Share

  1281. CLIPMAN SJ, Wesolowski AP, Gibson DG, Agarwal S, et al
    Rapid real-time tracking of non-pharmaceutical interventions and their association with SARS-CoV-2 positivity: The COVID-19 Pandemic Pulse Study.
    Clin Infect Dis. 2020 Sep 2. pii: 5900759. doi: 10.1093/cid/ciaa1313.
    >> Share

  1282. SHARMA M, Creutzfeldt CJ, Lewis A, Patel PV, et al
    Healthcare professionals' perceptions of critical care resource availability and factors associated with mental well-being during COVID-19: Results from a US survey.
    Clin Infect Dis. 2020 Sep 2. pii: 5900684. doi: 10.1093/cid/ciaa1311.
    >> Share

  1283. ALI F, Sweeney DA
    No One Likes a Stick up Their Nose: Making the Case for Saliva-Based Testing for COVID-19.
    Clin Infect Dis. 2020 Sep 2. pii: 5900404. doi: 10.1093/cid/ciaa1314.
    >> Share

  1284. BUETTI N, Patrier J, Le Hingrat Q, Loiodice A, et al
    Risk factors for SARS-CoV-2 detection in blood of critically ill patients.
    Clin Infect Dis. 2020 Sep 2. pii: 5900408. doi: 10.1093/cid/ciaa1315.
    >> Share

    August 2020
  1285. VENTER WDF, Nel J
    COVID-19: First data from Africa.
    Clin Infect Dis. 2020 Aug 31. pii: 5899682. doi: 10.1093/cid/ciaa1293.
    >> Share

  1286. DZINAMARIRA T, Mukwenha S, Eghtessadi R, Cuadros DF, et al
    COVID-19 response in Zimbabwe: A Call for Urgent Scale-up of Testing to meet National Capacity.
    Clin Infect Dis. 2020 Aug 31. pii: 5899551. doi: 10.1093/cid/ciaa1301.
    >> Share

  1287. BOULLE A, Davies MA, Hussey H, Ismail M, et al
    Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.
    Clin Infect Dis. 2020 Aug 29. pii: 5899044. doi: 10.1093/cid/ciaa1198.
    >> Share

  1288. WHITE PL, Dhillon R, Cordey A, Hughes H, et al
    A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU.
    Clin Infect Dis. 2020 Aug 29. pii: 5899192. doi: 10.1093/cid/ciaa1298.
    >> Share

  1289. LIU Q, Lu P, Shen Y, Li C, et al
    Collateral Impact of the Covid-19 Pandemic on Tuberculosis Control in Jiangsu Province, China.
    Clin Infect Dis. 2020 Aug 28. pii: 5898659. doi: 10.1093/cid/ciaa1289.
    >> Share

  1290. LEVINE MM, Abdullah S, Arabi YM, Darko DM, et al
    Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers.
    Clin Infect Dis. 2020 Aug 28. pii: 5898660. doi: 10.1093/cid/ciaa1290.
    >> Share

  1291. MA J, Qi X, Chen H, Li X, et al
    COVID-19 patients in earlier stages exhaled millions of SARS-CoV-2 per hour.
    Clin Infect Dis. 2020 Aug 28. pii: 5898624. doi: 10.1093/cid/ciaa1283.
    >> Share

  1292. DORA AV, Winnett A, Fulcher JA, Sohn L, et al
    Using Serologic Testing to Assess the Effectiveness of Outbreak Control Efforts, Serial PCR Testing, and Cohorting of Positive SARS-CoV-2 Patients in a Skilled Nursing Facility.
    Clin Infect Dis. 2020 Aug 28. pii: 5898656. doi: 10.1093/cid/ciaa1286.
    >> Share

  1293. BELLO-CHAVOLLA OY, Antonio-Villa NE, Vargas-Vazquez A, Fermin-Martinez CA, et al
    Profiling cases with non-respiratory symptoms and asymptomatic SARS-CoV-2 infections in Mexico City.
    Clin Infect Dis. 2020 Aug 28. pii: 5898658. doi: 10.1093/cid/ciaa1288.
    >> Share

  1294. DE MAN P, Paltansing S, Ong DSY, Vaessen N, et al
    Outbreak of COVID-19 in a nursing home associated with aerosol transmission as a result of inadequate ventilation.
    Clin Infect Dis. 2020 Aug 28. pii: 5898577. doi: 10.1093/cid/ciaa1270.
    >> Share

  1295. YOUNG BE, Ong SWX, Ng LFP, Anderson DE, et al
    Viral dynamics and immune correlates of COVID-19 disease severity.
    Clin Infect Dis. 2020 Aug 28. pii: 5898476. doi: 10.1093/cid/ciaa1280.
    >> Share

  1296. BAKER MA, Fiumara K, Rhee C, Williams SA, et al
    Low risk of COVID-19 among patients exposed to infected healthcare workers.
    Clin Infect Dis. 2020 Aug 28. pii: 5898497. doi: 10.1093/cid/ciaa1269.
    >> Share

  1297. HAGMAN K, Hedenstierna M, Gille-Johnson P, Hammas B, et al
    SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study.
    Clin Infect Dis. 2020 Aug 28. pii: 5898271. doi: 10.1093/cid/ciaa1285.
    >> Share

  1298. FRIED MW, Crawford JM, Mospan AR, Watkins SE, et al
    Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States.
    Clin Infect Dis. 2020 Aug 28. pii: 5898276. doi: 10.1093/cid/ciaa1268.
    >> Share

  1299. HUFF HV
    Controlling the COVID-19 Pandemic Blindly: Silent Spread in Absence of Rapid Viral Screening.
    Clin Infect Dis. 2020 Aug 28. pii: 5896910. doi: 10.1093/cid/ciaa1251.
    >> Share

  1300. DOFFERHOFF ASM, Piscaer I, Schurgers LJ, Visser MPJ, et al
    Reduced vitamin K status as a potentially modifiable risk factor of severe COVID-19.
    Clin Infect Dis. 2020 Aug 27. pii: 5898121. doi: 10.1093/cid/ciaa1258.
    >> Share

  1301. LENNOX JL
    Methylprednisolone for COVID-19: Was Benjamin Rush prescient?
    Clin Infect Dis. 2020 Aug 26. pii: 5897431. doi: 10.1093/cid/ciaa1262.
    >> Share

  1302. JUNG CY, Park H, Kim DW, Lim H, et al
    Association between Body Mass Index and Risk of COVID-19: A Nationwide Case-Control Study in South Korea.
    Clin Infect Dis. 2020 Aug 25. pii: 5897045. doi: 10.1093/cid/ciaa1257.
    >> Share

  1303. MARRIOTT D, Beresford R, Mirdad F, Stark D, et al
    Concomitant marked decline in prevalence of SARS-CoV-2 and other respiratory viruses among symptomatic patients following public health interventions in Australia: data from St Vincent's Hospital and associated screening clinics, Sydney, NSW.
    Clin Infect Dis. 2020 Aug 25. pii: 5897048. doi: 10.1093/cid/ciaa1256.
    >> Share

  1304. PELUSO MJ, Dee L, Shao S, Taylor J, et al
    Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-CoV-2 pandemic: A collaborative approach.
    Clin Infect Dis. 2020 Aug 25. pii: 5897039. doi: 10.1093/cid/ciaa1260.
    >> Share

  1305. TO KK, Hung IF, Ip JD, Chu AW, et al
    COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing.
    Clin Infect Dis. 2020 Aug 25. pii: 5897019. doi: 10.1093/cid/ciaa1275.
    >> Share

  1306. BUSANI S, Bedini A, Biagioni E, Serio L, et al
    Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies.
    Clin Infect Dis. 2020 Aug 25. pii: 5896943. doi: 10.1093/cid/ciaa1246.
    >> Share

  1307. REN L, Fan G, Wu W, Guo L, et al
    Antibody Responses and Clinical Outcomes in Adults Hospitalized with Severe COVID-19: A Post hoc Analysis of LOTUS China Trial.
    Clin Infect Dis. 2020 Aug 25. pii: 5896896. doi: 10.1093/cid/ciaa1247.
    >> Share

  1308. RHEE C, Kanjilal S, Baker M, Klompas M, et al
    Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?
    Clin Infect Dis. 2020 Aug 25. pii: 5896916. doi: 10.1093/cid/ciaa1249.
    >> Share

  1309. LESHO E, Reno L, Newhart D, Clifford R, et al
    Temporal, Spatial, and Epidemiologic Relationships of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Gene Cycle Thresholds: A Pragmatic Ambi-directional Observation.
    Clin Infect Dis. 2020 Aug 25. pii: 5896900. doi: 10.1093/cid/ciaa1248.
    >> Share

  1310. DE CHAISEMARTIN C, de Chaisemartin L
    BCG vaccination in infancy does not protect against COVID-19. Evidence from a natural experiment in Sweden.
    Clin Infect Dis. 2020 Aug 23. pii: 5896039. doi: 10.1093/cid/ciaa1223.
    >> Share

  1311. MCCARTY TR, Hathorn KE, Redd WD, Rodriguez NJ, et al
    How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients with COVID-19 Infection? Experience in Massachusetts.
    Clin Infect Dis. 2020 Aug 22. pii: 5896009. doi: 10.1093/cid/ciaa1245.
    >> Share

  1312. LIN DY, Zeng D, Eron JJ
    Evaluating the Efficacy of Therapies in COVID-19 Patients.
    Clin Infect Dis. 2020 Aug 21. pii: 5895068. doi: 10.1093/cid/ciaa1231.
    >> Share

  1313. CHAMIE G, Marquez C, Crawford E, Peng J, et al
    SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco.
    Clin Infect Dis. 2020 Aug 21. pii: 5895337. doi: 10.1093/cid/ciaa1234.
    >> Share

  1314. VAUGHN VM, Gandhi T, Petty LA, Patel PK, et al
    Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study.
    Clin Infect Dis. 2020 Aug 21. pii: 5895253. doi: 10.1093/cid/ciaa1239.
    >> Share

  1315. RIVERA F, Safdar N, Ledeboer N, Schaack G, et al
    Prevalence of SARS-CoV-2 asymptomatic infections in two large academic health systems in Wisconsin.
    Clin Infect Dis. 2020 Aug 19. pii: 5894146. doi: 10.1093/cid/ciaa1225.
    >> Share

  1316. BRUGGEMANN RJ, van de Veerdonk FL, Verweij PE
    The challenge of managing COVID-19 associated pulmonary aspergillosis.
    Clin Infect Dis. 2020 Aug 18. pii: 5893994. doi: 10.1093/cid/ciaa1211.
    >> Share

  1317. HARTMANN S, Rubin Z, Sato H, OYong K, et al
    Coronavirus 2019 (COVID-19) Infections Among Healthcare Workers, Los Angeles County, February - May 2020.
    Clin Infect Dis. 2020 Aug 17. pii: 5893141. doi: 10.1093/cid/ciaa1200.
    >> Share

  1318. ZUNIGA-MOYA JC, Norwood DA, Romero Reyes LE, Barrueto Saavedra E, et al
    Epidemiology, outcomes and associated factors of COVID-19 RT-PCR confirmed cases in the San Pedro Sula Metropolitan Area, Honduras.
    Clin Infect Dis. 2020 Aug 17. pii: 5893117. doi: 10.1093/cid/ciaa1188.
    >> Share

  1319. VEYER D, Kerneis S, Poulet G, Wack M, et al
    Highly sensitive quantification of plasma SARS-CoV-2 RNA shelds light on its potential clinical value.
    Clin Infect Dis. 2020 Aug 17. pii: 5893132. doi: 10.1093/cid/ciaa1196.
    >> Share

  1320. HUANG J, Xie N, Hu X, Yan H, et al
    Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study.
    Clin Infect Dis. 2020 Aug 17. pii: 5893115. doi: 10.1093/cid/ciaa1186.
    >> Share

  1321. LEWIS NM, Chu VT, Ye D, Conners EE, et al
    Household Transmission of SARS-CoV-2 in the United States.
    Clin Infect Dis. 2020 Aug 16. pii: 5893024. doi: 10.1093/cid/ciaa1166.
    >> Share

  1322. YAMAGISHI T, Doi Y
    Insights on COVID-19 epidemiology from a historic cruise ship quarantine.
    Clin Infect Dis. 2020 Aug 14. pii: 5892913. doi: 10.1093/cid/ciaa1214.
    >> Share

  1323. CERDA-CONTRERAS C, Nuzzolo-Shihadeh L, Camacho-Ortiz A, Perez-Alba E, et al
    Baricitinib as treatment for COVID-19: friend or foe of the pancreas?
    Clin Infect Dis. 2020 Aug 14. pii: 5892883. doi: 10.1093/cid/ciaa1209.
    >> Share

  1324. JORGENSEN SCJ, Burry L, Tse CLY, Dresser LD, et al
    Baricitinib: Impact on COVID-19 coagulopathy?
    Clin Infect Dis. 2020 Aug 14. pii: 5892859. doi: 10.1093/cid/ciaa1208.
    >> Share

  1325. TITANJI BK, Farley MM, Schinazi RF, Marconi VC, et al
    Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? Cerda-Contreras et.al.
    Clin Infect Dis. 2020 Aug 14. pii: 5892912. doi: 10.1093/cid/ciaa1212.
    >> Share

  1326. LUSTIG Y, Keler S, Kolodny R, Ben-Tal N, et al
    Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses.
    Clin Infect Dis. 2020 Aug 14. pii: 5892809. doi: 10.1093/cid/ciaa1207.
    >> Share

  1327. TITANJI BK, Farley MM, Schinazi RF, Marconi VC, et al
    Response to Correspondence: Baricitinib - Impact on COVID-19 Coagulopathy? Jorgensen et. al.
    Clin Infect Dis. 2020 Aug 14. pii: 5892909. doi: 10.1093/cid/ciaa1210.
    >> Share

  1328. JERONIMO CMP, Farias MEL, Val FFA, Sampaio VS, et al
    Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial.
    Clin Infect Dis. 2020 Aug 12. pii: 5891816. doi: 10.1093/cid/ciaa1177.
    >> Share

  1329. BAYAT V, Phelps S, Ryono R, Lee C, et al
    A SARS-CoV-2 Prediction Model from Standard Laboratory Tests.
    Clin Infect Dis. 2020 Aug 12. pii: 5891814. doi: 10.1093/cid/ciaa1175.
    >> Share

  1330. PLUCINSKI MM, Wallace M, Uehara A, Kurbatova EV, et al
    COVID-19 in Americans aboard the Diamond Princess cruise ship.
    Clin Infect Dis. 2020 Aug 12. pii: 5891779. doi: 10.1093/cid/ciaa1180.
    >> Share

  1331. ATCHISON C, Pristera P, Cooper E, Papageorgiou V, et al
    Usability and acceptability of home-based self-testing for SARS-CoV-2 antibodies for population surveillance.
    Clin Infect Dis. 2020 Aug 12. pii: 5891615. doi: 10.1093/cid/ciaa1178.
    >> Share

  1332. COBELENS FG, Harris VC
    Untangling SARS-CoV-2 epidemic control - lessons from Vietnam.
    Clin Infect Dis. 2020 Aug 11. pii: 5891228. doi: 10.1093/cid/ciaa1195.
    >> Share

  1333. CHAGLA Z, Hota S, Khan S, Mertz D, et al
    Airborne Transmission of COVID-19.
    Clin Infect Dis. 2020 Aug 11. pii: 5891227. doi: 10.1093/cid/ciaa1118.
    >> Share

  1334. HAIDAR G
    COVID-19, organ transplantation, and the nuances of immunomodulation: lessons learned and what comes next.
    Clin Infect Dis. 2020 Aug 11. pii: 5891286. doi: 10.1093/cid/ciaa1193.
    >> Share

  1335. KLANN E, Rich S, Mai V
    Gut microbiota and COVID-19: A superfluous diagnostic biomarker or therapeutic target?
    Clin Infect Dis. 2020 Aug 11. pii: 5891289. doi: 10.1093/cid/ciaa1191.
    >> Share

  1336. GONZALEZ-RUBIO F, Ioakeim-Skoufa I, Poblador-Plou B, Gimeno-Miguel A, et al
    Influenza vaccination: an ally to mitigate influenza-associated risks during the coronavirus pandemics.
    Clin Infect Dis. 2020 Aug 11. pii: 5891288. doi: 10.1093/cid/ciaa1190.
    >> Share

  1337. NELSON BC, Laracy J, Shoucri S, Dietz D, et al
    Clinical Outcomes Associated with Methylprednisolone in Mechanically Ventilated Patients with COVID-19.
    Clin Infect Dis. 2020 Aug 9. pii: 5890108. doi: 10.1093/cid/ciaa1163.
    >> Share

  1338. IVASHCHENKO AA, Dmitriev KA, Vostokova NV, Azarova VN, et al
    AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
    Clin Infect Dis. 2020 Aug 9. pii: 5890024. doi: 10.1093/cid/ciaa1176.
    >> Share

  1339. OTTO MP, Darles C, Valero E, Benner P, et al
    Posterior oropharyngeal salivafor the detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Aug 8. pii: 5889992. doi: 10.1093/cid/ciaa1181.
    >> Share

  1340. KOW CS, Hasan SS
    Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?
    Clin Infect Dis. 2020 Aug 8. pii: 5889984. doi: 10.1093/cid/ciaa1167.
    >> Share

  1341. BELLON M, Schweblin C, Lambeng N, Cherpillod P, et al
    Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients.
    Clin Infect Dis. 2020 Aug 8. pii: 5890019. doi: 10.1093/cid/ciaa1165.
    >> Share

  1342. RISTAGNO EH, Bryant KA
    COVID-19 and Children: Adding Another Piece to the Puzzle.
    Clin Infect Dis. 2020 Aug 8. pii: 5889991. doi: 10.1093/cid/ciaa1182.
    >> Share

  1343. KENDALL EA
    When infections don't reflect infectiousness: interpreting contact investigation data with care.
    Clin Infect Dis. 2020 Aug 8. pii: 5889982. doi: 10.1093/cid/ciaa1144.
    >> Share

  1344. SIPAHI OR
    What should be the ideal definite COVID-19 case definition?
    Clin Infect Dis. 2020 Aug 8. pii: 5889989. doi: 10.1093/cid/ciaa1179.
    >> Share

  1345. KHALIL A, Hill R, Wright A, Ladhani S, et al
    SARS-CoV-2-specific antibody detection in healthcare workers in a UK maternity Hospital: Correlation with SARS-CoV-2 RT-PCR results.
    Clin Infect Dis. 2020 Aug 8. pii: 5889986. doi: 10.1093.
    >> Share

  1346. BLOT M, Jacquier M, Manoha C, Piroth L, et al
    Alveolar SARS-CoV-2 viral load is tightly correlated with severity in COVID-19 ARDS.
    Clin Infect Dis. 2020 Aug 8. pii: 5889988. doi: 10.1093/cid/ciaa1172.
    >> Share

  1347. BUSCH MP, Stone M
    Serosurveillance for SARS-CoV-2 incidence using global blood donor populations.
    Clin Infect Dis. 2020 Aug 8. pii: 5889969. doi: 10.1093/cid/ciaa1116.
    >> Share

  1348. CHAMILOS G, Lionakis MS, Kontoyiannis DP
    Are all patients with cancer at heightened risk for severe Coronavirus Disease 2019 (COVID-19)?
    Clin Infect Dis. 2020 Aug 7. pii: 5885104. doi: 10.1093/cid/ciaa1079.
    >> Share

  1349. WALD ER, Schmit KM, Gusland DY
    A Pediatric Infectious Disease Perspective on COVID-19.
    Clin Infect Dis. 2020 Aug 7. pii: 5885157. doi: 10.1093/cid/ciaa1095.
    >> Share

  1350. PEREZ-GUZMAN PN, Daunt A, Mukherjee S, Crook P, et al
    Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study.
    Clin Infect Dis. 2020 Aug 7. pii: 5885151. doi: 10.1093/cid/ciaa1091.
    >> Share

  1351. KATES OS, Haydel BM, Florman SS, Rana MM, et al
    COVID-19 in solid organ transplant: A multi-center cohort study.
    Clin Infect Dis. 2020 Aug 7. pii: 5885162. doi: 10.1093/cid/ciaa1097.
    >> Share

  1352. RAO M, Rashid FA, Sabri FSAH, Jamil NN, et al
    Comparing nasopharyngeal swab and early morning saliva for the identification of SARS-CoV-2.
    Clin Infect Dis. 2020 Aug 6. pii: 5882012. doi: 10.1093/cid/ciaa1156.
    >> Share

  1353. BAGGIO S, L'Huillier AG, Yerly S, Bellon M, et al
    SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19.
    Clin Infect Dis. 2020 Aug 6. pii: 5881997. doi: 10.1093/cid/ciaa1157.
    >> Share

  1354. CLARK E, Chiao EY, Amirian ES
    Why contact tracing efforts have failed to curb COVID-19 transmission in much of the U.S.
    Clin Infect Dis. 2020 Aug 6. pii: 5881818. doi: 10.1093/cid/ciaa1155.
    >> Share

  1355. TO KK, Chan WM, Ip JD, Chu AW, et al
    Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong.
    Clin Infect Dis. 2020 Aug 5. pii: 5881446. doi: 10.1093/cid/ciaa1119.
    >> Share

  1356. GANG A, Gang J
    Evaluation of COVID-19 RT-qPCR tests in multi-sample pools.
    Clin Infect Dis. 2020 Aug 5. pii: 5881409. doi: 10.1093/cid/ciaa1099.
    >> Share

  1357. ZHAO J, Yang Y, Huang H, Li D, et al
    Relationship between the ABO Blood Group and the COVID-19 Susceptibility.
    Clin Infect Dis. 2020 Aug 4. pii: 5880600. doi: 10.1093/cid/ciaa1150.
    >> Share

  1358. WANG K, Long QX, Deng HJ, Hu J, et al
    Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection.
    Clin Infect Dis. 2020 Aug 3. pii: 5880016. doi: 10.1093/cid/ciaa1143.
    >> Share

  1359. IMBERT E, Kinley PM, Scarborough A, Cawley C, et al
    Coronavirus Disease 2019 (COVID-19) Outbreak in a San Francisco Homeless Shelter.
    Clin Infect Dis. 2020 Aug 3. pii: 5879965. doi: 10.1093/cid/ciaa1071.
    >> Share

  1360. PHAM QT, Rabaa MA, Duong HL, Dang QT, et al
    The first 100 days of SARS-CoV-2 control in Vietnam.
    Clin Infect Dis. 2020 Aug 1. pii: 5879764. doi: 10.1093/cid/ciaa1130.
    >> Share

    July 2020
  1361. GANDHI RT
    The Multidimensional Challenge of Treating COVID-19: Remdesivir is a Foot in the Door.
    Clin Infect Dis. 2020 Jul 31. pii: 5879440. doi: 10.1093/cid/ciaa1132.
    >> Share

  1362. CHENG GS, Hill JA
    To Toci or Not to Toci for COVID-19: Is That Still the Question?
    Clin Infect Dis. 2020 Jul 31. pii: 5879444. doi: 10.1093/cid/ciaa1133.
    >> Share

  1363. HU M, Lin H, Wang J, Xu C, et al
    The risk of COVID-19 transmission in train passengers: an epidemiological and modelling study.
    Clin Infect Dis. 2020 Jul 29. pii: 5877944. doi: 10.1093/cid/ciaa1057.
    >> Share

  1364. XU D, Zhou F, Sun W, Chen L, et al
    Relationship Between serum SARS-CoV-2 nucleic acid(RNAemia) and Organ Damage in COVID-19 Patients: A Cohort Study.
    Clin Infect Dis. 2020 Jul 28. pii: 5877289. doi: 10.1093/cid/ciaa1085.
    >> Share

  1365. YOUSAF AR, Duca LM, Chu V, Reses HE, et al
    A prospective cohort study in non-hospitalized household contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time.
    Clin Infect Dis. 2020 Jul 28. pii: 5877084. doi: 10.1093/cid/ciaa1072.
    >> Share

  1366. SANTOS DS, Menezes MO, Andreucci CB, Nakamura-Pereira M, et al
    Disproportionate impact of COVID-19 among pregnant and postpartum Black Women in Brazil through structural racism lens.
    Clin Infect Dis. 2020 Jul 28. pii: 5877027. doi: 10.1093/cid/ciaa1066.
    >> Share

  1367. BARTOLETTI M, Pascale R, Cricca M, Rinaldi M, et al
    Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study.
    Clin Infect Dis. 2020 Jul 28. pii: 5876990. doi: 10.1093/cid/ciaa1065.
    >> Share

  1368. BENE MC, de Carvalho Bittencourt M, Eveillard M, Le Bris Y, et al
    Good IgA Bad IgG in SARS-CoV-2 Infection?
    Clin Infect Dis. 2020;71:897-898.
    >> Share

  1369. RUAN L, Wen M, Zeng Q, Chen C, et al
    New Measures for the Coronavirus Disease 2019 Response: A Lesson From the Wenzhou Experience.
    Clin Infect Dis. 2020;71:866-869.
    >> Share

  1370. HANFF TC, Harhay MO, Brown TS, Cohen JB, et al
    Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations.
    Clin Infect Dis. 2020;71:870-874.
    >> Share

  1371. GIACOMELLI A, Pezzati L, Conti F, Bernacchia D, et al
    Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.
    Clin Infect Dis. 2020;71:889-890.
    >> Share

  1372. PAGLIANO P, Piazza O, De Caro F, Ascione T, et al
    Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019?
    Clin Infect Dis. 2020;71:887-888.
    >> Share

  1373. YI H
    2019 Novel Coronavirus Is Undergoing Active Recombination.
    Clin Infect Dis. 2020;71:884-887.
    >> Share

  1374. ZHANG L, Shen FM, Chen F, Lin Z, et al
    Origin and Evolution of the 2019 Novel Coronavirus.
    Clin Infect Dis. 2020;71:882-883.
    >> Share

  1375. JEONG HE, Lee H, Shin HJ, Choe YJ, et al
    Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study.
    Clin Infect Dis. 2020 Jul 27. pii: 5876905. doi: 10.1093/cid/ciaa1056.
    >> Share

  1376. ROWLEY AH
    Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.
    Clin Infect Dis. 2020 Jul 27. pii: 5876871. doi: 10.1093/cid/ciaa1080.
    >> Share

  1377. DEL BRUTTO OH, Costa AF, Mera RM, Recalde BY, et al
    SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador.
    Clin Infect Dis. 2020 Jul 27. pii: 5876901. doi: 10.1093/cid/ciaa1055.
    >> Share

  1378. LYNCH JB, Davitkov P, Anderson DJ, Bhimraj A, et al
    Infectious Diseases Society of America Guidelines on Infection Prevention for Health Care Personnel Caring for Patients with Suspected or Known COVID-19.
    Clin Infect Dis. 2020 Jul 27. pii: 5876809. doi: 10.1093/cid/ciaa1063.
    >> Share

  1379. LI J, Wu C, Zhang X, Chen L, et al
    Post-pandemic testing of SARS-CoV-2 in Huanan Seafood Market area in Wuhan, China.
    Clin Infect Dis. 2020 Jul 25. pii: 5876349. doi: 10.1093/cid/ciaa1043.
    >> Share

  1380. POLINE J, Gaschignard J, Leblanc C, Madhi F, et al
    Systematic SARS-CoV-2 screening at hospital admission in children:a French prospective multicenter study.
    Clin Infect Dis. 2020 Jul 25. pii: 5876373. doi: 10.1093/cid/ciaa1044.
    >> Share

  1381. MORALEDA C, Serna-Pascual M, Soriano-Arandes A, Simo S, et al
    Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain.
    Clin Infect Dis. 2020 Jul 25. pii: 5876334. doi: 10.1093/cid/ciaa1042.
    >> Share

  1382. OLENDER SA, Perez KK, Go AS, Balani B, et al
    Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care.
    Clin Infect Dis. 2020 Jul 24. pii: 5876045. doi: 10.1093/cid/ciaa1041.
    >> Share

  1383. DING T, Zhang J, Wang T, Cui P, et al
    Potential Influence of Menstrual Status and Sex Hormones on female SARS-CoV-2 Infection: A Cross-sectional Study from Multicentre in Wuhan, China.
    Clin Infect Dis. 2020 Jul 22. pii: 5875093. doi: 10.1093/cid/ciaa1022.
    >> Share

  1384. ESCOBAR DJ, Lanzi M, Saberi P, Love R, et al
    Mitigation of a COVID-19 Outbreak in a Nursing Home Through Serial Testing of Residents and Staff.
    Clin Infect Dis. 2020 Jul 20. pii: 5873784. doi: 10.1093/cid/ciaa1021.
    >> Share

  1385. FLANNERY B, Meece JK, Williams JV, Martin ET, et al
    Systematic testing for influenza and COVID-19 among patients with respiratory illness.
    Clin Infect Dis. 2020 Jul 20. pii: 5873821. doi: 10.1093/cid/ciaa1023.
    >> Share

  1386. ERLICHSTER M, Chana G, Zantomio D, Goudey B, et al
    Pan-Family Assays for Rapid Viral Screening: Reducing Delays in Public Health Responses During Pandemics.
    Clin Infect Dis. 2020 Jul 20. pii: 5873823. doi: 10.1093/cid/ciaa1028.
    >> Share

  1387. LOUIE JK, Scott HM, DuBois A, Sturtz N, et al
    Lessons from Mass-Testing for COVID-19 in Long Term Care Facilities for the Elderly in San Francisco.
    Clin Infect Dis. 2020 Jul 20. pii: 5873783. doi: 10.1093/cid/ciaa1020.
    >> Share

  1388. LARREMORE DB, Bubar KM, Grad YH
    Implications of test characteristics and population seroprevalence on 'immune passport' strategies.
    Clin Infect Dis. 2020 Jul 20. pii: 5873748. doi: 10.1093/cid/ciaa1019.
    >> Share

  1389. PLOTKIN SA
    The Value of Human Challenges in SARS-2-nCoV Vaccine Development.
    Clin Infect Dis. 2020 Jul 16. pii: 5872587. doi: 10.1093/cid/ciaa1013.
    >> Share

  1390. ALTERI C, Cento V, Vecchi M, Colagrossi L, et al
    Nasopharyngeal SARS-CoV-2 load at hospital admission as predictor of mortality.
    Clin Infect Dis. 2020 Jul 16. pii: 5872588. doi: 10.1093.
    >> Share

  1391. MITJA O, Corbacho-Monne M, Ubals M, Tebe C, et al
    Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.
    Clin Infect Dis. 2020 Jul 16. pii: 5872589. doi: 10.1093/cid/ciaa1009.
    >> Share

  1392. KIM L, Garg S, O'Halloran A, Whitaker M, et al
    Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET).
    Clin Infect Dis. 2020 Jul 16. pii: 5872581. doi: 10.1093/cid/ciaa1012.
    >> Share

  1393. DUPONT V, Kanagaratnam L, Goury A, Poitevin G, et al
    Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients.
    Clin Infect Dis. 2020 Jul 16. pii: 5872439. doi: 10.1093/cid/ciaa1007.
    >> Share

  1394. WI YM, Lim SJ, Kim SH, Lim S, et al
    Response System for and Epidemiological Features of COVID-19 in Gyeongsangnam-do Province in South Korea.
    Clin Infect Dis. 2020 Jul 16. pii: 5872474. doi: 10.1093.
    >> Share

  1395. SING CW, Tan KCB, Wong ICK, Cheung BMY, et al
    Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors.
    Clin Infect Dis. 2020 Jul 16. pii: 5872092. doi: 10.1093.
    >> Share

  1396. FANG FC, Schooley RT
    Treatment of COVID-19 - Evidence-Based or Personalized Medicine?
    Clin Infect Dis. 2020 Jul 15. pii: 5872014. doi: 10.1093.
    >> Share

  1397. ZHANG AJ, Lee AC, Chu H, Chan JF, et al
    SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.
    Clin Infect Dis. 2020 Jul 15. pii: 5871998. doi: 10.1093.
    >> Share

  1398. GOLDBERG SA, Lennerz J, Klompas M, Mark E, et al
    Presymptomatic Transmission of SARS-CoV-2 Amongst Residents and Staff at a Skilled Nursing Facility: Results of Real-Time PCR and Serologic Testing.
    Clin Infect Dis. 2020 Jul 15. pii: 5871989. doi: 10.1093.
    >> Share

  1399. CONTEJEAN A, Leporrier J, Canoui E, Alby-Laurent F, et al
    Comparing dynamics and determinants of SARS-CoV-2 transmissions among health care workers of adult and pediatric settings in central Paris.
    Clin Infect Dis. 2020 Jul 15. pii: 5871438. doi: 10.1093.
    >> Share

  1400. LYNCH KL, Whitman JD, Lacanienta NP, Beckerdite EW, et al
    Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.
    Clin Infect Dis. 2020 Jul 14. pii: 5871431. doi: 10.1093.
    >> Share

  1401. SOMERS EC, Eschenauer GA, Troost JP, Golob JL, et al
    Tocilizumab for treatment of mechanically ventilated patients with COVID-19.
    Clin Infect Dis. 2020 Jul 11. pii: 5870306. doi: 10.1093.
    >> Share

  1402. GARCIA-VIDAL C, Moreno-Garcia E, Hernandez-Meneses M, Puerta-Alcalde P, et al
    Personalized therapy approach for hospitalized patients with COVID-19.
    Clin Infect Dis. 2020 Jul 10. pii: 5869871. doi: 10.1093.
    >> Share

  1403. TORRES JP, Pinera C, De La Maza V, Lagomarcino AJ, et al
    SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study.
    Clin Infect Dis. 2020 Jul 10. pii: 5869860. doi: 10.1093.
    >> Share

  1404. WONG YC, Lau SY, Wang To KK, Mok BWY, et al
    Natural transmission of bat-like SARS-CoV-2PRRA variants in COVID-19 patients.
    Clin Infect Dis. 2020 Jul 10. pii: 5869859. doi: 10.1093.
    >> Share

  1405. DONG YM, Sun J, Li YX, Chen Q, et al
    Development and Validation of a Nomogram for Assessing Survival in Patients with COVID-19 Pneumonia.
    Clin Infect Dis. 2020 Jul 10. pii: 5869870. doi: 10.1093.
    >> Share

  1406. CURRY SR, Salgado CD
    When hospitals Harm: Multi-modal entry of SARS-CoV-2 into inpatient healthcare.
    Clin Infect Dis. 2020 Jul 10. pii: 5869668. doi: 10.1093.
    >> Share

  1407. WILDER JM
    The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States.
    Clin Infect Dis. 2020 Jul 10. pii: 5869621. doi: 10.1093.
    >> Share

  1408. MATHERS AJ
    The practical challenges of making clinical use of the quantitative value for SARS-CoV-2 viral load across several dynamics.
    Clin Infect Dis. 2020 Jul 10. pii: 5869506. doi: 10.1093.
    >> Share

  1409. MARCIALIS MA, Bardanzellu F, Fanos V
    Microbiota and Covid-19. Which came first, the chicken or the egg?
    Clin Infect Dis. 2020 Jul 10. pii: 5869504. doi: 10.1093.
    >> Share

  1410. CUMMINGS DAT, Radonovich LJ, Gorse GJ, Gaydos CA, et al
    Risk Factors for Healthcare Personnel Infection with Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT).
    Clin Infect Dis. 2020 Jul 9. pii: 5869459. doi: 10.1093.
    >> Share

  1411. LI Z, Li Y, Chen L, Li S, et al
    A Confirmed Case of SARS-CoV-2 Pneumonia with Routine RT-PCR Negative and Virus Variation in Guangzhou, China.
    Clin Infect Dis. 2020 Jul 9. pii: 5869155. doi: 10.1093.
    >> Share

  1412. REICHBERG SB, Mitra PP, Haghamad A, Ramrattan G, et al
    Rapid Emergence of SARS-CoV-2 in the Greater New York Metropolitan Area: Geolocation, Demographics, Positivity Rates, and Hospitalization for 46,793 Persons Tested by Northwell Health.
    Clin Infect Dis. 2020 Jul 8. pii: 5868956. doi: 10.1093.
    >> Share

  1413. WANG Y, Liu Y, Struthers J, Lian M, et al
    Spatiotemporal Characteristics of COVID-19 Epidemic in the United States.
    Clin Infect Dis. 2020 Jul 8. pii: 5868985. doi: 10.1093.
    >> Share

  1414. SIEDNER MJ, Gandhi RT
    Proposing minimum requirements for announcing clinical trial results during the COVID-19 pandemic.
    Clin Infect Dis. 2020 Jul 8. pii: 5868929. doi: 10.1093.
    >> Share

  1415. QIAN Q, Fan L, Liu W, Li J, et al
    Direct evidence of active SARS-CoV-2 replication in the intestine.
    Clin Infect Dis. 2020 Jul 8. pii: 5868547. doi: 10.1093.
    >> Share

  1416. CHEN J, Bai H, Liu J, Chen G, et al
    Distinct clinical characteristics and risk factors for mortality in female COVID-19 inpatients: a sex-stratified large-scale cohort study in Wuhan, China.
    Clin Infect Dis. 2020 Jul 8. pii: 5868544. doi: 10.1093.
    >> Share

  1417. YEHYA N, Venkataramani A, Harhay MO
    Statewide Interventions and Covid-19 Mortality in the United States: An Observational Study.
    Clin Infect Dis. 2020 Jul 8. pii: 5868545. doi: 10.1093.
    >> Share

  1418. KRAGHOLM K, Andersen MP, Gerds TA, Butt JH, et al
    Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19) - a Danish nationwide, register-based study.
    Clin Infect Dis. 2020 Jul 8. pii: 5868546. doi: 10.1093.
    >> Share

  1419. ZHOU J, Otter JA, Price JR, Cimpeanu C, et al
    Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London.
    Clin Infect Dis. 2020 Jul 8. pii: 5868534. doi: 10.1093.
    >> Share

  1420. SANDMANN FG, White PJ, Ramsay M, Jit M, et al
    Optimising benefits of testing key workers for infection with SARS-CoV-2: A mathematical modelling analysis.
    Clin Infect Dis. 2020 Jul 8. pii: 5868532. doi: 10.1093.
    >> Share

  1421. PRICE JR, Mookerjee S, Dyakova E, Myall A, et al
    Development and delivery of a real-time hospital-onset COVID-19 surveillance system using network analysis.
    Clin Infect Dis. 2020 Jul 8. pii: 5868508. doi: 10.1093.
    >> Share

  1422. LEE DICKENS BS, Lim JT, Low JW, Lee CK, et al
    Simple 'Rule-of-6' predicts severe COVID-19 disease.
    Clin Infect Dis. 2020 Jul 6. pii: 5868031. doi: 10.1093.
    >> Share

  1423. STUBBLEFIELD WB, Talbot HK, Feldstein L, Tenforde MW, et al
    Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for COVID-19 Patients - Nashville, Tennessee.
    Clin Infect Dis. 2020 Jul 6. pii: 5868028. doi: 10.1093.
    >> Share

  1424. NGUYEN LC, Bakerlee CW, McKelvey TG, Rose SM, et al
    Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development.
    Clin Infect Dis. 2020 Jul 6. pii: 5868014. doi: 10.1093.
    >> Share

  1425. NICHOLS BE, Jamieson L, Zhang SRC, Rao GA, et al
    The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity.
    Clin Infect Dis. 2020 Jul 6. pii: 5868030. doi: 10.1093.
    >> Share

  1426. MORAWSKA L, Milton DK
    It is Time to Address Airborne Transmission of COVID-19.
    Clin Infect Dis. 2020 Jul 6. pii: 5867798. doi: 10.1093.
    >> Share

  1427. LENZ HJ, Richardson P, Stebbing J
    The Emergence of Baricitinib: A Story of Tortoises Versus Hares.
    Clin Infect Dis. 2020 Jul 6. pii: 5868032. doi: 10.1093.
    >> Share

  1428. OUSSALAH A, Gleye S, Clerc Urmes I, Laugel E, et al
    Long-Term ACE Inhibitor/ARB Use Is Associated with Severe Renal Dysfunction and Acute Kidney Injury in Patients with severe COVID-19: Results from a Referral Center Cohort in the North East of France.
    Clin Infect Dis. 2020 Jul 5. pii: 5867535. doi: 10.1093.
    >> Share

  1429. DE FERIA A, Ortega-Legaspi JM
    ACE inhibitors/ARB use and COVID-19. Time to change practice or keep gathering data?
    Clin Infect Dis. 2020 Jul 4. pii: 5867490. doi: 10.1093.
    >> Share

  1430. BRYANT KA, Isaacs P
    Commentary: Rapid Testing of Healthcare Employees for COVID-19: What Can We Learn from the Seattle Experience?
    Clin Infect Dis. 2020 Jul 4. pii: 5867496. doi: 10.1093.
    >> Share

  1431. TSO RV, Cowling BJ
    Importance of face masks for COVID-19 - a call for effective public education.
    Clin Infect Dis. 2020 Jul 2. pii: 5866410. doi: 10.1093.
    >> Share

  1432. KAMERLIN SCL, Kasson PM
    Managing COVID-19 spread with voluntary public-health measures: Sweden as a case study for pandemic control.
    Clin Infect Dis. 2020 Jul 1. pii: 5866094. doi: 10.1093.
    >> Share

  1433. MANG S, Kaddu-Mulindwa D, Metz C, Becker A, et al
    Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection.
    Clin Infect Dis. 2020 Jul 1. pii: 5865456. doi: 10.1093.
    >> Share

  1434. VAHIA A, Chaudhry ZS, Kaljee L, Parraga-Acosta T, et al
    Rapid Reorganization of an Academic Infectious Diseases Program During the COVID-19 Pandemic in Detroit: A Novel Unit-Based Group Rounding Model.
    Clin Infect Dis. 2020 Jul 1. pii: 5865454. doi: 10.1093.
    >> Share

  1435. LEHMANN CJ, Pho MT, Pitrak D, Ridgway JP, et al
    Community Acquired Co-infection in COVID-19: A Retrospective Observational Experience.
    Clin Infect Dis. 2020 Jul 1. pii: 5865452. doi: 10.1093.
    >> Share

  1436. HALL MW, Joshi I, Leal L, Ooi EE, et al
    Immune modulation in COVID-19: Strategic considerations for personalized therapeutic intervention.
    Clin Infect Dis. 2020 Jul 1. pii: 5865455. doi: 10.1093.
    >> Share

    June 2020
  1437. MAGLEBY R, Westblade LF, Trzebucki A, Simon MS, et al
    Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019.
    Clin Infect Dis. 2020 Jun 30. pii: 5865363. doi: 10.1093.
    >> Share

  1438. TITANJI BK, Farley MM, Mehta A, Connor-Schuler R, et al
    Use of Baricitinib in Patients with Moderate and Severe COVID-19.
    Clin Infect Dis. 2020 Jun 29. pii: 5864596. doi: 10.1093.
    >> Share

  1439. PINNINTI S, Trieu C, Pati SK, Latting M, et al
    Comparing Nasopharyngeal and Mid-Turbinate Nasal Swab Testing for the Identification of SARS-CoV-2.
    Clin Infect Dis. 2020 Jun 29. pii: 5864592. doi: 10.1093.
    >> Share

  1440. MALTEZOU HC, Dedoukou X, Tseroni M, Tsonou E, et al
    SARS-CoV-2 infection in healthcare personnel with high-risk occupational exposure: evaluation of seven-day exclusion from work policy.
    Clin Infect Dis. 2020 Jun 29. pii: 5864498. doi: 10.1093.
    >> Share

  1441. GARCIA-PRATS AJ, Salazar-Austin N, Conway JH, Radtke K, et al
    COVID-19 pharmacologic treatments for children: research priorities and approach to pediatric studies.
    Clin Infect Dis. 2020 Jun 29. pii: 5864500. doi: 10.1093.
    >> Share

  1442. BIELECKI M, Zust R, Siegrist D, Meyerhofer D, et al
    Social distancing alters the clinical course of COVID-19 in young adults: A comparative cohort study.
    Clin Infect Dis. 2020 Jun 29. pii: 5864495. doi: 10.1093.
    >> Share

  1443. SHRESTHA NK, Marco Canosa F, Nowacki AS, Procop GW, et al
    Distribution of Transmission Potential during Non-Severe COVID-19 Illness.
    Clin Infect Dis. 2020 Jun 29. pii: 5864499. doi: 10.1093.
    >> Share

  1444. SIGEL K, Swartz T, Golden E, Paranjpe I, et al
    Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City.
    Clin Infect Dis. 2020 Jun 28. pii: 5864410. doi: 10.1093.
    >> Share

  1445. LEEGWATER E, Strik A, Wilms EB, Bosma LBE, et al
    Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with P-glycoprotein inhibitors.
    Clin Infect Dis. 2020 Jun 28. pii: 5864408. doi: 10.1093.
    >> Share

  1446. NAGLER AR, Goldberg ER, Aguero-Rosenfeld ME, Cangiarella J, et al
    Early Results from SARS-CoV-2 PCR testing of Healthcare Workers at an Academic Medical Center in New York City.
    Clin Infect Dis. 2020 Jun 28. pii: 5864404. doi: 10.1093.
    >> Share

  1447. YANG P, Esper AM
    Investigating the sex differences in COVID-19: Another step forward, but many unanswered questions.
    Clin Infect Dis. 2020 Jun 28. pii: 5864403. doi: 10.1093.
    >> Share

  1448. KEMPKER RR, Kempker JA, Peters M, Rebolledo PA, et al
    Loss of Smell and Taste Among Healthcare Personnel Screened for Coronavirus 2019.
    Clin Infect Dis. 2020 Jun 28. pii: 5879851. doi: 10.1093.
    >> Share

  1449. FUNG M, Babik JM
    COVID-19 in Immunocompromised Hosts: What We Know So Far.
    Clin Infect Dis. 2020 Jun 27. pii: 5864040. doi: 10.1093.
    >> Share

  1450. LI S, Hu Z, Song X
    High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19.
    Clin Infect Dis. 2020 Jun 26. pii: 5863128. doi: 10.1093.
    >> Share

  1451. CRUZ AF, Ruiz-Antoran B, Munez Rubio E, Lopez AS, et al
    THE RIGHT TIME FOR STEROIDS IN COVID-19.
    Clin Infect Dis. 2020 Jun 25. pii: 5862696. doi: 10.1093.
    >> Share

  1452. YUNG CF, Kam KQ, Nadua KD, Chong CY, et al
    Novel coronavirus 2019 transmission risk in educational settings.
    Clin Infect Dis. 2020 Jun 25. pii: 5862649. doi: 10.1093.
    >> Share

  1453. JAMAL AJ, Mozafarihashjin M, Coomes E, Powis J, et al
    Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Clin Infect Dis. 2020 Jun 25. pii: 5862658. doi: 10.1093.
    >> Share

  1454. VERMUND SH, Pitzer VE
    Asymptomatic transmission and the infection fatality risk for COVID-19: Implications for school reopening.
    Clin Infect Dis. 2020 Jun 25. pii: 5862668. doi: 10.1093.
    >> Share

  1455. ERIKSTRUP C, Hother CE, Pedersen OBV, Molbak K, et al
    Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors.
    Clin Infect Dis. 2020 Jun 25. pii: 5862661. doi: 10.1093.
    >> Share

  1456. JORDAN SC, Zakowski P, Tran HP, Smith EA, et al
    Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
    Clin Infect Dis. 2020 Jun 23. pii: 5861638. doi: 10.1093.
    >> Share

  1457. MATAR R, Alrahmani L, Monzer N, Debiane LG, et al
    Clinical Presentation and Outcomes of Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2020 Jun 23. pii: 5861636. doi: 10.1093.
    >> Share

  1458. KIMBERLIN DW, Puopolo KM
    Breastmilk and COVID-19: What Do We Know?
    Clin Infect Dis. 2020 Jun 21. pii: 5860618. doi: 10.1093.
    >> Share

  1459. CHEUK S, Wong Y, Tse H, Siu HK, et al
    Posterior oropharyngeal saliva for the detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Jun 21. pii: 5860439. doi: 10.1093.
    >> Share

  1460. DAWSON P, Rabold EM, Laws RL, Conners EE, et al
    Loss of Taste and Smell as Distinguishing Symptoms of COVID-19.
    Clin Infect Dis. 2020 Jun 21. pii: 5860440. doi: 10.1093.
    >> Share

  1461. WIESE AD, Everson J, Grijalva CG
    Social distancing measures: evidence of interruption of seasonal influenza activity and early lessons of the SARS-CoV-2 pandemic.
    Clin Infect Dis. 2020 Jun 20. pii: 5860406. doi: 10.1093.
    >> Share

  1462. RICKMAN HM, Rampling T, Shaw K, Martinez-Garcia G, et al
    Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital.
    Clin Infect Dis. 2020 Jun 20. pii: 5860253. doi: 10.1093.
    >> Share

  1463. TAI DBG, Shah A, Doubeni CA, Sia IG, et al
    The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States.
    Clin Infect Dis. 2020 Jun 20. pii: 5860249. doi: 10.1093.
    >> Share

  1464. NAIK GOA
    COVID-19 and the RAAS.
    Clin Infect Dis. 2020 Jun 20. pii: 5860242. doi: 10.1093.
    >> Share

  1465. ANNWEILER C, Sacco G, Salles N, Aquino JP, et al
    National French survey of COVID-19 symptoms in people aged 70 and over.
    Clin Infect Dis. 2020 Jun 18. pii: 5859558. doi: 10.1093.
    >> Share

  1466. WU S, Du Z, Shen S, Zhang B, et al
    Identification and validation of a novel clinical signature to predict the prognosis in confirmed COVID-19 patients.
    Clin Infect Dis. 2020 Jun 18. pii: 5859562. doi: 10.1093.
    >> Share

  1467. XU XK, Liu XF, Wu Y, Ali ST, et al
    Reconstruction of Transmission Pairs for novel Coronavirus Disease 2019 (COVID-19) in mainland China: Estimation of Super-spreading Events, Serial Interval, and Hazard of Infection.
    Clin Infect Dis. 2020 Jun 18. pii: 5859582. doi: 10.1093.
    >> Share

  1468. PACCOUD O, Tubach F, Baptiste A, Bleibtreu A, et al
    Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital.
    Clin Infect Dis. 2020 Jun 18. pii: 5859555. doi: 10.1093.
    >> Share

  1469. ZHANG X, Li M, Chen T, Lv D, et al
    Persistent negative antibody test in COVID-19 patient: a case report.
    Clin Infect Dis. 2020 Jun 17. pii: 5859154. doi: 10.1093.
    >> Share

  1470. PATEL MR, Carroll D, Ussery E, Whitham H, et al
    Performance of oropharyngeal swab testing compared to nasopharyngeal swab testing for diagnosis of COVID-19 -United States, January-February 2020.
    Clin Infect Dis. 2020 Jun 16. pii: 5858273. doi: 10.1093.
    >> Share

  1471. PATEL MC, Chaisson LH, Borgetti S, Burdsall D, et al
    Asymptomatic SARS-CoV-2 infection and COVID-19 mortality during an outbreak investigation in a skilled nursing facility.
    Clin Infect Dis. 2020 Jun 16. pii: 5858271. doi: 10.1093.
    >> Share

  1472. CHROBOCZEK T, Lacoste M, Wackenheim C, Challan-Belval T, et al
    Corticosteroids in patients with COVID-19: what about the control group?
    Clin Infect Dis. 2020 Jun 16. pii: 5858270. doi: 10.1093.
    >> Share

  1473. MANI NS, Budak JZ, Lan KF, Bryson-Cahn C, et al
    Prevalence of COVID-19 Infection and Outcomes Among Symptomatic Healthcare Workers in Seattle, Washington.
    Clin Infect Dis. 2020 Jun 16. pii: 5858272. doi: 10.1093.
    >> Share

  1474. SHEPHERD J, Friedland G
    Preventing COVID-19 collateral damage.
    Clin Infect Dis. 2020 Jun 16. pii: 5858267. doi: 10.1093.
    >> Share

  1475. SORIANO V, Meirino R, Corral O, Guallar MP, et al
    SARS-CoV-2 antibodies in adults in Madrid, Spain.
    Clin Infect Dis. 2020 Jun 16. pii: 5858269. doi: 10.1093.
    >> Share

  1476. ZHANG HJ, Su YY, Xu SL, Chen GQ, et al
    Asymptomatic and symptomatic SARS-CoV-2 infections in close contacts of COVID-19 patients: a seroepidemiological study.
    Clin Infect Dis. 2020 Jun 16. pii: 5858266. doi: 10.1093.
    >> Share

  1477. BILDER CR, Iwen PC, Abdalhamid B
    Pool size selection when testing for SARS-CoV-2.
    Clin Infect Dis. 2020 Jun 16. pii: 5858265. doi: 10.1093.
    >> Share

  1478. MALECKI K, Keating JA, Safdar N
    Crisis Communication and Public Perception of COVID-19 Risk in the Era of Social Media.
    Clin Infect Dis. 2020 Jun 16. pii: 5858208. doi: 10.1093.
    >> Share

  1479. NIEUWLAAT R, Mbuagbaw L, Mertz D, Burrows L, et al
    COVID-19 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
    Clin Infect Dis. 2020 Jun 16. pii: 5858203. doi: 10.1093.
    >> Share

  1480. DUDOIGNON E, Camelena F, Deniau B, Habay A, et al
    Bacterial Pneumonia in COVID-19 critically ill patients: a case series.
    Clin Infect Dis. 2020 Jun 16. pii: 5858200. doi: 10.1093.
    >> Share

  1481. HANSON KE, Caliendo AM, Arias CA, Englund JA, et al
    Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19.
    Clin Infect Dis. 2020 Jun 16. pii: 5858938. doi: 10.1093.
    >> Share

  1482. WILKINSON RJ
    Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.
    Clin Infect Dis. 2020 Jun 13. pii: 5857156. doi: 10.1093.
    >> Share

  1483. ALTHOFF KN, Coburn SB, Nash D
    Contact tracing: Essential to the public health response and our understanding of the epidemiology of COVID-19.
    Clin Infect Dis. 2020 Jun 11. pii: 5856142. doi: 10.1093.
    >> Share

  1484. BECKERMAN KP
    Pregnancy and Pandemic Disease.
    Clin Infect Dis. 2020 Jun 10. pii: 5855544. doi: 10.1093.
    >> Share

  1485. BODKIN C, Mokashi V, Beal K, Wiwcharuk J, et al
    Pandemic Planning in Homeless Shelters: A pilot study of a COVID-19 testing and support program to mitigate the risk of COVID-19 outbreaks in congregate settings.
    Clin Infect Dis. 2020 Jun 8. pii: 5854739. doi: 10.1093.
    >> Share

  1486. POIGNANT S, Baudouin L, Vinclair M, Mons S, et al
    COVID-19 : Pacific Islands challenges.
    Clin Infect Dis. 2020 Jun 8. pii: 5854755. doi: 10.1093.
    >> Share

  1487. FANG FC, Naccache SN, Greninger AL
    The Laboratory Diagnosis of COVID-19-- Frequently-Asked Questions.
    Clin Infect Dis. 2020 Jun 8. pii: 5854652. doi: 10.1093.
    >> Share

  1488. LONG DR, Gombar S, Hogan CA, Greninger AL, et al
    Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients.
    Clin Infect Dis. 2020 Jun 7. pii: 5854366. doi: 10.1093.
    >> Share

  1489. BINNICKER MJ
    Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity?
    Clin Infect Dis. 2020 Jun 6. pii: 5854297. doi: 10.1093.
    >> Share

  1490. ZHOU L, Wu Z, Li Z, Zhang Y, et al
    100 Days of COVID-19 Prevention and Control in China.
    Clin Infect Dis. 2020 Jun 5. pii: 5851925. doi: 10.1093.
    >> Share

  1491. ANUGWOM CM, Aby ES, Debes JD
    Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?
    Clin Infect Dis. 2020 Jun 5. pii: 5851928. doi: 10.1093.
    >> Share

  1492. GRIFFITH DE, Cegielski JP
    Tuberculosis Healthcare Workers: There Goes My Hero.
    Clin Infect Dis. 2020 Jun 5. pii: 5853603. doi: 10.1093.
    >> Share

  1493. CHAU NVV, Thanh Lam V, Thanh Dung N, Yen LM, et al
    The natural history and transmission potential of asymptomatic SARS-CoV-2 infection.
    Clin Infect Dis. 2020 Jun 4. pii: 5851471. doi: 10.1093.
    >> Share

  1494. WANG X, Guo X, Xin Q, Pan Y, et al
    Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.
    Clin Infect Dis. 2020 Jun 4. pii: 5851474. doi: 10.1093.
    >> Share

  1495. GU S, Chen Y, Wu Z, Chen Y, et al
    Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.
    Clin Infect Dis. 2020 Jun 4. pii: 5851452. doi: 10.1093.
    >> Share

  1496. CANADAY DH, Gravenstein S
    On setting expectations for a SARS-CoV-2 Vaccine.
    Clin Infect Dis. 2020 Jun 4. pii: 5851447. doi: 10.1093.
    >> Share

  1497. KAO CM, Orenstein WA, Anderson EJ
    The Importance of Advancing SARS-CoV-2 Vaccines in Children.
    Clin Infect Dis. 2020 Jun 3. pii: 5850904. doi: 10.1093.
    >> Share

  1498. ANGOULVANT F, Ouldali N, Yang DD, Filser M, et al
    COVID-19 pandemic: Impact caused by school closure and national lockdown on pediatric visits and admissions for viral and non-viral infections, a time series analysis.
    Clin Infect Dis. 2020 Jun 3. pii: 5850910. doi: 10.1093.
    >> Share

    May 2020
  1499. GRIFONI E, Valoriani A, Cei F, Vannucchi V, et al
    The CALL score for predicting outcomes in patients with COVID-19.
    Clin Infect Dis. 2020 May 31. pii: 5849283. doi: 10.1093.
    >> Share

  1500. MANDONNET E, Molina JM
    Household COVID-19 Prevalence.
    Clin Infect Dis. 2020 May 31. pii: 5849290. doi: 10.1093.
    >> Share

  1501. NACHEGA JB, Grimwood A, Mahomed H, Fatti G, et al
    From Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.
    Clin Infect Dis. 2020 May 31. pii: 5849218. doi: 10.1093.
    >> Share

  1502. GOURTSOYANNIS J
    COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.
    Clin Infect Dis. 2020 May 31. pii: 5849219. doi: 10.1093.
    >> Share

  1503. ROSENBERG ES, Hall EW, Rosenthal EM, Maxted AM, et al
    Monitoring COVID-19 through Trends in Influenza-like Illness and Laboratory-confirmed Influenza and COVID-19 - New York State, excluding New York City, January 1 - April 12, 2020.
    Clin Infect Dis. 2020 May 31. pii: 5849237. doi: 10.1093.
    >> Share

  1504. NAGANO T, Arii J, Nishimura M, Yoshida N, et al
    Diligent medical activities of a publicly designated medical institution for infectious diseases pave the way for overcoming COVID-19: A positive message to people working at the cutting edge.
    Clin Infect Dis. 2020 May 31. pii: 5849291. doi: 10.1093.
    >> Share

  1505. IPPOLITO MM, Flexner C
    Dose Optimization of Hydroxychloroquine for COVID-19: Do Blood Concentrations Matter?
    Clin Infect Dis. 2020 May 31. pii: 5849325. doi: 10.1093.
    >> Share

  1506. OPENSHAW JJ, Travassos MA
    COVID-19 outbreaks in U.S. immigrant detention centers: the urgent need to adopt CDC guidelines for prevention and evaluation.
    Clin Infect Dis. 2020 May 31. pii: 5849328. doi: 10.1093.
    >> Share

  1507. QIAN J, Zhao L, Ye RZ, Li XJ, et al
    Age-dependent gender differences of COVID-19 in mainland China: comparative study.
    Clin Infect Dis. 2020 May 30. pii: 5849103. doi: 10.1093.
    >> Share

  1508. TEMIME L, Gustin MP, Duval A, Buetti N, et al
    A Conceptual Discussion about R0 of SARS-COV-2 in Healthcare Settings.
    Clin Infect Dis. 2020 May 30. pii: 5849067. doi: 10.1093.
    >> Share

  1509. CREECH CB
    It's True Even in a Pandemic: Children are Not Merely Little Adults.
    Clin Infect Dis. 2020 May 30. pii: 5849048. doi: 10.1093.
    >> Share

  1510. SEHRA ST, Salciccioli JD, Wiebe DJ, Fundin S, et al
    Maximum Daily Temperature, Precipitation, Ultra-Violet Light and Rates of Transmission of SARS-Cov-2 in the United States.
    Clin Infect Dis. 2020 May 30. pii: 5849063. doi: 10.1093.
    >> Share

  1511. LACOURSE SM, Kachikis A, Blain M, Simmons LE, et al
    Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal screening in Seattle, Washington.
    Clin Infect Dis. 2020 May 30. pii: 5848913. doi: 10.1093.
    >> Share

  1512. LEE H, Lee H, Song KH, Kim ES, et al
    Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea.
    Clin Infect Dis. 2020 May 30. pii: 5848838. doi: 10.1093.
    >> Share

  1513. NAGAPPA B, Marimuthu Y
    Seroconversion rate and diagnostic accuracy of serological tests for COVID-19.
    Clin Infect Dis. 2020 May 30. pii: 5848916. doi: 10.1093.
    >> Share

  1514. TAM PCK, Ly KM, Kernich ML, Spurrier N, et al
    Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2020 May 30. pii: 5848850. doi: 10.1093.
    >> Share

  1515. CHAN JF, Yuan S, Zhang AJ, Poon VK, et al
    Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2020 May 30. pii: 5848814. doi: 10.1093.
    >> Share

  1516. BHARGAVA A, Fukushima EA, Levine M, Zhao W, et al
    Predictors for Severe COVID-19 Infection.
    Clin Infect Dis. 2020 May 30. pii: 5848851. doi: 10.1093.
    >> Share

  1517. LARSON DT, Sherner JH, Gallagher KM, Judy CL, et al
    Clinical Outcomes of COVID-19 with Evidence-Based Supportive Care.
    Clin Infect Dis. 2020 May 30. pii: 5848933. doi: 10.1093.
    >> Share

  1518. ABU RAYA B, Goldfarb DM, Sadarangani M
    What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients?
    Clin Infect Dis. 2020 May 30. pii: 5848835. doi: 10.1093.
    >> Share

  1519. SHALEV N, Scherer M, LaSota ED, Antoniou P, et al
    Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.
    Clin Infect Dis. 2020 May 30. pii: 5848754. doi: 10.1093.
    >> Share

  1520. FAUST JS
    Towards a better case fatality estimate for SARS-CoV-2 during the early phase of the United States outbreak.
    Clin Infect Dis. 2020 May 30. pii: 5848756. doi: 10.1093.
    >> Share

  1521. TRUBIANO JA, Vogrin S, Kwong JC, Homes N, et al
    Alterations in smell or taste - Classic COVID-19?
    Clin Infect Dis. 2020 May 28. pii: 5848188. doi: 10.1093.
    >> Share

  1522. ZHANG H, Ai JW, Yang W, Zhou X, et al
    Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling.
    Clin Infect Dis. 2020 May 28. pii: 5848165. doi: 10.1093.
    >> Share

  1523. STREIFEL AC, Sikka MK
    The Urgent Need for Medicare Reimbursement for Home Infusion Antibiotics amidst a Pandemic.
    Clin Infect Dis. 2020 May 28. pii: 5848121. doi: 10.1093.
    >> Share

  1524. HUFF HV, Singh A
    Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies.
    Clin Infect Dis. 2020 May 28. pii: 5848092. doi: 10.1093.
    >> Share

  1525. CHILDS K, Post FA, Norcross C, Ottaway Z, et al
    Hospitalized patients with COVID-19 and HIV: a case series.
    Clin Infect Dis. 2020 May 27. pii: 5847856. doi: 10.1093.
    >> Share

  1526. RAABE VN, Lighter J, Caplan AL, Ratner AJ, et al
    Importance of Pediatric Inclusion in COVID-19 Therapeutic Trials.
    Clin Infect Dis. 2020 May 27. pii: 5847864. doi: 10.1093.
    >> Share

  1527. HUANG JT, Ran RX, Lv ZH, Feng LN, et al
    Chronological Changes of Viral Shedding in Adult Inpatients with COVID-19 in Wuhan, China.
    Clin Infect Dis. 2020 May 23. pii: 5843466. doi: 10.1093.
    >> Share

  1528. LUO X, Zhou W, Yan X, Guo T, et al
    Prognostic value of C-reactive protein in patients with COVID-19.
    Clin Infect Dis. 2020 May 23. pii: 5843450. doi: 10.1093.
    >> Share

  1529. YAMAOKA Y, Jeremiah SS, Miyakawa K, Saji R, et al
    Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays.
    Clin Infect Dis. 2020 May 23. pii: 5843448. doi: 10.1093.
    >> Share

  1530. BUCKNER FS, McCulloch DJ, Atluri V, Blain M, et al
    Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington.
    Clin Infect Dis. 2020 May 22. pii: 5842263. doi: 10.1093.
    >> Share

  1531. GNAVI R, Demaria M, Picariello R, Dalmasso M, et al
    Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection.
    Clin Infect Dis. 2020 May 22. pii: 5842164. doi: 10.1093.
    >> Share

  1532. LIU Y, Pang Y, Hu Z, Wu M, et al
    Thymosin alpha 1 (Talpha1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells.
    Clin Infect Dis. 2020 May 22. pii: 5842185. doi: 10.1093.
    >> Share

  1533. JUNG SY, Choi JC, You SH, Kim WY, et al
    Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.
    Clin Infect Dis. 2020 May 22. pii: 5842160. doi: 10.1093.
    >> Share

  1534. WANG Y, Tong J, Qin Y, Xie T, et al
    Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China.
    Clin Infect Dis. 2020 May 22. pii: 5842166. doi: 10.1093.
    >> Share

  1535. PATEL AB, Verma A
    Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What's next for ACE2?
    Clin Infect Dis. 2020 May 22. pii: 5842163. doi: 10.1093.
    >> Share

  1536. BULLARD J, Dust K, Funk D, Strong JE, et al
    Predicting infectious SARS-CoV-2 from diagnostic samples.
    Clin Infect Dis. 2020 May 22. pii: 5842165. doi: 10.1093.
    >> Share

  1537. SKOWRONSKI DM, Zou M, Clarke Q, Chambers C, et al
    Influenza vaccine does not increase the risk of coronavirus or other non-influenza respiratory viruses: retrospective analysis from Canada, 2010-11 to 2016-17.
    Clin Infect Dis. 2020 May 22. pii: 5842161. doi: 10.1093.
    >> Share

  1538. GU W, Deng X, Reyes K, Hsu E, et al
    Associations of Early COVID-19 Cases in San Francisco with Domestic and International Travel.
    Clin Infect Dis. 2020 May 21. pii: 5841581. doi: 10.1093.
    >> Share

  1539. TOM MR, Mina MJ
    To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value.
    Clin Infect Dis. 2020 May 21. pii: 5841456. doi: 10.1093.
    >> Share

  1540. FAN J, Zhang X, Liu J, Yang Y, et al
    Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating COVID-19 patients.
    Clin Infect Dis. 2020 May 21. pii: 5841401. doi: 10.1093.
    >> Share

  1541. ZACHARIAH P, Halabi KC, Johnson CL, Whitter S, et al
    Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children.
    Clin Infect Dis. 2020 May 20. pii: 5841161. doi: 10.1093.
    >> Share

  1542. FADEL R, Morrison AR, Vahia A, Smith ZR, et al
    Early Short Course Corticosteroids in Hospitalized Patients with COVID-19.
    Clin Infect Dis. 2020 May 19. pii: 5840526. doi: 10.1093.
    >> Share

  1543. GUASP M, Laredo C, Urra X
    Higher solar irradiance is associated with a lower incidence of COVID-19.
    Clin Infect Dis. 2020 May 19. pii: 5840498. doi: 10.1093.
    >> Share

  1544. KERBAJ J, Cazorla C, De Greslan T, Serie M, et al
    COVID-19: The New Caledonia experience.
    Clin Infect Dis. 2020 May 16. pii: 5838234. doi: 10.1093.
    >> Share

  1545. PAWLOTSKY JM
    SARS-CoV-2 pandemic : Time to revive the cyclophilin inhibitor alisporivir.
    Clin Infect Dis. 2020 May 15. pii: 5837360. doi: 10.1093.
    >> Share

  1546. DENG X, Yang J, Wang W, Wang X, et al
    Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China.
    Clin Infect Dis. 2020 May 15. pii: 5837356. doi: 10.1093.
    >> Share

  1547. ZHENG L, Wang X, Zhou C, Liu Q, et al
    Analysis of the infection status of the health care workers in Wuhan during the COVID-19 outbreak: A cross-sectional study.
    Clin Infect Dis. 2020 May 15. pii: 5837357. doi: 10.1093.
    >> Share

  1548. KOU SC, Yang S, Chang CJ, Ho TH, et al
    Unmasking the Actual COVID-19 Case Count.
    Clin Infect Dis. 2020 May 15. pii: 5837359. doi: 10.1093.
    >> Share

  1549. BORDONI V, Sacchi A, Cimini E, Notari S, et al
    An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.
    Clin Infect Dis. 2020 May 15. pii: 5837139. doi: 10.1093.
    >> Share

  1550. GERVASONI C, Meraviglia P, Riva A, Giacomelli A, et al
    Clinical features and outcomes of HIV patients with coronavirus disease 2019.
    Clin Infect Dis. 2020 May 14. pii: 5837155. doi: 10.1093.
    >> Share

  1551. ZHANG JJY, Lee KS, Ang LW, Leo YS, et al
    Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis.
    Clin Infect Dis. 2020 May 14. pii: 5837140. doi: 10.1093.
    >> Share

  1552. MEHTA NS, Mytton OT, Mullins EWS, Fowler TA, et al
    SARS-CoV-2 (COVID-19): What do we know about children? A systematic review.
    Clin Infect Dis. 2020 May 11. pii: 5835843. doi: 10.1093.
    >> Share

  1553. QU B, Yang J
    Monologue of a physician who tested persistently positive for COVID-19.
    Clin Infect Dis. 2020 May 11. pii: 5835852. doi: 10.1093.
    >> Share

  1554. SPECTOR-BAGDADY K, Higgins PDR, Lok AS
    COVID-19 Clinical Trial Oversight at a Major Academic Medical Center: Approach of the Michigan Medicine COVID-19 Clinical Trial Committees.
    Clin Infect Dis. 2020 May 11. pii: 5835855. doi: 10.1093.
    >> Share

  1555. KATSIDZIRA L, Gwaunza L, Hakim JG
    The SARS-CoV-2 epidemic in Zimbabwe: Quo vadis?
    Clin Infect Dis. 2020 May 11. pii: 5835837. doi: 10.1093.
    >> Share

  1556. MARTIN-BLONDEL G, Ruiz S, Murris M, Faguer S, et al
    Hydroxychloroquine in COVID-19 patients: what still needs to be known about the kinetics.
    Clin Infect Dis. 2020 May 11. pii: 5835847. doi: 10.1093.
    >> Share

  1557. WU J, Huang Y, Tu C, Bi C, et al
    Household Transmission of SARS-CoV-2, Zhuhai, China, 2020.
    Clin Infect Dis. 2020 May 11. pii: 5835845. doi: 10.1093.
    >> Share

  1558. SCHWARTZ DA
    The Effects of Pregnancy on Women with COVID-19: Maternal and Infant Outcomes.
    Clin Infect Dis. 2020 May 11. pii: 5835848. doi: 10.1093.
    >> Share

  1559. ONG SWX, Young BE, Leo YS, Lye DC, et al
    Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients.
    Clin Infect Dis. 2020 May 8. pii: 5831985. doi: 10.1093.
    >> Share

  1560. SINGH T, Heston SM, Langel SN, Blasi M, et al
    Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.
    Clin Infect Dis. 2020 May 8. pii: 5831984. doi: 10.1093.
    >> Share

  1561. ROSENBERG ES, Dufort EM, Blog DS, Hall EW, et al
    COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020.
    Clin Infect Dis. 2020 May 8. pii: 5831986. doi: 10.1093.
    >> Share

  1562. HU L, Chen S, Fu Y, Gao Z, et al
    Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China.
    Clin Infect Dis. 2020 May 3. pii: 5828282. doi: 10.1093.
    >> Share

  1563. WANG K, Zuo P, Liu Y, Zhang M, et al
    Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China.
    Clin Infect Dis. 2020 May 3. pii: 5828281. doi: 10.1093.
    >> Share

  1564. YELIN I, Aharony N, Shaer Tamar E, Argoetti A, et al
    Evaluation of COVID-19 RT-qPCR test in multi-sample pools.
    Clin Infect Dis. 2020 May 2. pii: 5828059. doi: 10.1093.
    >> Share

  1565. DI GIAMBENEDETTO S, Ciccullo A, Posteraro B, Lombardi F, et al
    Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection.
    Clin Infect Dis. 2020 May 2. pii: 5828060. doi: 10.1093.
    >> Share

  1566. RAWSON TM, Moore LSP, Zhu N, Ranganathan N, et al
    Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing.
    Clin Infect Dis. 2020 May 2. pii: 5828058. doi: 10.1093.
    >> Share

  1567. LUERS JC, Rokohl AC, Loreck N, Wawer Matos PA, et al
    Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19).
    Clin Infect Dis. 2020 May 1. pii: 5827752. doi: 10.1093.
    >> Share

  1568. ZHAO R, Li M, Song H, Chen J, et al
    Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection.
    Clin Infect Dis. 2020 May 1. pii: 5827750. doi: 10.1093.
    >> Share

  1569. STOWELL S, Guarner J
    Role of serology in the COVID-19 pandemic.
    Clin Infect Dis. 2020 May 1. pii: 5827751. doi: 10.1093.
    >> Share

  1570. CLANCY CJ, Nguyen MH
    COVID-19, superinfections and antimicrobial development: What can we expect?
    Clin Infect Dis. 2020 May 1. pii: 5828436. doi: 10.1093.
    >> Share

    April 2020
  1571. ALI F, Sweeney DA
    Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?
    Clin Infect Dis. 2020 Apr 30. pii: 5827418. doi: 10.1093.
    >> Share

  1572. NOSYK B, Armstrong WS, Del Rio C
    Contact tracing for COVID-19: An opportunity to reduce health disparities and End the HIV/AIDS Epidemic in the US.
    Clin Infect Dis. 2020 Apr 27. pii: 5825755. doi: 10.1093.
    >> Share

  1573. IDOGAWA M, Tange S, Nakase H, Tokino T, et al
    Interactive web-based graphs of novel coronavirus COVID-19 cases and deaths per population by country.
    Clin Infect Dis. 2020 Apr 27. pii: 5825754. doi: 10.1093.
    >> Share

  1574. BELINGHERI M, Paladino ME, Riva MA
    Working schedule, sleep quality and susceptibility to COVID-19 in healthcare workers.
    Clin Infect Dis. 2020 Apr 27. pii: 5825723. doi: 10.1093.
    >> Share

  1575. TEDESCHI S, Giannella M, Bartoletti M, Trapani F, et al
    Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19.
    Clin Infect Dis. 2020 Apr 27. pii: 5825741. doi: 10.1093.
    >> Share

  1576. BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
    Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
    Clin Infect Dis. 2020 Apr 27. pii: 5825667. doi: 10.1093.
    >> Share

  1577. LIN A, He ZB, Zhang S, Zhang JG, et al
    Early risk factors for the duration of SARS-CoV-2 viral positivity in COVID-19 patients.
    Clin Infect Dis. 2020 Apr 27. pii: 5825508. doi: 10.1093.
    >> Share

  1578. QU J, Wu C, Li X, Zhang G, et al
    Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Clin Infect Dis. 2020 Apr 27. pii: 5825506. doi: 10.1093.
    >> Share

  1579. SCHWIERZECK V, Konig JC, Kuhn J, Mellmann A, et al
    First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit.
    Clin Infect Dis. 2020 Apr 27. pii: 5825509. doi: 10.1093.
    >> Share

  1580. XIANG F, Wang X, He X, Peng Z, et al
    Antibody Detection and Dynamic Characteristics in Patients with COVID-19.
    Clin Infect Dis. 2020 Apr 19. pii: 5822173. doi: 10.1093.
    >> Share

  1581. LEE TH, Lin RJ, Lin RTP, Barkham T, et al
    Testing for SARS-CoV-2: Can We Stop at Two?
    Clin Infect Dis. 2020 Apr 19. pii: 5822543. doi: 10.1093.
    >> Share

  1582. XIAO AT, Tong YX, Zhang S
    Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients.
    Clin Infect Dis. 2020 Apr 19. pii: 5822175. doi: 10.1093.
    >> Share

  1583. LIU K, Ai S, Song S, Zhu G, et al
    Population movement, city closure in Wuhan and geographical expansion of the 2019-nCoV pneumonia infection in China in January 2020.
    Clin Infect Dis. 2020 Apr 17. pii: 5821327. doi: 10.1093.
    >> Share

  1584. ZHOU B, She J, Wang Y, Ma X, et al
    The duration of viral shedding of discharged patients with severe COVID-19.
    Clin Infect Dis. 2020 Apr 17. pii: 5821307. doi: 10.1093.
    >> Share

  1585. CHEN X, Zhao B, Qu Y, Chen Y, et al
    Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients.
    Clin Infect Dis. 2020 Apr 17. pii: 5821311. doi: 10.1093.
    >> Share

  1586. PARET M, Lighter J, Pellett Madan R, Raabe VN, et al
    SARS-CoV-2 infection (COVID-19) in febrile infants without respiratory distress.
    Clin Infect Dis. 2020 Apr 17. pii: 5821305. doi: 10.1093.
    >> Share

  1587. FRANCO-PAREDES C
    Albert Camus' 'The COVID-19 Plague' Revisited.
    Clin Infect Dis. 2020 Apr 17. pii: 5821271. doi: 10.1093.
    >> Share

  1588. LI W, Zhang B, Lu J, Liu S, et al
    The characteristics of household transmission of COVID-19.
    Clin Infect Dis. 2020 Apr 17. pii: 5821281. doi: 10.1093.
    >> Share

  1589. O'BRIEN TR, Thomas DL, Jackson SS, Prokunina-Olsson L, et al
    Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19.
    Clin Infect Dis. 2020 Apr 17. pii: 5821272. doi: 10.1093.
    >> Share

  1590. WENZEL RP
    After Covid-19.
    Clin Infect Dis. 2020 Apr 17. pii: 5821270. doi: 10.1093.
    >> Share

  1591. HAN MS, Seong MW, Heo EY, Park JH, et al
    Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2.
    Clin Infect Dis. 2020 Apr 16. pii: 5820869. doi: 10.1093.
    >> Share

  1592. SCORZOLINI L, Corpolongo A, Castilletti C, Lalle E, et al
    Comment of the potential risks of sexual and vertical transmission of Covid-19 infection.
    Clin Infect Dis. 2020 Apr 16. pii: 5820874. doi: 10.1093.
    >> Share

  1593. GONG J, Ou J, Qiu X, Jie Y, et al
    A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China.
    Clin Infect Dis. 2020 Apr 16. pii: 5820684. doi: 10.1093.
    >> Share

  1594. WEIMING T, Huipeng L, Gifty M, Zaisheng W, et al
    The changing patter of COVID-19 in China: A tempo-geographic analysis of the SARS-CoV-2 epidemic.
    Clin Infect Dis. 2020 Apr 15. pii: 5820681. doi: 10.1093.
    >> Share

  1595. LACOURSE SM, John-Stewart G, Adams Waldorf KM
    Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials.
    Clin Infect Dis. 2020 Apr 15. pii: 5820683. doi: 10.1093.
    >> Share

  1596. ARABI YM, Shalhoub S, Mandourah Y, Al-Hameed F, et al
    Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study.
    Clin Infect Dis. 2020;70:1837-1844.
    >> Share

  1597. MCATEER J, Yildirim I, Chahroudi A
    The VACCINES Act, Deciphering Vaccine Hesitancy in the Time of COVID19.
    Clin Infect Dis. 2020 Apr 13. pii: 5819529. doi: 10.1093.
    >> Share

  1598. DANIS K, Epaulard O, Benet T, Gaymard A, et al
    Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020.
    Clin Infect Dis. 2020 Apr 11. pii: 5819060. doi: 10.1093.
    >> Share

  1599. HOOLI S, King C
    Generalizability of COVID-19 Clinical Prediction Models.
    Clin Infect Dis. 2020 Apr 9. pii: 5818447. doi: 10.1093.
    >> Share

  1600. XU K, Chen Y, Yuan J, Yi P, et al
    Factors associated with prolonged viral RNA shedding in patients with COVID-19.
    Clin Infect Dis. 2020 Apr 9. pii: 5818308. doi: 10.1093.
    >> Share

  1601. GUO WL, Jiang Q, Ye F, Li SQ, et al
    Effect of throat washings on detection of 2019 novel coronavirus.
    Clin Infect Dis. 2020 Apr 9. pii: 5818370. doi: 10.1093.
    >> Share

  1602. ABU-RAYA B
    Predictors of refractory Coronavirus disease (COVID-19) pneumonia.
    Clin Infect Dis. 2020 Apr 9. pii: 5818313. doi: 10.1093.
    >> Share

  1603. LI G, Li W, He X, Cao Y, et al
    Asymptomatic and Presymptomatic Infectors: Hidden Sources of COVID-19 Disease.
    Clin Infect Dis. 2020 Apr 9. pii: 5818373. doi: 10.1093.
    >> Share

  1604. JI D, Zhang D, Xu J, Chen Z, et al
    Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score.
    Clin Infect Dis. 2020 Apr 9. pii: 5818317. doi: 10.1093.
    >> Share

  1605. LIGHTER J, Phillips M, Hochman S, Sterling S, et al
    Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission.
    Clin Infect Dis. 2020 Apr 9. pii: 5818333. doi: 10.1093.
    >> Share

  1606. CHU H, Chan JF, Wang Y, Yuen TT, et al
    Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19.
    Clin Infect Dis. 2020 Apr 9. pii: 5818134. doi: 10.1093.
    >> Share

  1607. ZHAO J, Liao X, Wang H, Wei L, et al
    Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV.
    Clin Infect Dis. 2020 Apr 9. pii: 5818121. doi: 10.1093.
    >> Share

  1608. YUAN J, Kou S, Liang Y, Zeng J, et al
    PCR Assays Turned Positive in 25 Discharged COVID-19 Patients.
    Clin Infect Dis. 2020 Apr 8. pii: 5817588. doi: 10.1093.
    >> Share

  1609. ALVAREZ-ARAGON LM, Cuesta-Munoz AL, Alvarez-Lopez I
    Inquiring into Benefits of Independent Activation of Non-Classical Renin-Angiotensin System in the Clinical Prognosis and Reduction of COVID-19 mortality.
    Clin Infect Dis. 2020 Apr 8. pii: 5817590. doi: 10.1093.
    >> Share

  1610. PERINEL S, Launay M, Botelho-Nevers E, Diconne E, et al
    Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.
    Clin Infect Dis. 2020 Apr 7. pii: 5816960. doi: 10.1093.
    >> Share

  1611. PERGAM SA
    Before the Flood.
    Clin Infect Dis. 2020 Apr 7. pii: 5816959. doi: 10.1093.
    >> Share

  1612. JI T, Chen HL, Xu J, Wu LN, et al
    Lockdown contained the spread of 2019 novel coronavirus disease in Huangshi city, China: Early epidemiological findings.
    Clin Infect Dis. 2020 Apr 7. pii: 5816958. doi: 10.1093.
    >> Share

  1613. SAITO M, Adachi E, Yamayoshi S, Koga M, et al
    Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan.
    Clin Infect Dis. 2020 Apr 2. pii: 5815296. doi: 10.1093.
    >> Share

  1614. QIU L, Liu X, Xiao M, Xie J, et al
    SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection.
    Clin Infect Dis. 2020 Apr 2. pii: 5815295. doi: 10.1093.
    >> Share

  1615. SCOTT SE, Zabel K, Collins J, Hobbs KC, et al
    First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States - Maricopa County, Arizona, 2020.
    Clin Infect Dis. 2020 Apr 2. pii: 5815221. doi: 10.1093.
    >> Share

  1616. MOMPLAISIR F
    The COVID-19 pandemic: we are all in this together.
    Clin Infect Dis. 2020 Apr 2. pii: 5814957. doi: 10.1093.
    >> Share

  1617. CAO J, Tu WJ, Cheng W, Yu L, et al
    Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China.
    Clin Infect Dis. 2020 Apr 2. pii: 5814897. doi: 10.1093.
    >> Share

    March 2020
  1618. XU J, Wu R, Huang H, Zheng W, et al
    Computed Tomographic Imaging of 3 Patients With Coronavirus Disease 2019 Pneumonia With Negative Virus Real-time Reverse-Transcription Polymerase Chain Reaction Test.
    Clin Infect Dis. 2020 Mar 31. pii: 5814104. doi: 10.1093.
    >> Share

  1619. DUDLEY JP, Lee NT
    Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea.
    Clin Infect Dis. 2020 Mar 31. pii: 5813861. doi: 10.1093.
    >> Share

  1620. NACHEGA JB, Seydi M, Zumla A
    The Late Arrival of COVID-19 in Africa - Mitigating Pan-Continental Spread.
    Clin Infect Dis. 2020 Mar 30. pii: 5813601. doi: 10.1093.
    >> Share

  1621. HAN X, Cao Y, Jiang N, Chen Y, et al
    Novel Coronavirus Pneumonia (COVID-19) Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section CT Features During Recovery.
    Clin Infect Dis. 2020 Mar 30. pii: 5813539. doi: 10.1093.
    >> Share

  1622. YU F, Yan L, Wang N, Yang S, et al
    Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients.
    Clin Infect Dis. 2020 Mar 28. pii: 5812997. doi: 10.1093.
    >> Share

  1623. ZHAO J, Yuan Q, Wang H, Liu W, et al
    Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019.
    Clin Infect Dis. 2020 Mar 28. pii: 5812996. doi: 10.1093.
    >> Share

  1624. WURCEL AG, Dauria E, Zaller N, Nijhawan A, et al
    Spotlight on Jails: COVID-19 Mitigation Policies Needed Now.
    Clin Infect Dis. 2020 Mar 28. pii: 5812998. doi: 10.1093.
    >> Share

  1625. LIAN J, Jin X, Hao S, Cai H, et al
    Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan.
    Clin Infect Dis. 2020 Mar 25. pii: 5811557. doi: 10.1093.
    >> Share

  1626. KLEMENT E, Godefroy N, Burrel S, Kornblum D, et al
    The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area.
    Clin Infect Dis. 2020 Mar 25. pii: 5811445. doi: 10.1093.
    >> Share

  1627. SUN Y, Koh V, Marimuthu K, Ng OT, et al
    Epidemiological and Clinical Predictors of COVID-19.
    Clin Infect Dis. 2020 Mar 25. pii: 5811426. doi: 10.1093.
    >> Share

  1628. GUASTALEGNAME M, Vallone A
    Could chloroquine /hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment?
    Clin Infect Dis. 2020 Mar 24. pii: 5811416. doi: 10.1093.
    >> Share

  1629. QIAN G, Yang N, Ma AHY, Wang L, et al
    A COVID-19 Transmission within a family cluster by presymptomatic infectors in China.
    Clin Infect Dis. 2020 Mar 23. pii: 5810900. doi: 10.1093.
    >> Share

  1630. GUO L, Ren L, Yang S, Xiao M, et al
    Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).
    Clin Infect Dis. 2020 Mar 21. pii: 5810754. doi: 10.1093.
    >> Share

  1631. FAN C, Lei D, Fang C, Li C, et al
    Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We Worry?
    Clin Infect Dis. 2020 Mar 17. pii: 5809260. doi: 10.1093.
    >> Share

  1632. RAN L, Chen X, Wang Y, Wu W, et al
    Risk Factors of Healthcare Workers with Corona Virus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China.
    Clin Infect Dis. 2020 Mar 17. pii: 5808788. doi: 10.1093.
    >> Share

  1633. WANG Z, Yang B, Li Q, Wen L, et al
    Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China.
    Clin Infect Dis. 2020 Mar 16. pii: 5807944. doi: 10.1093.
    >> Share

  1634. MO P, Xing Y, Xiao Y, Deng L, et al
    Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.
    Clin Infect Dis. 2020 Mar 16. pii: 5805508. doi: 10.1093.
    >> Share

  1635. SCHWARTZ J, King CC, Yen MY
    Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak -Lessons from Taiwan's SARS response.
    Clin Infect Dis. 2020 Mar 12. pii: 5804239. doi: 10.1093.
    >> Share

  1636. BRYSON-CAHN C, Duchin J, Makarewicz VA, Kay M, et al
    A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2).
    Clin Infect Dis. 2020 Mar 12. pii: 5804257. doi: 10.1093.
    >> Share

  1637. ZHAO D, Yao F, Wang L, Zheng L, et al
    A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias.
    Clin Infect Dis. 2020 Mar 12. pii: 5803302. doi: 10.1093.
    >> Share

  1638. WANG S, Guo L, Chen L, Liu W, et al
    A case report of neonatal COVID-19 infection in China.
    Clin Infect Dis. 2020 Mar 12. pii: 5803274. doi: 10.1093.
    >> Share

  1639. QIN C, Zhou L, Hu Z, Zhang S, et al
    Dysregulation of immune response in patients with COVID-19 in Wuhan, China.
    Clin Infect Dis. 2020 Mar 12. pii: 5803306. doi: 10.1093.
    >> Share

  1640. YAO X, Ye F, Zhang M, Cui C, et al
    In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Clin Infect Dis. 2020 Mar 9. pii: 5801998. doi: 10.1093.
    >> Share

  1641. MARCHAND-SENECAL X, Kozak R, Mubareka S, Salt N, et al
    Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS.
    Clin Infect Dis. 2020 Mar 9. pii: 5800047. doi: 10.1093.
    >> Share

  1642. SHEN Z, Xiao Y, Kang L, Ma W, et al
    Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients.
    Clin Infect Dis. 2020 Mar 4. pii: 5780800. doi: 10.1093.
    >> Share

  1643. WERTHEIM JO
    A glimpse into the origins of genetic diversity in SARS-CoV-2.
    Clin Infect Dis. 2020 Mar 4. pii: 5780151. doi: 10.1093.
    >> Share

  1644. MAXWELL DN, Perl TM, Cutrell JB
    "The Art of War" in the Era of Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2020 Mar 4. pii: 5800048. doi: 10.1093.
    >> Share

    February 2020
  1645. WU J, Liu J, Zhao X, Liu C, et al
    Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study.
    Clin Infect Dis. 2020 Feb 29. pii: 5766408. doi: 10.1093.
    >> Share

  1646. WANG X, Zhou Z, Zhang J, Zhu F, et al
    A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery.
    Clin Infect Dis. 2020 Feb 28. pii: 5771323. doi: 10.1093.
    >> Share

  1647. KAM KQ, Yung CF, Cui L, Lin Tzer Pin R, et al
    A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load.
    Clin Infect Dis. 2020 Feb 28. pii: 5766416. doi: 10.1093.
    >> Share

  1648. TAY JY, Lim PL, Marimuthu K, Sadarangani SP, et al
    De-isolating COVID-19 Suspect Cases: A Continuing Challenge.
    Clin Infect Dis. 2020 Feb 26. pii: 5758073. doi: 10.1093.
    >> Share

  1649. TO KK, Tsang OT, Chik-Yan Yip C, Chan KH, et al
    Consistent detection of 2019 novel coronavirus in saliva.
    Clin Infect Dis. 2020 Feb 12. pii: 5734265. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016